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Abstract 
The objective of this thesis was to develop and prepare multifunctional magnetic 
nanoparticles with targeting and bimodal imaging capabilities for cancer diagnostic 
applications.  
Superparamagnetic iron oxide nanoparticles (SPIONs) were the key component in the 
multifunctional nanoparticles prepared. In a first approach, alkoxysilane ligands were 
used to introduce functional groups such as amino, bromo, iodo, nitrile, and vinyl on the 
surface of SPIONs. Physicochemical analyses showed that each silane ligand formed a 
dense silane monolayer covalently attached to the nanoparticle surface. The amino-
functionalised SPIONs were successfully modified yielding amino and carboxylic acid-
bifunctionalised SPIONs using a succinylation reaction. This nanoparticle system 
showed no cytotoxicity during cell viability evaluations. Further conjugation with 
fluorescent dye and antibodies produced targeted bimodal optical/magnetic resonance 
imaging (MRI) agents, confirmed by good contrast enhancement capabilities. The 
conjugated antibody successfully enabled the targeted delivery of SPIONs to pancreatic 
cancer cells in vitro. The targeting efficiency and the nanoparticle cellular uptake were 
monitored using fluorescence and confocal microscopy.  
In a second approach, hydrophobic and monodisperse SPIONs were coated with 
amphiphilic polyoxazoline to produce colloidally stable magneto-micelles. This 
magneto-micellar system showed high colloidal stability in water, phosphate buffered 
saline as well as at different pH values. Fluorescent dyes were successfully co-
assembled into the magneto-micelles providing for the localisation of the nanoparticles 
in the cells by confocal microscopy. Antibodies conjugated to nontoxic magneto-
micelles allowed for binding to specific receptors present on pancreatic cancer cells. The 
targeting efficiency and accumulation of the antibody labelled magneto-micelles into 
pancreatic cancer cells was evaluated using live cell confocal microscopy. Their 
performance as MRI contrast agents was evaluated using relaxivity measurements and it 
was shown that the clustering effect of the SPIONs within the core of the micelle is 
particularly favourable for enhancing the contrast on MRI images. Both approaches 
provided efficient routes of preparation of multifunctional platforms to achieve the 
desired targeting and bimodal imaging capabilities. 
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Chapter 1  
Introduction - Superparamagnetic iron oxide nanoparticles in 
biomedicine 
1.1 Overview 
Nanomaterials have significantly influenced modern science and have found their way 
into important applications such as information storage1-3, catalysis,4-5 sensing,6-8 energy 
storage,9-10 coatings,11-12 food industry,13 water purification14 and biomedicine.15-16 
Biomedicine is a particularly promising direction for nanosciences as it can potentially 
transform the current therapeutic and diagnostic techniques. 
Amongst all types of nanomaterials, superparamagnetic iron oxide nanoparticles 
(SPIONs) are perhaps the most studied type of nanoparticles for biomedicine. The high 
interest for using SPIONs for biomedical diagnosis and therapy is attributed to their 
superparamagnetic properties at room temperature (actuated by an external magnetic 
field but no magnetic remanence once the field has been removed), biocompatibility, 
and low cost. While the in vivo application of other types of nanoparticles is still 
impeded by concerns over their toxicity, SPIONs have received the approval of the Food 
and Drug Administration (FDA) for clinical use in humans, for example, as magnetic 
resonance imaging (MRI) signal enhancers and hyperthermia therapeutical agents.17-18  
Three key biomedical areas of application of SPIONs, diagnosis, therapy and 
separations, are shown in Figure 1.1. Within these areas there are several specialised 
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domains such as cell isolation,19-20 bio-sensing,21-22 drug delivery,23-26 hyperthermia 18,27 
and MRI.15,28-29  
 
 
Figure 1.1 Possible areas of application for superparamagnetic iron oxide nanoparticles. 
The schematic is taken from ref. 30  
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This chapter will review some of the most recent work with respect to synthesis, surface 
modification and functionalisation of SPIONs. The recent advances of SPIONs 
application in MRI, hyperthermia, drug delivery and the current tendency of combining 
SPIONs with other functional components to form multifunctional nanocomposites will 
be reviewed as well in this chapter. 
1.2 Synthesis of SPIONs  
1.2.1 Background on magnetic properties 
An unpaired electron which rotates around its own axis has a “spin”. The spin induces a 
magnetic moment that means that the electron behaves as a small magnet. Therefore, the 
availability of unpaired electrons in a substance can lead to a variety of magnetic effects. 
Applying an external magnetic field to a material aligns the electrons within the field. In 
this case, the material is magnetised and responds with a force to the field. As a result 
the value of the magnetisation, M is proportional to the magnetic field, H and is defined 
as: 
                                                                 (1.1) 
The proportion constant χ is called susceptibility.  The susceptibility can depend on the 
number of oriented electrons per mol (χmol), volume (χvol) or gram (χg) of the material.  
As both M and H can be measured with high precision, for example, by measurements 
in superconducting quantum interference device (SQUID), the magnetic properties of 
solid materials can be evaluated and divided depending on the value of χ. 
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χ <0 – diamagnetic 
χ >0 – paramagnetic 
χ >>0 – ferro- or ferrimagnetic 
Substances, which have only paired electrons, are called diamagnetics. Quantum theory 
allows only two orientations of the electron spins with identical quantum number.  
Therefore, two paired electrons, which are characterised by magnetic spin number 
ms=S=+1/2 (spin up) or ms=S=-1/2 (spin down), would compensate each other. 
Diamagnetics show only weak magnetic response by being expelled from the applied 
magnetic field due to a weak electromagnetic field generated by rotating electrons. 
Diamagnetism is a property of every material due to eminent presence of paired 
electrons. 
Paramagnetics are characterised by presence of unpaired electrons which are randomly 
oriented on different atoms within the material. If an external magnetic field is applied 
to this material the electron spins tend to align themselves in the field and the material is 
magnetised as shown in the Figure 1.2a. Switching the field off returns the material into 
its original state due to the thermal motion. Thermal motion randomises the orientation 
of the electrons and therefore, the higher the temperature the smaller is the 
magnetisation of the paramagnetic material in an applied field. 
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Figure 1.2 Dependence of magnetisation (M) from applied magnetic field (H) for (a) a 
paramagnetic compound, LaCuO3 at T=100K and (b) superparamagnetic Fe3O4 
nanoparticles at T=300K. Reproduced from ref. 31 and 32  
In a ferro- and ferrimagnetic material the unpaired electrons are parallel to each other 
and act cooperatively. Due to magnetic domain formation, the magnetisation in such 
materials does not return to zero if the applied field is removed. Therefore, unlike 
paramagnetics, where thermal fluctuations negate alignment of the unpaired electrons, 
ferro- and ferrimagnetics show very strong magnetic properties. The cooperative action 
 
a)
b)
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of the unpaired electrons within adjusted domains prevents the misalignment which 
helps to retain the individual magnetic moments of the atoms lined up even in a zero 
field. Ferro- and ferrimagnets are important industrial materials and are used in 
electromagnets, generators, transformers and hard disks due to their magnetic properties. 
Magnetite, Fe3O4 is a particularly interesting example which is used in water 
decontamination, in catalysis or in magnetic storage.33-34  
Bulk magnetite, Fe3O4 is ferrimagnetic and crystallizes in an inverse spinel structure 
type.35 Within the structure there are two types of Fe cations – Fe2+ and Fe3+ which are 
coordinated tetrahedrally and octahedrally by oxygen atoms. Both Fe2+ and Fe3+ cations 
are in a high spin configuration that means they have four and five unpaired electrons 
respectively. However, in magnetite the unpaired electrons from Fe3+ cations 
compensate each other and the net magnetic moment originates only from the Fe2+ 
cations as shown in the Figure 1.3. In the bulk due to the presence of magnetic domains 
Fe3O4 shows very similar behaviour to a typical ferromagnetic material, for example, 
remanent magnetisation after the applied field is zero. However, if the magnetic 
domains in magnetite could be individually isolated, for example, in a form of magnetite 
(Fe3O4) nanoparticle, this can lead to an interesting property called 
superparamagnetism. 
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Figure 1.3 Spin arrangement in Fe3O4. The unpaired electrons from the Fe
3+ cations are 
compensating each other and the net moment is from four unpaired electrons from the 
Fe2+ cation which are shown in red.  
In a superparamagnetic state the material behaves paramagnetic while retaining the 
exceptionally strong magnetic properties of the corresponding bulk ferro- or 
ferrimagnetic material. For example, superparamagnetics show no remanent magnetic 
moment after applied field is switched to zero (Figure 1.2b). This effect makes 
superparamagnetic materials such as Fe3O4 nanoparticles especially appealing for 
biomedical applications as they can be manipulated by magnetic field without induced 
aggregation.  
Superparamagnetism is observed in iron oxide nanoparticles with sizes between 2 and 
30 nm.29 Within the nanoparticle the unpaired electrons are aligned and as a result each 
nanoparticle possesses an individual magnetic moment. However, as the nanoparticles in 
a superparamagnetic material consist of a single magnetic domain the thermal energy is 
enough to induce random fluctuations of the magnetic moments. The fluctuation of the 
magnetic moment of each nanoparticle is then determined by equation 1.2:     
    
       exp 


                                                    (1.2), 
Octahedrally 
coordinated Fe
Tetrahedrally
coordinated Fe
Fe3+ (3d5) with S=5/2
Fe3+ (3d5) with S=5/2
Fe2+ (3d6) with S=2
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where τ is the mean time between flips, τ0 is the relaxation time at one orientation, K is 
the magnetic anisotropy constant of the nanoparticle, V is the particle volume, kB is the 
Boltzmann constant and T is the temperature.  
From this equation it is evident that the nanoparticle volume (V) plays an important role 
in determining the superparamagnetic character. As the size of a nanoparticle decreases 
to a level where KV (free-energy barriers) becomes comparable to kBT (thermal 
energy), its magnetic moment starts to fluctuate from one orientation to another, leaving 
the overall magnetisation zero. Therefore, superparamagnetic nanoparticles exhibit a net 
magnetisation only when submitted to an external magnetic field and relax to the initial 
state once the field has been removed. 
Magnetite (Fe3O4) and maghemite (γ-Fe2O3) are two forms of iron oxide nanoparticles 
which are commonly used for biomedical applications.36-37 In the biomedical field the 
two forms are not distinguished and are generally called SPIONs. In bulk form iron 
oxides are strongly magnetic with saturation magnetisation values reaching 92 emu/g 
and 78 emu/g for magnetite and maghemite respectively. For the corresponding 
nanoparticle forms of iron oxides the saturation magnetisation is lower and is attributed 
to the size decrease and surface effects.38-41  
1.2.2 Characterisation of nanoparticles 
The characterisation of the physicochemical properties of nanoparticle is very important 
because these properties will determine their behaviour in the human body. This section 
provides a summary of the characterisation techniques that were used in this thesis 
Cristina I. Olariu                                                                                                                           Introduction 
 
9 
 
together with the advantages and disadvantages associated with the use of each 
technique.  
Transmission electron microscopy (TEM), X-ray diffraction (XRD) and dynamic light 
scattering (DLS) are three common methods which are used for evaluation of the size of 
the nanoparticles. The TEM operates by recording the interaction between electron and 
the analysed material using a digital camera. Due to the short wavelength of the 
electrons of 0.1nm TEM is capable of resolving small details in a material down to 
atomic level.42  Therefore, this technique can provide information about the size as well 
as the mono- or polydispersity of nanoparticles in the sample. Additionally it can give 
information about the morphology and aspect ratio of the nanoparticles. However, this 
technique requires sufficient electron densities in order to produce high quality TEM 
imaging because polymeric shells and organic ligands are poor scatters of the electron 
and appear transparent in an electron beam. Therefore, heavy-metal special staining or 
cryogenic methods are required for achieving enhanced contrast. Additionally an 
analysis by image treatment on a statistically significant number of particles is required 
in order to achieve a proper representation of the sample. Sample preparation can 
sometimes induce aggregation of the nanoparticles and as a result TEM measurements 
may be non-representative of the size and the distribution of the nanoparticles in a 
solution. Finally, the method is extremely time consuming, expensive to operate and 
subject to the operator abilities. 
Powder X-ray diffraction (XRD) can be used to provide information about the size of 
the iron oxide cores. This is a bulk method that means it can give representative 
information for a whole sample. In addition to probing the size of nanoparticles it can be 
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used for assessment of phase composition and potential impurities. It is easy to perform 
and does not require sophisticated preparation of the probe. The size of the nanoparticles 
can be calculated using the Scherrer equation, where the nanoparticles diameter is 
inversely proportional to the crystalline peak width:  
      


      (1.3), 
Where τ- is the particles size, β- is the line broadening at half the maximum intensity 
(FWHM), k- the shape factor (k=0.9), λ- is the X-ray wavelength (Mo, λ = 0.7107 Å), θ- 
is the Bragg diffraction angle.   
The major drawback of this method is that it can only be applied for crystalline 
materials and assumes a spherical shape of the nanoparticles. This method does not 
provide information about the morphology of the nanoparticles.  However, it is an 
excellent complementary tool to TEM for confirmation the size of the nanoparticles, e.g. 
Fe3O4 cores. 
DLS is a technique that can be used to determine the hydrodynamic size and the size 
distribution of nanoparticles in solution. During the DLS measurements, a laser beam 
passes through a sample (nanoparticle dispersion) and the light is scattered by the 
nanoparticles in solution. Small time-dependent fluctuations in the intensity of the 
scattered light are monitored using a photodetector. These fluctuations in the intensity 
are due to the nanoparticle Brownian diffusion and are dependent on the nanoparticle 
size. The Stokes-Einstein equation relates the diffusion coefficient (D) to the 
hydrodynamic diameter of the nanoparticles by taking into account the viscosity of the 
solution and the temperature during measurement: 43 
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Where kB is the Boltzmann constant, T is the temperature, η is the viscosity and R is the 
particle radius. The hydrodynamic diameter obtained from this technique corresponds to 
that of a rigid sphere (equivalent-sphere hydrodynamic diameter) that diffuses at the 
same rate as the measured nanoparticle. In a DLS measurement the equivalent-sphere 
hydrodynamic diameter is assumed and therefore no information can be provided about 
the shape of the particles.  For a non-spherical particle the shape would be assumed as 
diameter of a sphere with a corresponding diffusion coefficient. As a result this 
technique is non-reliable for non-spherical shaped particles. Furthermore, the intensity 
of scattered light is proportional to the diameter of the nanoparticles to the power of 6th 
(from Rayleighs approximation) and therefore, larger nanoparticles scatter more the 
light comparing to smaller nanoparticles. The size dependence of the scattered intensity 
of light will skew the results towards the larger nanoparticles. The advantage of DLS is 
rapid measurement times, along with facile operation and suitability for qualitative 
monitoring of agglomeration.44 Therefore, it is common to complement TEM and XRD 
with DLS measurements. 
1.2.3 Synthetic methods 
In general, it is desirable that the synthetic process of nanoparticles should be high-
throughput with the ability to scale to industrial level, high reproducibility from batch to 
batch, inexpensive and capable of producing monodisperse nanoparticles. Several 
synthetic methods to produce SPIONs have been intensively investigated for more than 
30 years including co-precipitation, hydrothermal synthesis, microemulsion and thermal 
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decomposition (thermolysis).29 Two methods were chosen for this work: the co-
precipitation and thermal decomposition as they can deliver high-scale synthesis and 
monodisperse nanoparticles respectively. Therefore, they will be discussed here in more 
details. 
The most early and widely used synthetic method is based on the alkaline co-
precipitation of iron salts in aqueous solution. Specifically, ferrous and ferric salts (Fe+2 
and Fe+3) are co-precipitated under aqueous conditions with a strong base (NH4OH or 
NaOH) to yield either magnetite (Fe3O4) or maghemite (γ-Fe2O3) according to equations 
1.5 and 1.6: 
Fe2+ +2Fe3+ + 8OH- → Fe3O4 + 4H2O  (1.5) 
Fe3O4 + 2H+→ γ-Fe2O3 + Fe2+ + H2O  (1.6) 
The co-precipitation method can produce SPIONs coated with surface stabilisers in a 
one-pot reaction either during or after the synthesis.45-49 Various polymers, such as 
dextran, poly-vinyl alcohol (PVA) or poly-lactic-co-glycolic acid (PLGA) can be added 
during the synthesis in order to stabilise the nanoparticles from agglomeration.50-52 The 
polymers are non-specifically interacting with the nanoparticle surface via hydrogen 
bonding. However, this type of interaction makes the polymer susceptible to detachment 
from the SPIONs surface leading to agglomeration of nanoparticles.23,53  
The major advantages of the co-precipitation method are the operational simplicity and 
scaling-up possibilities up to kilogram levels. The disadvantages are poor shape control 
and broad size distributions of nanoparticles (Figure 1.4); in addition reduced 
nanoparticle crystallinity can be a significant problem when the synthesis is carried out 
at room temperature.45,48,54 
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Figure 1.4 Representative TEM image of superparamagnetic iron oxide nanoparticles 
produced by co-precipitation method. The image is taken from ref. 45 
Major improvements with respect to nanoparticle size control and magnetic properties 
were obtained with the movement from low-temperature co-precipitation methods 
towards thermolytic procedures. These methods rely on the high temperature pyrolysis 
of iron-organic ligands in the presence of capping agents such as oleic acid.55-60 The 
types of iron-organic ligand precursors used in organic phase synthesis of SPIONs are 
iron cupferron Fe(Cup)3, iron pentacarbonyl Fe(CO)5, iron acetylacetonate Fe(acac)3 
and iron oleate, structures shown in Figure 1.5.  
Alivisatos and co-workers used the injection of iron cupferron precursor into hot 
trioctylamine at 300 °C to produce single-crystal maghemite (γ-Fe2O3) nanoparticles of 
10 nm with 10–15% size distribution.55 Trioctylamine acts as coordinating ligand and as 
a high boiling point solvent.   
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Figure 1.5 Structure of iron-organic ligand precursors used in the high temperature 
synthesis of iron oxide nanoparticles: a) iron cupferron, b) iron pentacarbonyl, c) iron 
acetylacetonate and d) iron oleate.  
Significant improvement was achieved by Hyeon et al. who utilised iron pentacarbonyl 
precursors for the synthesis of monodisperse maghemite (γ-Fe2O3) nanoparticles.56 The 
precursor was injected into a hot solution of oleic acid, oleylamine and 1,2-
hexadecanediol in octyl ether. The initially formed Fe metal nanoparticles were 
subsequently oxidised to maghemite using trimethylamine oxide as a mild oxidant.  
The same group demonstrated the synthesis of iron oxide nanoparticles with sizes 
ranging from 4 to 15 nm with one-nanometer defined control.57 Monodisperse iron 
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nanoparticles with 4, 8 and 11 nm were obtained from thermal decomposition of iron 
pentacarbonyl precursor with oleic acid at 1:1, 1:2 and 1:3 molar ratios. Iron 
nanoparticles with particle sizes of 6, 7, 9, 10, 12, 13 and 15 nm were synthesised by a 
seed mediated growth process (Figure 1.6). The process involved using different ratios 
of the nanoparticles seeds and iron oleate, pre-prepared by heating appropriate amounts 
of iron pentacarbonyl and oleic acid in dioctyl ether. 
 
Figure 1.6 TEM images of monodisperse iron oxide nanoparticles of a) 6-, b) 7-, c) 8-, d) 
9-, e) 10-, f) 11-, g) 12-, and h) 13-nm showing the one nanometer level increments in 
diameter. The images are taken from ref. 49  
Similarly, synthesis of monodisperse magnetite (Fe3O4) nanoparticles was established 
for the first time by Sun et al.58,60 The group used another type of iron-organic ligand 
precursor, namely iron acetylacetonate, which has evolved to be the most typical 
precursor for synthesis of metal oxide nanoparticles. In this synthetic procedure a 
mixture of iron acetylacetonate, 1,2-hexadecanediol, oleylamine and oleic acid in benzyl 
ether (high boiling solvent) are stepwise heated to reflux. 1,2-hexadecanediol is used as 
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reducing agent, while oleylamine and oleic acid are used as capping molecules which 
restrict the nanoparticles growth. This method was adopted for some of the work 
presented in this thesis and is further detailed in Chapter 5. Another advantage offered 
by this method is that the magnetic properties of nanoparticles can be tuned by changing 
the chemical composition of the initial precursor.58,61 For instance, other types of metal 
oxide nanoparticles such as MFe2O4 (M = Mn, Co or Ni) were synthesised by mixing 
the corresponding M(acac)2 (M = Mn, Co, or Ni) and Fe(acac)3 in an 2:1 ratio and 
following the same synthetic procedure. 
At the same time, stimulated by the idea that metal carboxylate salts are generated in 
situ during the thermolytic methods described previously, other groups have adopted 
iron-carboxylate salts (iron-oleate) as staring materials for the synthesis of iron oxide 
nanoparticles.59,62-63 It is known that metal carboxylate complexes decompose at 
elevated temperatures and metal oxides are common decomposition products.64-65 One 
notable procedure was reported by Park et al. who used iron chloride and sodium oleate 
first to form the iron oleate complex. In a second step, this complex was decomposed in 
1-octadecene and yielded tens of grams of monodisperse iron oxide nanoparticles in a 
single pot reaction.59  
The thermolytic methods are therefore generally more favoured due to the flexibility of 
the organic solvent for dissolving various precursors and surfactants that contribute to 
the control of nucleation and growth.66 Large-scale synthesis of iron oxide nanoparticles 
using the thermolytic method is already achievable when the synthesis parameters such 
as precursors, surfactants, heating rate and boiling point (solvent choice) are carefully 
considered and controlled.  
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The thermolytic methods reviewed here produce hydrophobic SPIONs which are 
insoluble in water as their surface is capped by the surfactant molecule used during the 
synthesis. A direct application of such SPIONs in a living organism would cause an 
immediate threat to health, since they would produce the embolisation of blood vessels 
and obstruct the blood circulation. It is therefore necessary to exchange the hydrophobic 
protection shell with hydrophilic coatings which are compatible with the physiological 
environment.  
1.3 Surface coating and functionalisation 
Coating of the SPION surface is important because it determines the fate of the 
nanoparticle in the physiological environment. Ideally the coating material should have 
high affinity for the SPION surface, be able to provide organic functional groups for 
conjugation of biomolecules as well as be nonimmunogenic and minimise the 
interaction with plasma proteins. Finally, it should provide colloidal stability so the 
nanoparticles would be able to resist agglomeration and precipitation. Colloidal stability 
can be achieved either by electrostatic or by steric repulsion as exemplified in Figure 
1.7. 
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Figure 1.8 Small molecules containing carboxylic acid, catechol, silane, and phosphonic 
acid functionalities used for surface coating of SPIONs. Figure is adapted from ref. 68 
Each type of anchoring functionality has advantages and disadvantages as can be 
illustrated by the following examples.  
Organic ligands containing carboxylic acid functionality, such as citric or oleic acid, 
bind with the surface of iron oxide nanoparticle by coordination interactions.69-70 The 
carboxylic groups bind to the iron ions 
 
in a bidentate coordination configuration.71 
However, the coordination bond can become unstable under certain conditions including 
temperature increase or acidic environment and therefore, induce detachment of the 
coating and precipitation of the nanoparticles.68  
Small organic ligands containing catechol groups, such as dopamine, have been reported 
to have strong affinity for the surface of SPIONs.72-73  The catechol functional groups 
bind to the surface of iron oxide nanoparticles also via coordination interactions. 
However, it has been reported that catechol groups  of dopamine are displaced from the 
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nanoparticle surface and undergo redox transformations (Figure 1.9).74 These processes 
promote the loss of colloidal stability leading to the precipitation of nanoparticles. The 
main advantage of using such ligands is associated with the rich chemistry they provide 
for post-functionalisation and bioconjugation reactions.  
 
Figure 1.9 Schematic representation of the proposed mechanism for the decomposition of 
iron oxide nanoparticles by dopamine in an aqueous solution. The figure is taken from ref. 
74 
Small ligands containing phosphonic acid functional groups, for example 
dodecylphosphonic acid or hexadecylphosphonic acid, were also employed for coating 
the surface of SPIONs.75-76 The phosphonic acid functionality interacts with the surface 
metal ions also via coordination bonds.77 In a comparison study, which looked at oleic 
acid and dodecylphosphonic acid coated SPIONs, it was shown that both types of 
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ligands generate SPIONs dispersible in organic solvent but the phosphonic acid coated 
nanoparticle are less colloidally stable than their oleic acid counterparts.75  
The small ligands presented up to now rely on the coordinative attachment of their 
organic functional groups to the metal ions of the SPIONs surface. As alternatives, 
alkoxysilanes are frequently utilised to coat the surface of SPIONs due to their ability to 
form stable covalent bonds with metal oxide surfaces.78-82 The process is usually termed 
as silanisation and offers a viable approach for surface functionalisation of SPIONs due 
to the high stability of the bond between the ligand and the nanoparticle. As there are 
many commercially available functional silane ligands the process can supply a range of 
organic functionalities at the periphery of SPIONs which can be used for subsequent 
bioconjugations. In addition, the alkoxysilanes generate a biocompatible and thin silica 
monolayer on the surface of nanoparticles which provides protection for the 
nanoparticle core against the electrolytes present in the physiological fluids.83 The 
potential drawback of the silanisation process is the chance of inducing particle 
agglomeration during the reaction. However, the agglomeration can be overcome by 
using dilute nanoparticles dispersions, controlled silane concentrations and catalysts to 
promote the condensation reaction predominantly on the nanoparticle surface.79 
1.3.2 Surface coating using polymers  
Hydrophilic polymers, particularly dextran,84-86  polyethylene glycol (PEG)87-90 and 
polyacrylic acid (PAA) 91-94 are very common coatings for SPIONs. The structures of 
these polymers are shown in Figure 1.10.  
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Dextran was the first generation of material used for coating SPIONs (Figure 1.8a). It 
contains multiple hydroxyl groups which provide fairly stable hydrogen bonding 
interaction between the SPIONs and the polymer.  
 
Figure 1.10 Examples of hydrophilic polymers employed for SPIONs surface coating, a) 
dextran, b) polyethylene glycol (PEG) and c) polyacrylic acid (PAA).  
All clinically approved SPIONs for use in MRI are almost exclusively coated with 
dextran and its derivates due to biocompatibility (dextran is clinically approved by FDA 
as an anticoagulant), affinity to the SPIONs surface and simplicity of coating procedures 
which can be achieved during the synthesis of SPIONs via the co-precipitation 
method.53,95 However, the dextran coating can detach from the SPIONs surface, 
especially, when post-modification reactions for conjugation of biomolecules are 
desired.23 One way to address the stability issues has involved cross-linking of the 
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dextran shell with epichlorohydrin to form cross-linked iron-oxide (CLIO) 
nanoparticles.96 Although this platform has shown promising results due to non-
biodegradability it has not been tested in clinical applications.  
Polyethylene glycol (PEG) is the most widely used synthetic polymer for coating the 
surface of  SPIONs owing to its hydrophilicity and protein resistant properties, i.e 
stealth properties97 (Figure 1.10b). For example, carboxylic acid-terminated PEG 
coated SPIONs have been synthesised using thermal decomposition of iron 
acetylacetonate in 2-pyrrolidone and α,ω-dicarboxylterminated PEG.88 Investigators 
demonstrated that these SPIONs have good colloidal stability and free carboxylic groups 
accessible for further functionalisations. A more sophisticated design was implemented 
by Kohler et al.82 who have used a tailored bifunctional PEG containing a silane at one 
terminus and an amino functional group at the other. The silane terminus was covalently 
attached to the nanoparticle surface while the amino groups were conjugated with folic 
acid which acted as a targeting ligand for tumour cells.   
Polyacrylic acid (PAA) is a synthetic anionic polymer which is hydrophilic and capable 
to coordinate with the SPIONs surface (Figure 1.10c). PAA coated SPIONs show good 
aqueous dispersibility due to both electrostatic and steric repulsion induced through the 
coating.  Zhang et al.93 transferred the hydrophobic SPIONs into water by using a ligand 
exchange procedure in which hydrophilic PAA chains replaced the original oleic acid 
ligands. PAA binds to the nanoparticle surface through multiple carboxylic acid groups, 
providing more robust surface adhesion than the original oleic acid.  
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In general, PEG-phospholipids are the most widely used amphiphilic polymers for 
coating of hydrophobic SPIONs due to the protein resistant properties offered by the 
PEG segment which enhance the nanoparticle ‘stealth’ behaviour in the biological 
environment.97,99-102 Additionally this amphiphilic polymer is commercially available 
with a variety of chain-end functional groups such as amino, carboxylic acid or thiol 
which allow for bioconjugation reactions (Figure 1.12).  
 
Figure 1.12 Amphiphilic PEG-phospholipids with different terminal functional groups 
such as amino, carboxylic acid, thiol or biotin. 
Park et al.100 synthesised SPIONs coated with PEG-phospholipids using a one-step 
nanoemulsion method (Figure 1.13). The authors showed that the amphiphilic polymer-
coated SPIONs were less than 30 nm in diameter and have high dispersibility and 
stability under physiological conditions for weeks without aggregation.  
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Polyoxazolines offer more versatile structures because of the greater variety of initiators, 
monomers and chain-end functionalities which can be used during their synthesis. 
Additionally polyoxazolines bearing short alkyl substituent are water-soluble, 
biocompatible and have been approved by the FDA as a food additive.107  
Therefore, in this thesis, amphiphilic polyoxazoline containing a C16 alkyl chain at one 
terminus and a carboxylic acid group at the other end was investigated as a coating 
material for hydrophobic SPIONs.  The carboxylic acid groups present at the periphery 
of the micelle corona have been used for functionalisation with antibody molecules.  
1.3.3 Biocompatibility and biodistribution of SPIONs 
One of the key advantages for using SPIONs in biomedical applications is their 
biocompatibility. Although different SPIONs have different fates in the human body 
depending on composition of the coating and the iron oxide core, standard toxicological 
tests have shown that iron oxides are safe to be used in the human body.108-110  
In most cases, such as MRI, drug delivery or hyperthermia, SPIONs are subject to 
intravenous administration, and reach the targeted tissues through blood circulation. The 
biodistribution and elimination of the nanoparticles depend on their hydrodynamic size 
and the nature of the surface coating.  
A maximum size requirement is given by the spleen filaments which are spaced at 
roughly 200 nm.111 Similarly, to traverse the liver, nanoparticles must be small enough 
to pass through the liver 150-200 nm sized fenestrated capillaries and avoid the Kupffer 
phagocytic cells.112 However, nanoparticles smaller than 10 nm are easily subjected to 
renal clearance and can be rapidly removed from the circulation.113 Hence, nanoparticles 
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with diameters between 10 and 200 nm are considered to be optimal for intravenous 
administration.  
The SPIONs biodistribution can also depend on the nature of the surface coating. Once 
injected intravenously, the SPIONs are exposed to the plasma proteins including 
opsonins which can adsorb onto the nanoparticle surface, a process called opsonisation. 
The adsorbed opsonins will enhance the elimination of the SPIONs from circulation 
through the macrophages belonging to the mononuclear phagocytic system (MPS). In 
this context some coating materials, like PEG and more recently polyoxazolines, are 
recognised for their capability of resisting opsonisation, hence increasing the SPIONs 
blood circulation time.114-115  
The SPIONs which are taken up by the cells, either by the phagocytic cells or the 
targeted cells, will be eventually degraded by intracellular digestive enzymes. The 
dextran coating was reported to be eliminated in the urine after degradation,116 while 
iron from the cores is metabolised in the liver and subsequently used in the formation of 
red blood cells or excreted via kidneys.17 Although iron is an essential nutrient, it can be 
toxic when very large amounts are ingested. In MRI diagnostics the recommended dose 
for humans is 0.56 mg iron/kg body weight in case of Feridex I.V. which is much lower 
than the human total iron stores of 3500 mg.113 Therefore if SPIONs are administered 
within the safe limits, the body has the ability to metabolise and finally eliminate them. 
However for each type of new SPION the safe limits have to be determined via 
toxicological safety studies.   
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1.3.4 Bioconjugations  
Coating the surface of SPIONs with a protective shell is important for colloidal stability 
and biocompatibility. However, the shell should additionally provide functional groups 
for the bioconjugation of active targeting ligands. Such nanoparticles are able to reach 
the tumour sites via a mechanism called active tumour targeting and significant amount 
of research has been put into achieving this goal.23  
To achieve the active targeting requirement, the coating material should have chemically 
active functional groups, such as amines, carboxylic acids or thiols. The functional 
groups can react with the active groups on the biomolecules directly or via an 
intermediate activation step (Table 1.1 and 1.2).23 For example, SPIONs with PEG-
silane coatings containing multiple amino groups cannot be directly conjugated with 
thiol-containing targeting peptides. The amino groups have to be converted to an 
iodoacetyl functionality which is reactive towards the thiol-containing peptides, for 
example chlorotoxin. Such nanoparticle bioconjugates were shown to be able to target 
brain cancer cells in vitro and to be detectable by MRI analysis.117  
Carbodiimide coupling chemistry is another frequently employed strategy for chemical 
conjugation of bioactive molecules. For example, the carboxylic acid groups present on 
the surface PEG-coated SPIONs formed a covalent amide bond with single chain Fv 
antibody fragments (scFv) after activation with EDC/NHS as catalyst.118 The scFv-
SPION conjugates were able to specifically bind to the Carcinoembrionyc antigen-
expressing cancers cells in vitro. Therefore surface functional groups play an important 
role at the last chemical design stage, when the conjugation of biomolecules is required 
for achieving tumour active targeting.  
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Table 1.1 Examples of direct bioconjugation chemistry on SPIONs surface.  
Nanoparticle Reactive ligand Conjugate Notes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stable link 
 
 
Cleaved under 
acid conditions 
 
 
 
 
 
 
 
 
 
 
 
 
Interparticle 
disulfide linkage 
may form 
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Table 1.2 Examples of bioconjugation chemistry using intermediate activation.  
Nanoparticle Intermediate 
activation 
Reactive 
ligand 
Conjugate Notes 
 
 
 
 
 
 
EDC/NHS  
 
 
Thionyl chloride 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stable  
link 
 
 
 
Cleaved 
in 
alkaline 
condition  
 
 
 
 
 
Iodoacetyl 
 
Maleimide 
Pyridyl Disulfide 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stable 
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Sulfhydryl 
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1.4 Applications of SPIONs in biomedicine 
1.4.1 Magnetic resonance imaging (MRI)  
MRI is a non invasive imaging technique for visualisation of the structure and function 
of soft tissues in the body. It relies on the property of the hydrogen protons to align and 
precess in the presence of an applied magnetic field (B0) generated by the MRI scanner. 
Upon application of a transverse radiofrequency pulse, these protons are perturbed from 
their initial alignment in the direction of B0. When the magnetic field is turned off, a 
relaxation phenomenon takes place and these protons return to their original state from 
the excited state. Two independent processes, called longitudinal relaxation (T1) and 
transverse relaxation (T2), can be monitored to generate an MRI image.  The image 
contrast is based upon the local variation in relaxation which arises from proton density 
as well as the chemical and physical nature of the tissue under investigation.119 To 
obtain more well-defined structural images, contrast agents can be utilised during the 
imaging recording procedure. The role of the constrast agent is to decrease relaxation 
times of the tissues, either T1 or T2, depending on the nature of the contrast agent.120  
Typically, gadolinium based agents are clinically used to modify T1 relaxation,121 
producing brighter images (hyperintensity), while SPIONs are used as T2 contrast agent, 
producing a darker contrast (hypointensity) on the MR image, corresponding to the 
tissue area where they are accumulated (Figure 1.15).120 Clinically approved SPIONs 
for MRI contrast enhancement are summarised in Table 1.3.  
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Figure 1.15 (a) Non-contrasted T2-weighted MR image in which the liver tumour is not 
visible. (b) Demarcation of liver tumour after Resovist intravenous injection. The Resovist-
enhanced MR image depicts a satellite tumour nodule (arrow). Images taken from ref. 122 
Table 1.3 Examples of clinically approved SPIONs. 
Name Application Administration   Relaxivity 
 mmol×s-1  
at 1.5 T 
Coating  Hydrodynamic 
diameter 
(nm) 
Ferumoxides
AMI-25 
(Feridex I.V./ 
Endorem)* 
Liver and 
spleen 
imaging 
 
I.V. 
 
r2=120 
r1=10.1 
Dextran T10 120-180 
Ferumoxtran-
10 AMI-227 
(Sinerem/ 
Combidex) 
Lymph 
node 
imaging 
I.V. 
 
r2=65 
r1=9.9 
Dextran 
T10, T1 
15-30 
Ferucarbotran 
SHU-555A 
(Resovist) 
Liver 
imaging 
 
I.V. 
r2=189 
r1=9.7 
Carboxy-
dextran 
 
60 
Ferumoxsil 
AMI-121 
(Lumirem/ 
Gastromark) 
GI imaging Oral n.a.  Silica 300 
Ferumoxytol 
AMI-228 
(Feraheme) 
Iron 
replacement 
therapy 
 
I.V. r2=89 
r1=15 
Carboxy 
methyl-
dextran 
30 
*No longer commercialised 
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The clinically approved MRI constrast agents based on SPIONs mainly consist of iron 
oxide nanoparticle cores of 5 to 10 nm size and a dextran stabilisation coating. The 
major drawbacks associated with currently available MRI agents are: 
(1) broad size distributions of iron oxide cores, 
(2) lack of strong covalent attachment of the coating material to the iron oxide 
nanoparticles cores as conventional dextran coatings are attached to the core via 
hydrogen bonding making them susceptible to detachment, 
(3) lack of surface functional groups which limits bioconjugation ability and results 
in a lack of selective binding to targeted cancer cells, 
(4) applicability only to hepatic, gastrointestinal or lymph nodes imaging. 
These limitations motivated the search for improved syntheses of high quality 
monodisperse and crystalline iron oxide nanoparticles with enhanced magnetic 
properties. At the same time it stimulated the research for alternative surface 
modification methods and novel coating materials capable of promoting defined and 
controllable interactions between SPIONs and living cells. 
For example, polyvinylpyrrolidone-coated SPIONs with 40-50 nm particle size 
distribution were shown to have higher macrophage uptake in vitro and in vivo than 
Feridex I.V. (Figure 1.16).123 As polyvinylpyrrolidone is a water-soluble, non-charged 
and non-toxic polymer such SPIONs can potentially be better contrast agents, for 
example, for inflammation detection. 
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Figure 1.16 (a) T2-weighted MR images of rabbit liver after intravenous injection of Feridex 
I.V. (top row) and polyvinylpyrrolidone-coated SPIONs (bottom row). (b) T2 signal 
intensity for Feridex I.V. and polyvinylpyrrolidone-coated SPIONs. Image is taken from 
ref. 123   
Park et al.100 synthesised a series of amphiphilic polymer coated SPIONs with an 
average size of 30 nm. The authors tested each type of these non-toxic and stable 
SPIONs as an MRI contrast agent for in vivo cancer detection. The MRI studies with 
lung tumour-bearing mice resulted in a T2 signal drop in the tumour tissues, indicating 
that the SPIONs reached the tumour tissues (Figure 1.17). 
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Figure 1.17 T2-weighted MRI images taken before and after injection of 15 mg Fe/kg of (a) 
poly(dodecyl methacrylate-b-ethylene glycol methyl ether methacrylate-b-methacrylic acid)-
coated SPIONs, (b) Pluronic-coated SPIONs, (c) PEG phospholipid-coated SPIONs and 
(d) Feridex I.V. The arrows denote the tumour region. The images are taken from ref. 100 
Active targeted SPIONs were investigated for MRI imaging and a notable study was 
carried out by Zhang et al.124 In this study, SPIONs were coated with 3-
aminopropyltrimethoxysilane and conjugated with arginine-glycine-aspartic acid (RGD) 
peptides. These peptides bind to the αvβ3 integrin which is a specific marker of 
angiogenesis and tumour growth. After RGD-SPIONs injection in mice bearing brain 
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1.4.2 Magnetic separations 
The use of SPIONs is not limited to MRI contrast agents, their superparamagnetic 
properties allow them to be efficiently used in magnetic separations.125-126 Magnetic 
separation techniques have several advantages in comparison to traditional separation 
procedures. The process is simple as the separation is assisted by an external magnetic 
field and all purification steps take place in one test tube.127 Typically the procedure 
involves the capture and separation of the biomolecule of interest using ligand 
functionalised SPIONs. For example, SPIONs have been widely used for affinity 
isolation of peptides,72 for detection and isolation of bacteria128 and for separation of 
proteins from biological samples.129  
Lin et al.130 developed a technique known as nanoprobe-based affinity mass 
spectrometry, NBAMS (Figure 1.19). In this technique, antibody-conjugated SPIONs 
were used for separation and detection of protein biomarkers in human serum. This 
technique was efficiently used to detect C-reactive protein, serum amyloid A and it 
involved three simple steps: (a) incubation of antibody-conjugated SPIONs with serum 
containing the targeted biomarker, (b) magnetic isolation of the SPIONs-biomarker 
conjugates and (c) direct mass spectrometry analysis of the biomarker captured on 
SPIONs. 
In another study, SPIONs were used to separate biological samples in a microfluidic 
device. Chen et al.131 produced a magnetic microfluidic device for separation of human 
immunodeficiency virus (HIV) from plasma. Anti-CD44 antibody conjugated SPIONs 
were used to capture the virus. Then the HIV-SPIONs conjugates were passed through a 
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packed bed of iron oxide particles. An external magnet was applied to magnetise the 
packed bed, which caused the HIV-SPIONs conjugates to be trapped, thus separating 
and concentrating the virus from the plasma. 
 
Figure 1.19 Role of the SPIONs in separations and immunoassays. The antibody-
conjugated SPIONs capture, separate, purify, concentrate the target biomarker and act as a 
platform for the mass spectrometry analysis. Figure is taken from ref. 130 
1.4.3 Hyperthermia  
SPIONs can be used as therapeutic agents by taking advantage of their hyperthermic 
ability. Hyperthermia can be induced by magnetic nanoparticles when an external 
alternating magnetic field forces oscillation of the magnetic moments of each 
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nanoparticle resulting in electromagnetic energy being converted into heat.18,81 It is 
possible to deliver SPIONs specifically to the tumour cells and generate heat locally 
with magnetic fields and as tumour cells are more susceptible to high temperatures (i.e. 
42-45 °C) than normal cells, they can be destroyed with minimal damage to normal 
cells.18 SPIONs have been intensively studied as hyperthermic agents due to their 
biocompatibility, surface functionalisation capabilities and adequate heat evolution rate.  
Most magnetic hyperthermia studies used SPIONs coated with either cationic liposomes 
or with aminosilane.18,132-133 For in vitro and in vivo studies that used SPIONs coated 
with cationic liposomes (MCL), their efficiency in hyperthermia induced tumour 
regression was attributed to their affinity towards the tumour cells which was enhanced 
by the electrostatic interaction between positively charged MCL and negatively charged 
cell membranes.132 Le et al.134  have demonstrated that the MCL, not only could be used 
for tumour hyperthermia but also could be linked to a specific antibody fragment, which 
increased their specificity for tumour cells.  
Human clinical studies of magnetic hyperthermia began in 2001 with Jordan et al.135 
who produced and presented a new system of magnetic field to generate hyperthermia 
for applications in the treatment of glioblastomas and prostate carcinoma. These studies 
used SPION coated with aminosilane and showed that this therapeutic technique is well 
tolerated by patients without side effects. In 2010 Maier-Hauff et al.136 published the 
results of a clinical study on 69 patients with recurrent glioblastoma who underwent 
radiotherapy in combination with hyperthermia induced by SPIONs. The results of this 
study showed an increase in patient survival when compared with conventional 
therapies. From the first clinical trials, magnetic hyperthermia has been seen as a 
Cristina I. Olariu                                                                                                                           Introduction 
 
41 
 
promising complementary therapy when combined with other conventional therapies 
such as radiotherapy or chemotherapy.  
1.4.4 Multifunctional nanocomposites 
In recent years SPIONs have been combined with other types of species such as 
fluorescent, drug or targeting molecules in order to expand their capabilities and to 
produce multifunctional nanocomposites.92,137-138  
The combination of SPIONs with fluorescent molecules holds great promise in enabling 
preoperative MRI localisation of the tumour and intraoperative tumour delineation via 
optical imaging. These nanocomposites will have dual imaging capabilities. One typical 
approach to add another function to SPIONs is by taking advantage of the organic 
chemical groups on their surface for conjugation with a molecule of interest. Another 
approach is to use hydrophobic interactions for combining different functionalities in the 
same nanoparticle platform. Santra et al.92 prepared PAA-coated SPIONs using a step-
wise synthetic procedure which involved co-precipitation of nanoparticles, surface 
stabilisation with PAA and chemical modification of the remaining carboxylic acid 
groups. The resulting PAA-coated SPIONs were functionalised with alkyne groups in 
order to attach an azide containing folate via click chemistry. In addition, hydrophobic 
fluorescent dyes and drug molecules were encapsulated within the hydrophobic pockets 
of the nanoparticles coating to yield multifunctional theranostic nanoparticles (Figure 
1.20). 
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Figure 1.20 Schematic representation of the synthesis of theranostics and multimodal 
SPIONs. The image is taken from ref. 92  
As previously mentioned, alkoxysilanes have also been commonly chosen as SPIONs 
coating material and as building platforms for multifunctional nanocomposites. For 
example, Kohler et al.137 have synthesised aminosilane coated SPIONs and subsequently 
conjugated them with an anti-cancer drug Methotrexate (MTX) via amidation between 
the carboxylic acid end groups on MTX and the amine groups on the SPIONs surface 
(Figure 1.21). Methotrexate is an analogue of folic acid which exhibits not only a 
targeting role as folic acid but also a therapeutic effect to many types of cancer cells that 
overexpress the folate receptor on their surface.  
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Figure 1.21 Surface conjugation of SPIONs with MTX, intracellular uptake of SPIONs-
MTX conjugate and the following drug release. The figure is taken from ref. 137  
The SPIONs-MTX conjugates were shown to have improved cellular uptake in glioma 
cancer cells. Following cellular uptake, the MTX was cleaved from the SPIONs surface 
in the lysosomes due to the low pH and presence of proteases. This method could 
potentially be extended to conjugate other drugs bearing chemically active groups for 
coupling.  
A recent report by Sun et al.138 showed a multifunctional PEG silane-coated SPION 
system which incorporated a near-infrared fluorescent (NIRF) dye (Cy5.5) and a 
targeting peptide (chlorotoxin). Using both MRI and optical imaging, the authors 
evaluated the nanoparticles capability to accumulate specifically in a brain tumour 
model after conjugation with the targeting peptide (Figure 1.22). The studies were 
performed both in vitro and in vivo in mice bearing brain tumour. The authors have also 
carried out preliminary biodistribution and toxicity assessment of the nanoparticles in 
mice using histological analysis of clearance organs and hematologic assays. The results 
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showed that the nanoparticles did not induce detectable cytotoxic effects on the liver and 
that the nanoparticles were well-tolerated at the doses evaluated in the study. 
 
Figure 1.22 a) Representative MRI of the mouse bearing a brain tumour before and after 
injection of SPION/PEG-chlorotoxin-Cy5.5 (10 mg Fe/kg). Accumulation of the SPIONs 
was observed by negative contrast enhancement. b) Ex-vivo NIRF images of brain tumour 
acquired from a non-injected mouse (left) and the mouse receiving SPION/PEG- 
chlorotoxin-Cy5.5 (right). The image is taken from ref. 138 
The introduction of suitable coatings with functional groups can allow the preparation of 
a nanoparticle platform capable of achieving different tasks simultaneously, with the 
final goal of improving diagnostics and therapeutic capabilities.  
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1.5 Thesis aims  
Superparamagnetic iron oxide nanoparticles possess a highly desirable combination of 
properties including superparamagnetism, biocompatibility, stability, imaging 
capabilities and flexibility for surface functionalisations which make them attractive for 
a variety of biomedical applications.  
The overall goal of this work was to synthesise multifunctional magnetic nanoparticles 
with several integrated properties that can be applied for early stage diagnosis of cancer 
using biomedical imaging. The multifunctionality refers to the combination of SPIONs 
with fluorescent molecules and antibodies to create a nanoparticle system capable of 
active targeting, optical and MR imaging of cancer cells overexpressing a specific 
marker.  
The specific aims of this PhD thesis were as follows: 
1. Synthesis of superparamagnetic iron oxide nanoparticles using high temperature 
decomposition of iron-organic ligands in the presence of capping agents  
2. Developing surface modification chemistries for superparamagnetic iron oxide 
nanoparticles using as safe and biocompatible materials as possible. 
3. Surface coating and functionalisation of the iron oxide nanoparticles using 
covalent interactions. Use of alkoxysilanes to introduce chemically reactive 
groups such as amino, bromo, iodo, nitrile and vinyl on the surface of iron oxide 
nanoparticles.  
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4. Surface coating and modification of hydrophobic iron oxide nanoparticles using 
bioinspired amphiphilic polyoxazoline polymers to form multifunctional 
magneto-micelles. 
5. Chemical bioconjugation of fluorescent dyes and biomolecules such as 
antibodies to the surface of functionalised nanoparticles and their use as a 
platform for targeting and biomedical imaging of cancer cells, in particular 
pancreatic cancer cells.  
6. Characterise all the materials used for this thesis to understand their 
physicochemical properties.  
Although the principal aim of the work was to develop multifunctional magnetic 
nanoparticles for biomedical imaging and diagnosis, the developed nanoparticles could 
also be employed for other biological applications such as bioseparations or magnetic 
hyperthermia.  
The report of this PhD work includes in chapter 1, a review of the most recent work with 
respect to synthesis, surface coating and functionalisation of superparamagnetic iron 
oxide nanoparticles. Chapter 1 also reviews the advances of SPION applications in MRI, 
hyperthermia, bioseparations and multifunctional applications.  
Chapter 2 describes the chemical modification of iron oxide nanoparticles using 
silanisation as an effective method for introducing functional groups such as amino, 
bromo, vinyl onto the nanoparticle surface followed in some cases with post-
modification reactions to further increase the potential for particle bioconjugations.  
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One application of amino/carboxylic acid bifunctional nanoparticles is described in 
chapter 3, where the nanoparticles bioconjugated with fluorescent molecules and 
antibodies are used for in vitro targeting and dual imaging of pancreatic cancer cells.  
Chapter 4 describes a novel surface modification chemistry of monodisperse iron oxide 
nanoparticles using amphiphilic polyoxazolines. A multifunctional magneto-micellar 
(MMM) platform was developed with high colloidal stability, targeting and dual 
fluorescent/MRI imaging capability for pancreatic cancer cells.  
Chapter 5 summarises the final conclusions and outcomes of this work, followed by 
acknowledgements to all the people that helped make this work possible. 
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Chapter 2  
Surface modification of iron oxide nanoparticles using 
functional silane ligands 
2.1 Introduction 
The low toxicity profile and the magnetic properties of superparamagnetic iron oxide 
nanoparticles (SPIONs) have made them promising platforms for a wide range of 
biological applications such as magnetic resonance imaging (MRI), drug delivery, 
magnetic hyperthermia and magnetic separations of biomolecules.1-9 In this context, 
surface coating and functionalisation of SPIONs is important as it can afford solubility 
and dispersibility in different environments as well as protection of the magnetic core 
from the biological medium. At the same time, the functionalisation should provide an 
opportunity for further chemical development such as conjugation of active 
biomolecules and complementary imaging labels such as fluorescent tags. Various 
strategies have been explored for introducing functional coatings on SPIONs. The use of 
coordinative, electrostatic, hydrophobic and covalent interactions has been demonstrated 
for SPION coating and functionalisation.6,10 The detachment of weakly physisorbed 
coatings from SPIONs in commercially available MRI agents has already highlighted 
the importance of the nature of the interaction.8,11  Covalently attached coatings can 
provide a robust bond with the surface of the nanoparticle while offering a great variety 
of surface functionalities and therefore can provide an excellent platform for use of 
SPIONs in the biomedical applications.  
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Organosilane ligands, in particular alkoxysilanes, can form stable covalent bonds with 
the metal oxide surfaces and thus offer a viable approach for surface modification of 
SPIONs.3,7,12-17 The reaction of alkoxysilanes with the surface of SPIONs involves 
several steps as summarized in Scheme 2.1. Initilally, hydrolysis of the alkoxy groups of 
the silane to reactive silanol groups, condensation of the silanol groups, adsorption of 
silanols on the nanoparticle surface and covalent bond formation with the surface during 
the final dehydration reaction.16,18 In addition to strong covalent bonding the silanes can 
be employed to introduce a variety of organic functionalities on the surface of SPIONs, 
which are useful for further biofunctionalisation.  
 
Scheme 2.1 Generalised mechanism for the hydrolytic silanisation of the metal oxide 
nanoparticle surface. Figure adapted from ref. 18  
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Amino functional groups (-NH2) have been grafted on the surface of SPIONs using 3-
aminopropyltriethoxy silane (APTES) which is one of the most used silane ligands for 
biological applications. The amine groups can facilitate conjugation of both 
biomolecules (proteins, folic acid) or fluorescent tags making APTES functionalised 
SPIONs promising platforms for application in biological systems.16,19-22 Mikhaylova et 
al. used the silanisation of iron oxide nanoparticles (NPs) with APTES to prove that 
introduction of amino groups to the particle surface can promote the conjugation of 
bovine serum albumin (BSA) as shown in Figure 2.1.19  
 
Figure 2.1 Schematic representation of a) carbodiimide and hydroxysuccinimide activation 
of carboxylic groups of BSA and b) coupling of activated BSA onto aminosilane-
functionalised NPs. Figure adapted from ref. 19 
Importantly, the authors showed that the NPs retain their superparamagnetic properties 
after the surface functionalisation with the silane and the BSA. In vitro cell studies using 
the BSA coated SPIONs demonstrated that the surface functionalisation has no effect on 
cell viability. Zhang et al.20 adopted silane modifications of the SPIONs to introduce 
target-recognising molecules such as folic acid on the surface of the nanoparticles. In 
order to conjugate with the folic acid, APTES was modified with a polyethylene glycol 
(PEG) spacer and a terminal amino group. Using this tailored PEG silane, the ligand 
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successfully modified the surface of the SPIONs and functionalisation was confirmed 
using FTIR, UV/VIS and TEM.20 In a follow-up paper, Zhang et al. used the tailored 
PEG silane with the terminal amino groups to conjugate a drug methotrexate (MTX) to 
the surface of the SPIONs.21 MTX conjugated SPIONs were tested in vitro as a drug 
carrier system using brain cancer cells.  
Polymerisable functional groups like methacrylates were introduced on the surface of 
SPIONs using organosilane ligands.15,17 Flesh et al. copolymerised methacrylate-
functionalised poly(ethyleneglycol) macromonomer from the surface of methacrylate-
functionalised SPIONs.15 Using direct copolymerisation and inverse emulsion 
polymerisation, the authors showed that only inverse emulsion produced high grafting 
densities of the polymer on SPIONs surface. Frickel et al. have used methacrylic and 
chlorobenzyl functional silanes to modify the surface of SPIONs and demonstrate the 
irreversible attachment of the silane monolayers.17 These two functionalities were used 
to prepare magnetic core/polymeric brush hybrid particles. 
The work in this chapter describes the surface modification chemistry of commercially 
available SPIONs (25 nm, Fe3O4) by a series of organosilane ligands. It was shown that 
a number of follow-up modification reactions become accessible leading to 
multifunctional organic-inorganic hybrids.  
APTES was used to graft cationic amine groups (–NH2 groups) on surface of the Fe3O4 
NPs. Part of the amine groups were then converted to carboxylic acid groups using a 
reaction with succinic anhydride. As a result, robust silane linkages were introduced to 
the surface of NPs along with bifunctionality originating from amine and carboxylic 
acid groups. A full set of physico-chemical characterisations was undertaken to analyse 
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the bifunctionalised nanoparticles such as surface coverage by organic ligands, size of 
the NPs and their magnetic properties. Organic functional groups such as amines and 
carboxyls are of interest for biological applications because they allow coupling of 
biomolecules under mild conditions, such as reactions at ambient temperature and in 
physiological buffers. Furthermore chemical multifunctionality is important especially 
for use of independent conjugation chemistries to attach bioactive molecules. In addition 
to APTES functionalisation, Fe3O4 NPs were modified using other functional silanes to 
evaluate the formation of the silane layer and compare the level of surface coverage 
derived from the reaction with each silane reagent. These silane ligands were 
deliberately selected due to their structural similarity with APTES. This approach 
allowed introducing a range of functional groups, such as –Br, –I, −C≡N or vinyl (–
CH=CH2) on the surface of the nanoparticles. In a “grafting from” polymerisation 
reaction, the –Br functionalities were used as initiating groups for coating the 
nanoparticles with a pH sensitive polymer poly(2-(diethylamino)ethyl methacrylate), 
PDEAEMA. In another example, the vinyl silane functionalised nanoparticles were used 
in a thiol-ene click model reaction with mercaptopropionic acid to prepare a fully 
carboxylated surface. Full characterisation of the synthesised nanoparticles was 
undertaken to provide confirmation of the surface functionality. The coverage with 
different organic functionalities at each chemical modification step was detailed and 
additional evidence of chemical conjugation with fluorescent tags was provided by 
means of fluorescence microscopy.  
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2.2 Experimental section 
2.2.1 Materials 
Iron (II, III) oxide (Fe3O4, magnetite) nanoparticles were used as purchased from the 
commercial source Alfa Aesar (Nanopowder, 98% metal basis, 20-30 nm core size 
measured using TEM). 3-Aminopropyltriethoxysilane (APTES, 99%), 3-
bromopropyltrimethoxysilane (BPTMS, ≥98.0%), 3-iodopropyltrimethoxysilane 
(IPTMS, ≥99.0%), vinyltrimethoxysilane (VTMS, 98%) and 3-
cyanopropyltriethoxysilane (CPTES, 98%) were purchased from Fluorochem. Succinic 
anhydride (≥ 99%), 3-mercaptopropionic acid (≥ 99%), 2,2′-azobis(2-
methylpropionitrile)  (AIBN, 98%), Fluorescein-5-thiosemicarbazide, N,N-
dimethylformamide anhydrous (DMF, 99.8%), 2- (diethylamino)ethyl methacrylate 
(DEAEMA, 99%), 2-propanol anhydrous (IPA, 99.5% ), copper (I) bromide (99.99% 
trace metals basis), toluene (≥ 99.5%) and 2,2′-bipyridyl (≥ 99%) were purchased from 
Sigma Aldrich. All chemicals were used as received without any further purification 
except the DEAEMA monomer which was passed through an alumina column prior to 
use. Toluene was dried using 4Å molecular sieves (Sigma-Aldrich) activated at 300°C 
for 3 hours. All aqueous solutions were prepared using ultrapure water Milli-Q 
(Millipore, resistivity 18.2 MΩ.cm at 25°C). The magnet used was a rare earth NdFeB 
magnet (MagnetSales) with 10 mm diameter, 5 mm thickness and 1.18 T strength. 
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2.2.2 Synthetic methods 
2.2.2.1 SPION Fe3O4 nanoparticles 
Superparamagnetic iron (II, III) oxide (Fe3O4, magnetite) nanoparticles were purchased 
and used as received from Alfa Aesar (Nanopowder, 98% metal basis, core size 20-30 
nm measured using TEM).  
2.2.2.2 Surface functionalisation of Fe3O4 nanoparticles with −NH2 groups using 3-
aminopropyltriethoxysilane (APTES) 
Fe3O4 nanoparticles (500 mg) were dispersed in anhydrous toluene (50 mL) using an 
ultrasonic bath for 10 minutes under ambient conditions. Subsequently to this 
suspension, APTES (0.5 mL) was added dropwise and the reaction mixture was heated 
to reflux using vigorous mechanical stirring. After 16 hours, the nanoparticles were 
retrieved using a permanent magnet and washed five times with excess acetone to 
remove all traces of unreacted silanes and toluene. The amino-functional nanoparticles 
(denoted as Fe3O4−NH2) were dried overnight under vacuum at room temperature. This 
route is adapted from Xu et al.7 
2.2.2.3 Surface functionalisation of Fe3O4 nanoparticles with −Br groups using 3-
bromopropyltrimethoxysilane (BPTMS) 
Fe3O4 nanoparticles (500 mg) were dispersed in anhydrous toluene (50 mL) using an 
ultrasonic bath for 10 minutes under ambient conditions. To this, BPTMS (0.5 mL) was 
added dropwise and the reaction mixture was heated to reflux using mechanical stirring. 
After 16 hours, the nanoparticles were retrieved using a permanent magnet and washed 
five times with excess acetone to remove all traces of unreacted silane and toluene. The 
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bromo-functional nanoparticles (denoted as Fe3O4−Br) were dried overnight under 
vacuum at room temperature. 
2.2.2.4 Surface functionalisation of Fe3O4 nanoparticles with −I groups using 3-
iodopropyltrimethoxysilane (IPTMS) 
Fe3O4 nanoparticles (500 mg) were dispersed in anhydrous toluene (50 mL) using an 
ultrasonic bath for 10 minutes under ambient conditions. Subsequently IPTMS (0.5 mL) 
was added dropwise to this suspension while sonicating, followed by refluxing the 
reaction mixture for 16 hours using mechanical stirring. The nanoparticles were then 
retrieved using a permanent magnet and washed five times with excess acetone to 
remove all traces of unreacted silane and toluene. The iodo-functional nanoparticles 
(denoted as Fe3O4−I) were dried overnight under vacuum at room temperature. 
2.2.2.5 Surface functionalisation of Fe3O4 nanoparticles with −CH=CH2 groups 
using vinyltrimethoxysilane (VTMS) 
Fe3O4 nanoparticles (500 mg) were dispersed in dry toluene (50 mL) using an ultrasonic 
bath for 10 minutes under ambient conditions. Subsequently to this suspension VTMS 
(0.5 mL) was added dropwise and the reaction mixture was heated to reflux using 
mechanical stirring. After 16 hours, the nanoparticles were retrieved using a permanent 
magnet and washed five times with excess acetone to remove all traces of unreacted 
silane and toluene. The vinyl-functional nanoparticles (denoted as Fe3O4−CH=CH2) 
were dried overnight under vacuum at room temperature. 
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2.2.2.6 Surface functionalisation of the Fe3O4 nanoparticles with −C≡N groups 
using 3-cyanopropyltriethoxysilane (CPTES) 
Fe3O4 nanoparticles (500 mg) were dispersed in dry toluene (50 mL) using an ultrasonic 
bath for 10 minutes under ambient conditions. Subsequently to this suspension, CPTES 
(0.5 mL) was added dropwise and the reaction mixture was heated to reflux using 
mechanical stirring. After 16 hours, the nanoparticles were retrieved using a permanent 
magnet and washed five times with excess acetone to remove all traces of unreacted 
silane and toluene. The cyano-functional nanoparticles (denoted as Fe3O4−C≡N) were 
dried overnight under vacuum at room temperature. 
2.2.2.7 Post-modification reaction of Fe3O4−NH2 nanoparticles with succinic 
anhydride 
Fe3O4−NH2 nanoparticles (100 mg, 0.03 mmol −NH2 groups calculated as described in 
section 2.2.3.9) were suspended in anhydrous DMF (45 mL) under nitrogen atmosphere. 
Succinic anhydride (30 mg, 0.3 mmol) was then dissolved in anhydrous DMF (5 mL) 
and was added slowly to the nanoparticles suspension under nitrogen. The resulting 
mixture was stirred for 24 hours at room temperature under nitrogen. The resulting 
nanoparticles (denoted as Fe3O4-NH2/COOH) were collected using a magnet and then 
washed five times with acetone before being dried overnight under vacuum at room 
temperature. 
2.2.2.8 Thiol-ene click reaction of Fe3O4−CH=CH2 nanoparticles with 3-
mercaptopropionic acid 
Fe3O4−CH=CH2 nanoparticles (100 mg, 0.05 mmol −CH=CH2 groups) were 
suspended in anhydrous toluene (45 mL) under nitrogen atmosphere. 3-
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mercaptopropionic acid (50 µL, 0.5 mmol) and AIBN (20 mg) pre-dissolved in toluene 
(5 mL) were then slowly added to the nanoparticle dispersion. The reaction mixture was 
stirred overnight at 85 ⁰C under nitrogen. The resulting nanoparticles (denoted as 
Fe3O4−S−COOH) were collected using magnetic decantation and then washed five 
times with acetone before being dried under vacuum at room temperature. 
2.2.2.9 Polymerisation of Fe3O4−Br nanoparticles using atom transfer radical 
polymerisation (ATRP): a grafting from approach  
ATRP was used to graft 2-(diethylamino)ethyl methacrylate (DEAEMA) residues from 
the surface of Fe3O4−Br thus rendering the nanoparticles soluble in different solvents. 
Briefly, Fe3O4−Br nanoparticles (50 mg, 0.013 mmol –Br groups) were dispersed in 
anhydrous isopropanol (10 mL) using ultrasonic agitation. DEAEMA monomer (5 g, 27 
mmol) was then added slowly to the magnetic suspension and the mixture was degassed 
using nitrogen bubbling. Copper (I) bromide (0.1 g, 0.7 mmol) and 2, 2’-bipyridine 
(0.33 g, 2 mmol) were added to the degassed mixture. The sealed reaction system was 
then agitated by rolling for 24 hours at room temperature. The resulting polymer-grafted 
nanoparticles (denoted as Fe3O4−PDEAEMA) were collected using magnetic 
decantation followed by repeated washes with water, ethanol and hexane. Particles were 
then dried under vacuum at room temperature.  
This experiment was performed by Dr. Erol Hasan at the University of Liverpool, 
Centre for Materials Discovery. 
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2.2.3 Characterisation methods  
2.2.3.1 Elemental analysis  
Elemental analysis (C-H-N) was performed on a Thermo Flash EA1112 Series CHNS-O 
analyser and was used to analyse the organic content of the functionalised nanoparticle 
samples. The C-H-N content (C %, H %, N %) cited was an average of three 
measurements.  
2.2.3.2 Thermogravimetric Analysis (TGA)  
TGA was carried out using a TA instrument Q600 thermal balance. Typically 5-10 mg 
of nanoparticles were heated to 600 °C at 10 °C/min in air and kept at 600 °C for 30 min 
to determine the amount of organic content on the nanoparticle surface. The weight loss 
of non-coated nanoparticles was compared to the weight loss of coated nanoparticles. 
By subtracting the two, the difference was attributed to the extent of surface coverage. 
For a full description of this technique, see ref. 23. 
2.2.3.3 Fourier Transform Infrared spectroscopy (FTIR) 
FTIR spectra were recorded on powder samples using a Bruker Tensor 27 Spectrometer. 
Iron oxide nanoparticles functionalised with different organic ligands were analysed as 
powders. For each sample, 100 scans in the region from 400 to 4000 cm-1 with a 
resolution of 4 cm-1 were accumulated. Spectra were recorded and evaluated with 
OPUS/MAP version 4.0 software. FTIR were used to qualitatively identify each type of 
organic coating on the surface of functionalised iron oxide nanoparticles or to assess the 
chemical modifications made to the coating materials.24 
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2.2.3.4 Powder X-ray diffraction (PXRD) - Scherrer equation for size distribution  
Powder X-ray diffraction patterns of the commercial Fe3O4 NPs sealed in a 0.5 mm 
glass capillary were collected on a Bruker D8 diffractometer using Mo Kα radiation (λ = 
0.7107 Å). The PXRD data was used to identify the iron oxide phase composition and to 
confirm the average size specified by the manufacturer using automatic software (X’Pert 
Highscore Plus version 2.0). A particle size of 24 ± 2 nm was calculated using the 
Scherrer equation: 
 

 	 

 
Where τ- is the particles size, β- is the line broadening at half the maximum intensity 
(FWHM), k- the shape factor (k=0.9), λ- is the x-ray wavelength (Mo, λ = 0.7107 Å), θ- 
is the Bragg diffraction angle.  
2.2.3.5 Transmission Electron Microscopy (TEM) 
TEM images of functionalised Fe3O4 NPs were recorded using a FEI Tecnai G2 Spirit 
BioTWIN instrument with a W filament and a SIS Megaview III digital camera, 
operating at 100 kV. All TEM samples were prepared by brief sonication of Fe3O4 NPs 
in appropriate solvent (ethanol or H2O) and 50 µL sample was then deposited onto a 
carbon coated 300 mesh copper grid. The grids were then allowed to dry in air prior to 
imaging. The size distribution of the nanoparticles was derived from TEM images using 
ImageJ software and 400 measurements. 
2.2.3.6 Measurements of magnetic properties 
Magnetic measurements were performed in a Quantum Design MPMS XL 
Superconducting Quantum Interference Device (SQUID) magnetometer using the 
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system DC measurement capabilities. Milligram quantities of the sample were placed in 
a standard gelatine capsule. Magnetisation measurements were made at room 
temperature (300 K) by varying fields over a +1T to -1T range. The SQUID magnetic 
measurements were performed by Dr. Pavel Borisov at the University of Liverpool, 
Department of Chemistry. 
2.2.3.7 Fluorescence microscopy 
Fluorescence microscopy was employed to qualitatively analyse the chemical reactivity 
of functional groups on nanoparticles surface. The images were acquired using a Leica 
DM2500 inverted microscope equipped with a Leica DFC350 FX camera.  The 
nanoparticles functionalised with different organic groups were conjugated with 
fluorescent molecules (fluorescein isothiocyanate-FITC and rhodamine B 
isothiocyanate-RITC). Since iron oxide does not fluoresce, the fluorescence microscopy 
provides high sensitivity for detecting the attached fluorophores.25  
2.2.3.8 Dynamic Light Scattering (DLS) 
The hydrodynamic diameters of the functionalised nanoparticles were measured using a 
Malvern Zetasizer NanoZS equipped with a helium laser at a wavelength of 633 nm. A 1 
mL aliquot of nanoparticle dispersion in deionised H2O (pH 6.5) was used in the 
measurements. Scattered light was collected at a fixed angle of 173⁰ and the 
measurements were performed at 25 ⁰C. The intensity-average hydrodynamic diameters 
reported are obtained from at 3 measurements; for each measurement at least 20 repeat 
runs were used.  
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2.2.3.9 Particle coverage calculations 
The quantitative information on the silane layer formation is based on the carbon 
content from elemental analysis and TGA after careful isolation of functional particles. 
It should be stated that the analysis by 29Si NMR is impeded by the magnetic nature of 
the cores. The general set of formulae used for characterising the surface coverage is 
presented below.  
Taking into account the average nanoparticle diameter d = 25 nm of a spherical 
individual nanoparticle obtained from TEM, the surface area and the volume, SNP and 
VNP, can be calculated as: 
  4
  4  12.5  10  19.63  10  m   (2.1) 
" 
#
$
$ 
#
$
  12.5  10$  8.16  10# m$   (2.2) 
The mass of this nanoparticle is, m1NP: 
&  '  "  5.17  10
  8.16  10#  42.18  10) g, where ρ is the 
density of Fe3O4.        (2.3) 
The number of NPs per g material is: 
+ 

,-./


#.)01-2
 2.37  10  g    (2.4) 
The specific surface area is:  
 
3./
,-./
 46.52 m  g       (2.5) 
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2.3 Results and discussion 
2.3.1 Formation of dual (−NH2 and −COOH) functional groups on the 
surface of Fe3O4 nanoparticles 
Bifunctional Fe3O4 nanoparticles with both –NH2 and –COOH functionalities co-
existing on the surface were synthesised using a simple direct-grafting method which 
consisted in an initial reaction with APTES and a follow-up reaction with succinic 
anhydride. The functionalisation procedure of Fe3O4 NPs with APTES involved the 
reaction between the hydroxyl groups which are present on the NPs surface and the 
ethoxy groups of the aminosilane, forming a covalent Fe-O-Si bond.26 The grafting 
reaction consists of the hydrolysis of ethoxy groups of APTES and the condensation of 
the silanol groups with the surface hydroxyl groups. During the reaction ethanol is 
eliminated as a byproduct as illustrated in Scheme 2.2. By grafting APTES on the 
surface of the Fe3O4 NPs, amine-functionalised nanoparticles were prepared and the 
sample was denoted as Fe3O4-NH2. 
 
Scheme 2.2 Schematic representation of the grafting of an aminosilane molecule to the 
surface of a Fe3O4 nanoparticle. 
Several techniques were used to characterise the functionalised nanoparticles after the 
washing and drying steps. Firstly, qualitative confirmation of the surface 
Cristina I. Olariu               Surface modification of iron oxide nanoparticles using functional silane ligands 
 
80 
 
functionalisation and presence of amino groups on the Fe3O4-NH2 was obtained from 
infrared spectroscopy and compared with the spectrum of unfunctionalised Fe3O4 
nanoparticles (Figure 2.2). The successful grafting of silane molecules was confirmed 
in the FTIR spectrum of the Fe3O4-NH2 by the presence of the two broad bands at 3435 
and 1600 cm-1 which were assigned to the N-H stretching vibration and N-H bending 
respectively. The bands observed at 2925 and 2850 cm-1 are due to the symmetric and 
the asymmetric CH2 stretching modes respectively. The Fe-O-Si bonds are masked in 
the FTIR spectrum due to overlapping with the Fe-O vibrations of magnetite at 
580 cm-1.27 On the other hand, the formation of the silane layer on the surface of 
nanoparticles was confirmed by the presence of the band at 1015 cm-1 corresponding to 
the Si-O-Si bond.28 
 
Figure 2.2 FTIR spectra of magnetic nanoparticles: Fe3O4 (black line), Fe3O4-NH2 (red 
line) showing the presence of NH2 groups.  
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In order to estimate the number of amino grafted groups on the surface quantitative 
analysis for the composition of the Fe3O4-NH2 was carried out using elemental analysis. 
Elemental analysis data showed the presence of nitrogen and an increase in the carbon 
content (C = 1.22%, H = 0.38%, N = 0.37%) compared with non-functionalised sample 
(C = 0.08%, H = 0.23%, N = 0%). From this data, the surface coverage of aminosilane 
ligands could be calculated as: 
The mass of carbon in 1g of material: 1  .
00
 12.2 mg      (2.6) 
Number of mols of carbon in 12.2 mg:   .

 1.02 mmol carbon     (2.7) 
The degree of functionalisation per mass unit, ;  .0
$
 0.34 mmol  g   (2.8) 
(where 3 is the number of carbons in each APTES ligand). 
From equations 2.5 (in section 2.2.3.9) and 2.8 it is possible to calculate the surface 
coverage C : 
< 
;

 7.38 µmol  m 
The number of mols of ligands per nanoparticle is: 
+,>?@ 
A
./

0.$#01B
.$C0-D
 143  10       (2.9) 
Therefore the number of aminosilane ligands per nanoparticle can be calculated as:  
EF  +,>?@  +G  143  10
  6.022  10$  8611 
Where NA is Avogadro’s number.       (2.10) 
The results show good agreement with previously reported coverage values which were 
calculated based on space filling projections.29 For an APTES monolayer formation, the 
surface functionalisation density varies between 2.8 µmol/m2 and 12 µmol/m2 depending 
on the nanoparticle size and the silane orientation with respect to the surface.26,30-31 The 
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formation of the dense silane layer is an important feature if biological applications are 
in mind, as it would prevent possible degradation of the protective layer and leaching of 
iron into a biological environment. Another desired feature for the biomedical 
applications is multifunctionality which would allow the use of independent chemistries 
to attach biomolecules to the nanoparticle surface. 
In order to introduce a second functionality on the surface and to test the reactivity of 
the amine groups on the Fe3O4-NH2 a reaction with succinic anhydride was carried out. 
This modification reaction was chosen because it is commonly used in biology to 
introduce terminal carboxylate functionalities from an existing amino group as 
illustrated in Scheme 2.3.32 The sample derived from this reaction was denoted as 
Fe3O4-NH2/COOH.   
 
Scheme 2.3 Schematic representation of the reaction between succinic anhydride and the 
Fe3O4-NH2. 
The presence of the free carboxylic groups was assessed qualitatively using FTIR 
spectroscopy (Figure 2.3). The free carboxylic acid groups present were confirmed by 
the characteristic C=O stretching absorption at 1725 cm-1 in the spectrum of Fe3O4-
NH2/COOH. The frequencies in the region of 1640 cm-1 and 1560 cm-1 were assigned 
to the C=O stretching band and N-H bending band in the amide linkage respectively. 
Cristina I. Olariu               Surface modification of iron oxide nanoparticles using functional silane ligands 
 
83 
 
 
Figure 2.3 FTIR spectra of functionalised magnetic nanoparticles: Fe3O4-NH2 (red line) 
and Fe3O4-NH2/COOH (blue line).  
Elemental analysis of Fe3O4-NH2/COOH nanoparticles showed an increase in carbon 
and hydrogen content (C = 1.62%, H = 0.41%, N = 0.38%) compared with Fe3O4-NH2. 
Based on the elemental analysis values and applying the equations 2.6 to 2.8 the fraction 
of amine groups reacted with succinic anhydride can be estimated: 
Mass of carbon in 1g of material = 16.2 mg       (2.11) 
Number of mols of carbon in 16.2 mg:      .

 1.35 mmol carbon  (2.12) 
Assigning ‘x’ to be the amount of unreacted amine functional groups and ‘y’ to be the 
amount of reacted groups, and considering there are 3 carbon atoms in the unreacted 
amine functional group and 7 in the succinic anhydride-reacted functional group: 
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A: 3x + 7y = 1.35 mmol carbon, post succinic anhydride reaction 
B: x + y = 0.34 as the total number of bound groups should be the same before and after 
the succinic anhydride reaction (from equation 2.8). 
Solving simultaneous equations A and B, x and y were calculated as x= 0.25 mmol and 
y = 0.09 mmol, the number of un-reacted and reacted amine functional groups 
respectively. Thus the percentage of added –COOH groups is: 
H
I J H

0.09
0.34
 100  26.5 % 
Following equations 2.9 and 2.10 the number of carboxylic groups per nanoparticle was 
determined to be 2300. The results showed that the amine groups were reactive towards 
succinic anhydride but the reaction did not go to completion. Such incomplete 
conversion was likely due to steric hindrance which prevented the reaction of succinic 
anhydride with all accessible amino groups. Performing the reaction at variable 
temperatures could provide additional control over the ratio of –NH2/–COOH groups 
on the surface of the nanoparticles. At ambient temperature, the partial conversion of the 
amine groups to carboxylic acids offered a bifunctional surface with 75% amino and 
25% of carboxylic acid groups.  
TGA was additionally used to confirm the composition for the two sets of nanoparticles. 
The thermograms recorded for Fe3O4-NH2 and Fe3O4-NH2/COOH nanoparticles 
presented in Figure 2.4 show the weight losses associated with each sample.  
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Figure 2.4 TGA thermograms of Fe3O4-NH2 (red line) and Fe3O4-NH2/COOH (blue 
line) nanoparticles. The corresponding weight losses are 2.03% in Fe3O4-NH2 against 
3.08% in Fe3O4-NH2/COOH. 
For Fe3O4-NH2, two weight losses are evident: the first between 30 °C and 150 °C was 
due to the evaporation of physically absorbed moisture on the surface. The second 
weight loss (between 150 °C and 600 °C) corresponded to the decomposition of 
propylamine groups. Similar temperature decomposition profile was reported for 
aminosilane-coated cobalt ferrite nanoparticles.26 TGA was also used to estimate the 
number of silane ligands anchored on the nanoparticles according to the following 
formula: 
                                                        + 
L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Where N is the number of ligands on one nanop
is Avogadro’s number, ρ
nanoparticle core and MW
The weight loss of the Fe
2.03% (Figure 2.4 red line) which led to approximately 8750 amine groups per 
nanoparticle. This value was in good agreement with the results obtained from the 
elemental analysis. The deconvolution of the TGA d
Fe3O4-NH2/COOH (3.08% 
estimation of the number of carboxylic acid groups as approximately 2300 per NP, 
which was also consistent with the result from the elemental analysis. 
The size of the nanoparticles before an
transmission electron microscopy (TEM). The nanoparticle images along with the 
histograms of the size distributions are presented in 
Figure 2.5 Transmission electron microscopy images of a) unfunctionalised 
bifunctionalised Fe3O4-NH
TEM particle size distribution. 
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86 
article, ω is the mass loss in percent, 
 is the density of the nanoparticle, V is the volume of one 
 is the molar weight of the ligands.  
3O4-NH2 between 150 °C and 600 °C recorded by TGA was 
ata (Figure 2.4
- 2.03% = 1.05% between 150  °C and 600 °C) allowed the 
 
d after surface modifications was examined using
Figure 2.5.    
2/COOH nanoparticles. The inset shows the histogram of the 
 
 
NA 
 blue line) for 
 
 
Fe3O4 and b) 
Cristina I. Olariu               Surface modification of iron oxide nanoparticles using functional silane ligands 
 
87 
 
The TEM images show that commercial Fe3O4 nanoparticles have monomodal 
distribution and their diameter is 25 ± 5 nm (Figure 2.5a). After chemical 
functionalisation with APTES and succinic anhydride, the morphology of the 
nanoparticles was not affected as shown in Figure 2.5b. The average particle size for 
Fe3O4-NH2/COOH was 24 ± 4 nm.  
In addition to the size measurement of the magnetic cores with TEM, the hydrodynamic 
diameter of the particles in aqueous solution was measured using DLS. The results 
showed that the average hydrodynamic size for the commercial unfunctionalised Fe3O4 
nanoparticles was 164 ± 6 nm (Figure 2.6).  
 
Figure 2.6 DLS histogram of unfunctionalised Fe3O4 nanoparticles. The hydrodynamic 
particles size distribution for Fe3O4 nanoparticles is 164 ± 6 nm.  
The difference between TEM and DLS results was attributed to the aggregation of the 
nanoparticles in solution. Due to the fact that larger nanoparticles or aggregates scatter 
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more the light compared with the smaller nanoparticles, the DLS results are skewed 
towards the larger nanoparticles. Compared with the unfunctionalised Fe3O4 
nanoparticles, the hydrodynamic size for the Fe3O4-NH2/COOH was 142 ± 8 nm as 
shown by the DLS distribution in Figure 2.7. It is important to notice that the chemical 
modifications on the surface did not introduce any major agglomeration between 
particles.  
 
Figure 2.7 DLS histogram of bifunctionalised Fe3O4-NH2/COOH nanoparticles. The 
hydrodynamic particles size distribution for Fe3O4-NH2/COOH is 142 ± 8 nm.  
Compared to the existing commercial MRI contrast agent Feridex I.V. (120-180 nm),33 
Fe3O4-NH2/COOH exhibited a similar overall hydrodynamic diameter with a larger 
iron oxide core. This may prove advantageous for biological applications. At the same 
time, the Fe3O4-NH2/COOH nanoparticles have a thinner organic shell compared with 
the Feridex I.V. agent (short silane ligand as opposed to high molecular weight dextran 
shell). In order to prove the effect of thinner shell on the magnetic properties of the 
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system and thus potentially greater MRI contrasting capability, the magnetic 
measurements were carried out on the Fe3O4-NH2/COOH. 
The magnetic properties of the bifunctional nanoparticles were compared with the 
starting material from a SQUID magnetometer data. Figure 2.8 shows the field 
dependence of magnetisation measured at room temperature (300 K) from -1T to +1T. 
Both samples have a good magnetic response and exhibit the expected 
superparamagnetic behaviour as evident by no hysteresis at 300 K.  
 
Figure 2.8 Magnetic field dependence of magnetisation at room temperature for 
unfunctionalised Fe3O4 (black) and Fe3O4-NH2-COOH (blue) nanoparticles. Inset shows 
a zoom-in plot between -500 Oe and 500 Oe magnetic field. 
The magnetisation values at saturation are 72.5 emu × g-1 and 69.3 emu × g-1 for 
unfunctionalised Fe3O4 and Fe3O4-NH2/COOH, respectively.  As expected, the value 
obtained for unfunctionalised Fe3O4 NPs is lower than that of bulk magnetite (92 emu × 
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g-1) which was attributed to particle size and to surface effects such the presence of a 
magnetically inactive layer.34 The saturation magnetisation for the Fe3O4-NH2/COOH 
is smaller than that of unfunctionalised Fe3O4 NPs by 5 % and is due to the non-
magnetic shell around the nanoparticles. The results are in line with elemental analysis 
and TGA data. As anticipated, the saturation values for the Fe3O4-NH2/COOH are 
significantly higher than that reported for the commercial formulation of iron oxide MRI 
agent Feridex I.V. (Ms= 9.5 emu × g-1).35 The higher magnetisation values can be 
attributed not only to the thinner organic coating on the surface of the NPs but also to 
the larger nanoparticle cores (25 nm compared with 5 nm). It is important to note that 
Fe3O4-NH2/COOH nanoparticles maintained their superparamagnetic properties which 
are essential for the intended biological applications described in Chapter 3.  
The dispersibility and stability of functionalised nanoparticles in water is dependent on 
the interaction between water and the functional groups present on their surface. The 
Fe3O4-NH2/COOH dispersions resulted in almost transparent solutions indicative of the 
good interaction with water. On the other hand, for the unfunctionalised Fe3O4 and 
Fe3O4-NH2 NPs opaque dispersions were obtained in which aggregation could be 
observed (Figure 2.9). 
 
Figure 2.9 Images of 0.1 mg/mL nanoparticle dispersions of (A) Fe3O4, (B) Fe3O4-NH2 
and (C) Fe3O4-NH2/COOH in water. 
A B C
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The colloidal stability properties of Fe3O4-NH2/COOH nanoparticles in comparison 
with the unfunctionalised Fe3O4 and Fe3O4-NH2 NPs were investigated using an 
absorbance method adapted from de Palma et al.26 The absorbance of known 
nanoparticles concentrations in water was monitored at a fixed wavelength (850 nm) for 
five hours (Figure 2.10). A constant value of the absorbance as a function of time would 
indicate of a stable dispersion while a decrease in absorbance would indicate of 
sedimentation of the nanoparticles.  
 
Figure 2.10 Colloidal stability of the Fe3O4 (blue line), Fe3O4−NH2 (red line) and Fe3O4-
NH2/COOH (green line) NPs in water, at room temperature. 
The results are concentration dependent but from the absorbance curves at the 
investigated concentration (0.1 mg/mL), it can be seen that the nanoparticles are settling 
with time. After a five hour period the absorbance of Fe3O4 and Fe3O4-NH2 NPs 
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dispersions showed 100 % decrease. This is indicative of complete sedimentation of 
nanoparticles at the bottom of the vial. The Fe3O4-NH2/COOH showed improved 
stability and hence slower sedimentation which can be attributed to the presence of the 
amino and carboxylic acid groups on the surface of the nanoparticles. Both 
functionalities act as a polyelectrolyte and help to stabilise the nanoparticles via 
electrostatic repulsion. The presence of the surface charge was confirmed using zeta 
potential measurements which showed that the Fe3O4-NH2/COOH are negatively 
charged (-31.0 ±0.5 mV) when dispersed in water. As expected the surface charge 
influenced their colloidal stability. 
Post-modification with succinic anhydride of the amino functionalised Fe3O4 
nanoparticles is an efficient route for inducing bifunctional properties originating both 
from carboxylic acid and amine groups. The improved magnetic properties are making 
the bifunctionalised nanoparticles superior to the existing MRI contrast agent Feridex 
I.V. However, there is a room to improvement of the colloidal stability which could be 
possibly optimised by varying the size of the magnetic core and the ratio between 
carboxylic acid and amine groups present on their surface. 
2.3.2 Surface modification Fe3O4 nanoparticles with other functional 
silane ligands  
The commercial unfunctionalised Fe3O4 NPs were used in functionalisation experiments 
performed with –Br, –I, –CH=CH2, –C≡N terminated silane ligands following the exact 
conditions developed for APTES functionalisation. The reactions with different 
terminated silane ligands were performed to obtain more information on the silane layer 
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formation (surface coverage) and to access iron oxide nanoparticles with various surface 
functionalities. The chemical structure of the silane molecules employed in this study 
for the functionalisation of iron oxide particles are shown in Scheme 2.4. 
 
Scheme 2.4 Functional surface-modifying organosilanes employed for Fe3O4 nanoparticle 
functionalisation: (a) 3-bromopropyltrimethoxysilane (BPTMS), (b) 3-
iodopropyltrimethoxysilane (IPTMS), (c) vinyltrimethoxysilane (VTMS), (d) 3-
cyanopropyltriethoxysilane (CPTES). 
The success of the surface modification with these organosilane molecules was 
qualitatively evaluated by FTIR spectroscopy and quantified by elemental analysis. In 
comparison with the unfunctionalised Fe3O4 nanoparticles, the infrared spectra (Figure 
2.11) of the functionalised particles show the characteristic peaks of the respective 
modifying reagents. The formation of the silane layer was confirmed by the presence of 
the characteristic bands Si-O-Si in the fingerprint region between 1300 and 900 cm-1.28 
These bands could be observed for all functionalised nanoparticles. The vibrational 
absorption of C-H, characteristic for all samples, is present in the fingerprint region 
between 2925 and 2850 cm-1.  
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For Fe3O4–Br and Fe3O4–I nanoparticles the C-Br and C-I bands cannot be observed as 
they overlap with the footprint of Fe3O4. In case of Fe3O4–CH=CH2 nanoparticles, the 
spectrum shows two distinct signals: one at 3056 cm-1 and the other one at 1620 cm-1 
indicative of the =C-H stretch in terminal vinyl and of the unsaturated hydrocarbon C=C 
stretch respectively. In case of Fe3O4–C≡N nanoparticles the typical stretching band for 
nitriles (–C≡N) which appears at 2252 cm-1 could be identified in the FTIR spectrum. 
 
Figure 2.11 FTIR spectra of unfunctionalised Fe3O4 (black line), Fe3O4−Br (purple line), 
Fe3O4−I (green line), Fe3O4−CH=CH2 (pink line) and Fe3O4−C≡N (olive line). 
Surface coverage was evaluated from the elemental analysis data for each type of 
functionalised-nanoparticle. The results (functionalisation degree per mass unit particles 
f, the surface coverage C, the number of ligands
 
per nanoparticle nL and the average 
number of ligands per surface area A) are summarised in Table 2.1. The surface 
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coverage calculations were carried out following the established line of equations from 
2.1 to 2.10.  
Table 2.1 Functionalisation degree f (from elemental analysis), calculated surface coverage 
C, number of ligands per nanoparticle nL, average number of ligands per surface area A for 
Fe3O4 nanoparticles surface-modified with different silane molecules. 
Functional  
silane 
f 
(mmol × g-1) 
C 
(µmol × m-2) 
nL 
(×103 per 
particle) 
A 
(ligands/nm2) 
APTES 
BPTMS 
0.34 
0.26 
7.30  
5.58 
8.61 
6.62 
4.38 
3.37 
IPTMS 0.27 5.80 6.86 3.5 
VTMS 0.50 10.74 12.6 6.4 
CPTES 0.26 5.58 6.62 3.37 
 
It is important to note that the numbers presented are an estimation as to the extent of 
functionalisation because the reactivity of the silane ligands towards the surface depends 
on a number of factors including: silane binding mode to NPs surface, the nature of the 
terminal functional group, silane concentration, reaction temperature and nature of the 
anchoring group amongst other parameters.14 
The calculated values of the surface coverage for all modified nanoparticles show the 
formation of a dense silane layer. Vinyl-modified nanoparticles show the highest surface 
coverage most probably because of the presence of a shorter aliphatic ethylene chain in 
the original silane ligand. In case of Fe3O4−Br, Fe3O4−I or Fe3O4−C≡N modified 
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nanoparticles the degree of functionalisation f is in the same range due to the structural 
similarity of the silane ligands. The results are comparable to other reported values for 
the monolayer formation of silanes on different surfaces.26, 12  
Surface functionalisation could be achieved with all silane ligands. VTMS showed the 
highest coverage while all the other silanes had comparable coverage due to their similar 
structures. 
The introduction of different chemical groups on surface of nanoparticles allowed the 
access to a number of post-modification reactions leading to multifunctional organic-
inorganic hybrids. For example, the –Br functionalised nanoparticles were used to coat 
the nanoparticles with pH sensitive polymer chains like poly(diethyl 2-diethylamino) 
ethyl methacrylate (PDEAEMA); while the –CH=CH2 terminated nanoparticles were 
used in a thiol-ene click model reaction with mercaptopropionic acid.
 
  
2.3.3 pH-responsive PDEAEMA-functionalised Fe3O4 nanoparticles 
using the “grafting from” approach 
The –Br groups on Fe3O4−Br particles were used as initiating groups to start 
polymerisation from the nanoparticle surface in a “grafting from” approach. Surface-
initiated atom transfer radical polymerisation was used to graft (2-diethylamino) ethyl 
methacrylate (DEAEMA) chains on the surface thus enabling the synthesis of magnetic 
core-polymer brush like structures.36-37 The resulting sample was denoted as 
Fe3O4−PDEAEMA (Scheme 2.5).   
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Scheme 2.5 Schematic illustration of PDEAEMA coating on the surface of Fe3O4 
nanoparticles using a grafting from approach. 
Successful grafting was confirmed by FTIR, elemental analysis and TGA. FTIR spectra 
of Fe3O4-Br, pure PDEAEMA polymer and Fe3O4−PDEAEMA nanoparticles are 
shown in Figure 2.12. The spectrum for Fe3O4−PDEAEMA showed the key bands 
origination from both nanoparticle and the polymer component. The characteristic bands 
for the C-H stretching vibrations of methylene and methyl are present in the region 
between 2980 and 2800 cm-1. Additionally, the carbonyl peak at 1729 cm-1 together with 
the peaks at 1221 cm-1 (Si-O-Si bond) and at 580 cm-1 (Fe-O stretch) are evidence for 
the attached silane layer and grown PDEAEMA polymer chains.  
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Figure 2.12 FTIR spectra of Fe3O4−Br (black line), Fe3O4−PDEAEMA (green line) 
hybrid nanoparticles and PDEAEMA pure polymer (red line). 
The composition of the resulting Fe3O4−PDEAEMA nanoparticles was confirmed by 
thermogravimetric analysis. As expected, the polymer grafted nanoparticles showed a 
significant weight loss difference compared to the original Fe3O4−Br nanoparticles 
(Figure 2.13). The results show that the weight losses of Fe3O4−Br and 
Fe3O4−PDEAEMA are 4.1% and 15.5% respectively, when the samples are heated to 
600 °C. In the case of the Fe3O4−Br nanoparticles, a large weight loss is observed in the 
region of 300-400 °C which can be attributed to the presence of heavy bromine atoms. 
This type of thermal decomposition profile was previously reported for other 
bromosilane functionalised nanoparticles.38 Subsequently, the grafted polymer 
component was calculated by subtraction of the weight loss of Fe3O4−Br from the 
Fe3O4−PDEAEMA. The calculated polymer grafted fraction was 11.4% by weight 
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which shows that PDEAEMA chains are successfully grafted on the surface of the 
nanoparticles. 
 
Figure 2.13 TGA curves of Fe3O4−Br (black line) and Fe3O4−PDEAEMA (green line).  
Additionally the Fe3O4−PDEAEMA nanoparticles, after extensive purification 
performed to remove any potential free monomer or polymer, were water dispersible at 
low pH in contrast with the Fe3O4−Br.  This is an indication of the change in the surface 
functionality of the nanoparticles and that the pH sensitivity properties of the polymer 
have been transferred to the particles. PDEAEMA above the pKa of 7.3 is neutral and 
not soluble in water.39 In acidic environment below the pKa, the polymer becomes 
soluble as a weak cationic polyelectrolyte and the protonated chains have an extended 
conformation (Scheme 2.6).  
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Scheme 2.6 Schematic representation of the structural changes of the PDEAEMA 
polymer chains in different pH environments. 
After grafting the PDEAEMA chains on the surface of the nanoparticles, the pH-
dependent dispersibility of 0.1 mg/mL of Fe3O4−PDEAEMA suspensions (pH 4 and 
pH 10) was optically monitored (Figure 2.14). In acidic environment (pH 4), the 
Fe3O4−PDEAEMA nanoparticles are stable in solution due to the polymer chains which 
become partly or entirely protonated. The electrostatic repulsions and strong steric effect 
of the extended chains help to stabilise the nanoparticles. However, in alkaline 
conditions, NPs flocculate and precipitate due to the collapse of the polymeric chains.   
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Figure 2.14 Images of Fe3O4−PDEAEMA nanoparticle dispersions at pH 10 and pH 4.  
The Fe3O4−PDEAEMA nanoparticles could be used as pH-responsive materials, as 
solubility modifiers or in drug delivery systems where the pH control is required. In the 
drug delivery system, pH-responsive polymer chains on the nanoparticles would hold 
the drug molecules within the polymer shell during particle circulation. Whereas, upon 
exposure to a low pH environment, the polymer attached to the NPs would swell 
resulting in the release of the drug which would be beneficial in a case such as the 
treatment of tumours.40-41 
2.3.4 Thiol-ene click reaction of Fe3O4−CH=CH2 with 3-
mercaptopropionic acid 
Click reactions have created a great deal of attention for post-modification of materials 
due to their high efficiency, little or no side reactions, aqueous and low temperature 
competency, avoidance of protecting groups and broad applicability on different 
substrates.42  
pH 10 pH 4
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Among these reactions, thiol-ene click is a type of free-radical reaction that proceeds by 
a step-growth mechanism involving two main steps: a free-radical addition followed by 
a chain transfer reaction (Scheme 2.7).43 
 
Scheme 2.7 Generalised thiol-ene click coupling mechanism. 
 
The accessible double bonds on the surface of Fe3O4−CH=CH2 nanoparticles allow 
direct coupling with 3-mercaptopropionic acid. Using this approach, carboxylic acid 
functionalities were introduced on the surface of nanoparticles. The surface modified 
nanoparticles, denoted Fe3O4−S−COOH, were characterized by TGA, FTIR 
spectroscopy and fluorescence imaging. The chemical composition of the nanoparticles 
after the addition of 3-mercaptopropionic acid at the surface was investigated using 
TGA. Figure 2.15 shows the TGA curves of Fe3O4−CH=CH2 and Fe3O4−S−COOH 
nanoparticles.  
Cristina I. Olariu               Surface modification of iron oxide nanoparticles using functional silane ligands 
 
103 
 
 
Figure 2.15 TGA curves of Fe3O4−CH=CH2 (pink line) and Fe3O4−S−COOH (cyan line) 
nanoparticles.  
The TGA results show that the associated weight losses for Fe3O4−CH=CH2 and 
Fe3O4−S−COOH nanoparticles are 2.5% and 8.5% respectively when the nanoparticles 
are heated to 600 ⁰C. From this data, the number of vinyl ligands which were modified 
during the thiol-ene reaction was calculated using the formula 2.13 presented in section 
2.3.1 of this chapter. The deconvoluted weight loss is 6% wt which allowed estimation 
of the number of carboxylic acid as 11.4 × 103 groups per nanoparticle. When compared 
with the total number of −CH=CH2 calculated per nanoparticles (Table 2.1) it is clear 
that the reaction yield is very high (~ 90%). This is another demonstration of the 
efficiency of thiol-ene click chemistry.   
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Figure 2.16 shows the FTIR transmission spectra of the thiol-ene modified 
Fe3O4−S−COOH nanoparticles and the native Fe3O4−CH=CH2 nanoparticles for 
comparison. The characteristic band for C=O stretching vibration of the carboxylic acid 
groups at 1702 cm-1 are present in the spectrum of Fe3O4−S−COOH. Additionally, after 
the reaction with mercaptopropionic acid, the =C-H stretching band for the vinyl group 
in the region of 3056 cm-1 has disappeared indicating that all the vinyl groups have 
reacted during the  thiol addition reaction.  
 
Figure 2.16 FTIR spectra of thiol-ene reaction with 3-mercaptopropionic acid. Spectra of 
Fe3O4−S−COOH (cyan) and Fe3O4−CH=CH2 (pink) nanoparticles.  
To demonstrate the reactivity of the carboxylic acid groups on the outer layer of 
Fe3O4−S−COOH, fluorescein-5-thiosemicarbazide (FITC, λex =492 nm, λem =517 nm) a 
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green fluorescent tag, was used to 
tag was covalently conjugated to the carboxyl groups on
nanoparticles via EDC/sulfo
Scheme 2.8 Fluorescein
nanoparticles using EDC/
The excess of fluorescent dye was removed by washing the nanoparticles repeatedly 
with DMSO and water. The fluorescently labelled nanoparticles were evaluated using 
fluorescence microscopy. 
of the fluorescein-labelled Fe
Figure 2.17 Bright field (left) and green fluorescent image (right) of fluorescein
magnetic nanoparticles. Scale bar represents 10 µm.
rticles using functional silane ligands
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label and visualise the nanoparticles. Th
 Fe
-NHS coupling as shown in Scheme 2.8. 
-5-semithiocarbazide covalent conjugation to Fe
sulfo-NHS coupling. 
Figure 2.17 shows a representative fluorescence micrograph 
3O4 nanoparticles.  
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The fluorescent emission in green clearly confirms the selective functionalisation with 
fluorescein of the carboxylic acid groups on the surface via EDC/sulfo-NHS coupling 
chemistry. A control experiment, which was carried out under identical conditions 
except for the addition of EDC and sulfo-NHS to the Fe3O4−S−COOH particles, did 
not yield fluorescent nanoparticles. This demonstrated that the fluorescently labelled 
nanoparticles were not the result of a physical mixture but actual chemical binding.  
The vinyl terminated nanoparticles can provide a convenient platform for conjugation of 
any thiol containing proteins or peptides to the surface of the nanoparticles. For 
example, the thiol-ene click reaction proved to have a good yield when 3-
mercaptopropionic acid was used as a model compound.  
2.4 Conclusions  
The versatile silanisation strategy presented in this chapter is an effective method for 
introducing various functional groups directly onto the surface of unfunctionalised 
Fe3O4 nanoparticles. The value of this approach is to demonstrate that not only amino 
and carboxylic groups (commonly employed in the literature) but also other functional 
group can be used to attach biomolecules or biocompatible coatings. Five different 
silane ligands were used to introduce functional groups such as –NH2, –Br, –CH=CH2,  
–I and –C≡N on the surface of Fe3O4 with each silane ligand to be shown capable of 
forming a dense silane monolayer covalently attached to the surface of the nanoparticle. 
This simple one-step procedure could be employed to commercially available 
nanoparticles and should provide an affordable route with good reproducibility and 
scaling up opportunities.  
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The nanoparticles functionalised by amino groups were further modified by a partial 
conversion –NH2 to –COOH groups using a simple succinylation reaction. The presence 
of the amino and the carboxylic acid groups on the surface of the nanoparticles afforded 
a bifunctional surface. Such surfaces can offer an advantageous possibility for 
independent attachment of fluorescent tags and bioactive molecules through conjugation 
reactions. The development of the bioconjugation protocols, MRI imaging and targeting 
of specific receptors on cancer cells using bifunctionalised nanoparticles will be 
explored in Chapter 3.  
The other functional groups such as –Br and –CH=CH2 could be successfully engaged 
in post-modification reactions to further increase the potential for particle 
functionalisation. The pH sensitive properties of PDEAEMA polymeric chains can be 
directly transferred to the nanoparticles pre-functionalised with the bromine groups 
while thiol-ene click is a convenient platform for introducing functionalities on the vinyl 
terminated nanoparticles.  
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Chapter 3  
Tumour targeting and imaging potential of bifunctionalised 
nanoparticles 
3.1 Introduction 
Active tumour targeting refers to selective accumulation and uptake of 
superparamagnetic iron oxide nanoparticles (SPIONs) in tumours and can be achieved 
by using tumour-selective ligands. Carefully selected ligands (e.g. antibodies, peptides, 
small molecules) that are peripherally attached to the SPIONs surface specifically bind 
receptors that are overexpressed on the tumour cells.1-3 In particular, antibody targeting 
is regarded as a promising strategy to selectively direct the SPIONs to the tumour region 
and accomplish early tumour detection. Various therapeutic antibodies are available on 
the market and have shown promising results for treatment of breast cancer 
(Herceptin®), colorectal cancer (Erbitux®), as well as brain cancer, colon cancer and 
kidney cancer (Avastin®). In addition, Hodgkin lymphoma (Adcetris®), prostate cancer 
(ProstaScint®) and non-Hodgkin's lymphoma (Zevalin®) could be treated when 
antibodies were used in combination with chemotherapeutic drugs or with 
radioisotopes.4 However up to date there are no examples of clinically approved 
formulations of antibodies conjugated to SPIONs or other nanoparticles. The 
conjugation of antibodies to SPIONs can offer versatility through integration of the 
nanoparticle magnetic properties with the antibody-antigen affinity and therefore 
specificity for detecting cancer as illustrated in Figure 3.1.5 Although certain challenges 
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should be overcome before the launch of clinical applications there are some examples 
of antibody-conjugated SPIONs systems that have shown promising in vitro and in vivo 
results.6-12   
 
Figure 3.1 Advantages of antibody conjugation of to nanoparticles. The figure was adapted 
from ref. 5 
In a notable study, Toma et al. evaluated binding ability of the monoclonal antibody A7 
conjugated to SPIONs with human colonic carcinoma cells.6 A larger amount of the 
specific A7-SPIONs was accumulated in the tumour cells when compared to a control 
experiment which involved SPIONs conjugated with a non-specific antibody. 
Furthermore, the specificity was demonstrated by the higher levels of A7-SPIONs 
detected in the tumour than in either blood or normal tissues. In MR imaging of nude 
mice bearing human colorectal carcinoma it was shown that in the tumour region the 
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intensity of transverse relaxation signal (T2) was reduced due to the presence of the A7-
SPIONs.  
Antibody molecules such as Herceptin (commercial name Trastuzumab) have been 
explored in combination with SPIONs as targeting and biotherapeutic agents. Herceptin 
targets the Her2/neu receptor which is a growth factor and is essential for cell 
proliferation. The receptor is expressed on the surface of early stage breast cancer 
tumours and the interaction with Herceptin has been shown to lead to inactivation of the 
receptor and subsequent inhibition of cell proliferation.7 As such, Yang et al. conjugated 
the Herceptin antibody to poly(amino acid)-coated iron oxide nanoparticles (PAION), 
which have abundant amine groups on their surface.8 Bradford protein assay confirmed 
that there were about eight antibodies conjugated to the surface of each nanoparticle via 
amino groups. The authors showed that the T2 relaxation is significantly different 
between the PAION-antibody-treated and untreated cells expressing the Her2 receptor. 
The results demonstrated that Herceptin antibody-conjugated PAION have specific 
targeting ability for Her2/neu receptors. Such Herceptin antibody-conjugated PAION 
with high sensitivity could potentially be used as an MRI contrast agent for the detection 
of Her2/neu positive breast cancer cells. 
Recently, a number of studies have adopted the use of single chain antibodies (scFv) as 
tumour targeting ligands and their conjugation to SPIONs.9-10 One important example of 
using SPIONs conjugated with sm3E, a high affinity scFv reactive to carcinoembryonic 
antigen (CEA) is the study of Vigor et al.9 The group investigated the ability of sm3E, 
conjugated to three types of SPIONs, for selective targeting and imaging of             
CEA-expressing cells. It was shown that the specific targeting with sm3E/ nanoparticles 
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was achievable in vitro but improved MRI contrasting properties, colloidal stability and 
biocompatibility could be achieved only after further optimisation of the size and the 
coating of the nanoparticles. In their work Yang et al. have reported the use of a single-
chain anti-EGFR (endothelial growth factor receptor) antibody (scFvEGFR) conjugated 
to amphiphilic polymer coated iron oxide nanoparticles (IO) for in vivo tumour imaging 
(Figure 3.2).10 
 
Figure 3.2 Examination of target specificity of ScFvEGFR-IO nanoparticles by MRI using 
a human pancreatic tumour model. The areas of the pancreatic tumour were marked as 
pink dash-lined circle. Right is the picture of tumour tissues, showing sizes and locations of 
two intra-pancreatic tumour lesions (arrows) that correspond with the tumour images of 
MRI. The figure was reproduced from ref. 10 
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ScFvEGFR was conjugated to IO nanoparticles using ethyl-3-dimethylaminopropyl 
carbodiimide (EDC) coupling. The in vitro results showed that the scFvEGFR-IO 
nanoparticles specifically bind to EGFR, as demonstrated by Prussian blue staining and 
MRI. For in vivo evaluation of targeting capabilities, EGFR-targeted or nontargeted IO 
nanoparticles were administrated via the tail vein to nude mice bearing orthotopical 
human pancreatic cancer xenograft. The results showed that the scFvEGFR-IO 
nanoparticles were selectively accumulated within the pancreatic tumours as evidenced 
by a decrease in MRI signal in the tumour region and further confirmed by histological 
examination.10  
In this chapter, previously synthesised bifunctionalised Fe3O4-NH2/COOH 
nanoparticles as described in Chapter 2 were evaluated for their targeting and imaging 
capabilities with epithelial pancreatic cancer cells overexpressing the epithelial cell 
adhesion molecule receptor (EPCAM). For achieving these objectives first the potential 
cytotoxicity of the Fe3O4-NH2/COOH was investigated using different cells lines and 
three types of viability assays, i.e. MTS, WST-8 and live/dead assays. Then the     
Fe3O4-NH2/COOH nanoparticles were conjugated with a fluorescent dye (RITC, 
Rhodamine B isothiocyante) and a monoclonal anti-EPCAM antibody. RITC was 
covalently conjugated to the nanoparticles using the available –NH2 groups, while 
EPCAM was conjugated with the –COOH groups via carbodiimide coupling chemistry. 
An essential requisite for successful conjugation of biomolecules was not to 
compromise their native conformation and binding profile. This can be a challenging 
task because for many biomolecules only limited chemical modifications can be 
tolerated in order not to lose their bioactivity.13  
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Quantification of the EPCAM antibodies conjugated to the surface of the functionalised 
nanoparticles was determined using an optimised protein Bradford assay. The MRI 
contrast capabilities of the bifunctionalised nanoparticles were evaluated by relaxation 
time measurements with specific focus on the T2 relaxation time. The selectivity of the 
specific antibody-nanoparticle conjugates to the targeted cells in vitro was evaluated 
using fluorescence microscopy, while the internalisation of these was visualised via 
confocal microscopy.  
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3.2 Experimental Section 
3.2.1 Materials 
Sodium phosphate dibasic dihydrate (Na2HPO4*2H2O, ≥ 99.5 %), potassium phosphate 
monobasic (KH2PO4, ≥99%), potassium phosphate dibasic (K2HPO4, ≥ 99%), sodium 
chloride (NaCl, ≥ 99.5%), potassium chloride (KCl, ≥ 99%), fluorescein isothiocyanate 
(FITC, 98%), rhodamine B isothiocyanate (RITC, BioReagent), albumin–fluorescein 
isothiocyanate conjugate (BSA-FITC, Bioreagent), tris(hydroxymethyl)aminomethane 
(TRIZMA base, ≥ 99.9 %), N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (EDC, ≥ 99.0 %), N-hydroxysulfosuccinimide sodium salt (sulfo-NHS, ≥ 
98.5 %), Dulbecco’s modified eagle’s medium - high glucose (DMEM), fetal calf serum 
(FCS), L-glutamine solution, penicillin G sodium salt (BioReagent), streptomycin 
sulfate salt (BioReagent), trypsin-EDTA solution (0.5 g porcine trypsin and 0.2 g EDTA 
× 4Na per liter), Bradford assay, Vivaspin 500 centrifugal concentrators 30kDa, Nunc 2-
wells chamber slide system, 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-
disulfophenyl)-2H-tetrazolium monosodium salt (WST-8 assay), Live/Dead cell double 
staining kit, 4’,6-diamidino-2-phenylindole dilactate (DAPI, ≥ 98%),                          
1,4-diazobicyclo-octane (DABCO), Mowiol 4-88 (MW 31000), glycerol (≥ 99%), 
dimethyl sulfoxide (DMSO, ≥ 99.9%) were purchased from Sigma-Aldrich, UK.  
The 27 mm glass base IWAKI tissue culture dishes were purchased from Scientific 
Laboratory Supplies UK. 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium (MTS assay) was purchased from Biomedica, Vienna, 
Austria. The monoclonal anti-EPCAM antibody specific for human EPCAM antigen 
was purchased from Monosan, Cambridge, UK. The polyclonal antibody, an Isotype 
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control was obtained from Abcam, Cambridge, UK. A list of the buffer recipes prepared 
and used during bioconjugation reactions and cell work is detailed below.  
Table 3.1 Solutions for RITC coupling to Fe3O4-NH2/COOH nanoparticles 
Buffers Formula 
500 mM Carbonate buffer  1.7 g Na2CO3, 2.8 g NaHCO3 dissolved 
into 90 mL dH2O. pH adjusted to 9.5 and 
volume topped-up to 100 mL. 
PBS  
[137 mM NaCl, 2.7 mM KCl,  
8 mM Na2HPO4, 1.46 mM KH2PO4] 
8 g NaCl, 0.2 g KCl, 1.424 g 
Na2HPO4*2H2O, 0.2 g KH2PO4 dissolved 
into 900 mL dH2O. pH adjusted to 7.4 and 
volume topped-up to 1 liter.  
10 mM Tris buffer  0.142 g TRIZMA base, 0.87 g NaCl 
dissolved into 90 mL dH2O. pH adjusted 
to 8.2 and volume topped-up to 100 mL. 
 
Table 3.2 Solutions for BSA-FITC/ EPCAM coupling to Fe3O4-NH-RITC/COOH 
Buffers Formula 
10 mM Phosphate buffer  
 
0.14 g K2HPO4, 1.24 g KH2PO4, 0.87 g 
NaCl dissolved in 90 mL dH2O. pH 
adjusted to 5.5 and volume topped-up to 
100 mL. 
 
EDC/ sulfo-NHS activation solution 38.3 mg EDC and 10.8 mg sulfo-NHS 
dissolved in 1 mL potassium phosphate 
buffer.  
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Table 3.3 Solutions for cell culture   
Buffers Formula 
Cell culture medium 10% Fetal calf serum, 2 mM L-glutamine, 
2500 I.U./mL penicillin and 5 µg/mL 
streptomycin added to supplement DMEM 
cell culture medium 
Freezing medium 90% Fetal calf serum, 10% DMSO 
 
Table 3.4 Solutions for immunostaining of adherent cells 
Buffers Formula 
4% PFA Fixating solution   4 g paraformaldehyde dispersed in 50 mL 
dH2O heated to 60 ⁰C. During heating 1 N 
NaOH was added drop by drop with 
stirring until the solution became clear. 
The solution was cooled down to room 
temperature and volume was adjusted with 
40 mL dH2O and 10 mL PBS. Finally the 
solution was filtered using a 0.2 µm 
syringe filter. 
Blocking buffer 5% bovine serum albumin (BSA) in PBS. 
DAPI solution  
 
0.2 M Tris buffer pH 8.5 
0.5 µg/mL in PBS. Stored in 1mL aliquots 
in the dark at -20 ⁰C. 
2.42 g TRIZMA base into 90 mL dH2O. 
pH adjusted to 8.5 and volume topped-up 
to 100 mL. 
Mowiol mounting solution  2.4 g of Mowiol 4-88 and 6 g of glycerol 
combined in 6 mL of dH2O and mixed for 
3 hours. 12 mL of 0.2 M Tris (pH 8.5) 
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were added and the solution was incubated 
with mixing at 50°C for 10 min. To 
remove any insoluble material the solution 
was centrifuged at 5000g for 15 min. The 
anti-photobleaching agent DABCO was 
added to a final concentration of 2.5%. 
Finally the solution was stored in 500 µL 
aliquots at −20°C. 
 
3.2.2 Bioconjugation methods 
The bioconjugation methods for coupling of the fluorescent molecules and proteins with 
the bifunctionalised nanoparticles, Fe3O4-NH2/COOH, were adapted from the 
Hermanson textbook.14 
3.2.2.1 Fluorescent dye coupling to Fe3O4-NH2/COOH nanoparticles 
Fe3O4-NH2/COOH nanoparticles (1 mg) were suspended by 2 minutes sonication in 
carbonate buffer (0.9 mL, pH=9.5, Table 3.1). Then RITC dissolved in DMSO         
(0.1 mL, 0.01% w/v) was added to the nanoparticle suspension. The reaction mixture 
was covered with aluminium foil to avoid any photobleaching and gently rotated 
overnight at room temperature. The fluorescently labelled nanoparticles were collected 
with a magnet and washed with Tris buffer (aliquots of 1 mL, pH=8.2, Table 3.1) until 
the solution ran clear. The resulting nanoparticles were re-dispersed in Tris buffer         
(1 mL) and stored at 4 ⁰C fully covered with aluminium foil. The resulting nanoparticles 
labelled with fluorescent dye were denoted as Fe3O4-NH-RITC/COOH. 
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3.2.2.2 Bioconjugation of fluorescently labelled bovine serum albumin (BSA-FITC) 
with the Fe3O4-NH-RITC/COOH  
The BSA protein labelled with a green fluorescent tag (BSA-FITC) was conjugated to 
the carboxylic acid groups of Fe3O4-NH-RITC/COOH via carbodiimide coupling 
chemistry using EDC and sulfo-NHS.  
Fe3O4-NH-RITC/COOH nanoparticles (1 mg) were dispersed in potassium phosphate 
buffer (0.5 mL, pH=5.5, Table 3.2). To this dispersion, an aliquot of EDC/sulfo-NHS 
activation solution (0.5 mL, Table 3.2) was added and the mixture was gently rotated 
for 4 hours at room temperature. COOH activated nanoparticles were washed with PBS 
in order to remove residual EDC and sulfo-NHS. BSA-FITC was added to the 
nanoparticles (10 µg in 1 mL PBS) and the mixture was gently rotated overnight fully 
covered with aluminium foil. The resulting nanoparticles were collected with a magnet 
and repeatedly washed with PBS to remove any unbound BSA-FITC. 
This bioconjugation protocol was also followed when coupling a specific antibody 
(EPCAM) or a non-specific isotype control antibody (ISO) to the Fe3O4-NH-
RITC/COOH nanoparticles. Two different samples were prepared and denoted as 
Fe3O4-NH-RITC/CO-EPCAM and Fe3O4-NH-RITC/CO-ISO respectively.  
3.2.3 Analysis of EPCAM conjugation to the Fe3O4-NH-RITC/COOH 
nanoparticles 
The number of EPCAM antibody molecules conjugated to surface of the Fe3O4-NH-
RITC/COOH nanoparticles was estimated using the Bradford assay. The EPCAM 
antibody was conjugated to the fluorescently labelled nanoparticles using the protocol 
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described in section 3.2.2.2. The carboxylic acid groups of Fe3O4-NH-RITC/COOH 
nanoparticles (1 mg) were activated using EDC and sulfo-NHS for 4 hours. The 
activated nanoparticles were washed and then incubated overnight with the EPCAM 
antibody (23 µg in 1 mL PBS). After the conjugation, the nanoparticles were washed 
with PBS. The supernatants were collected, concentrated and mixed with Bradford 
reagent to give a blue coloured complex with a maximum absorbance at 595 nm. A 
calibration curve of known antibody concentrations was plotted and the unreacted 
EPCAM in the supernatants was determined. Finally the concentration of EPCAM 
bound to the nanoparticles was determined by difference from the initial concentration.  
3.2.4 Magnetic Resonance Imaging (MRI) capability of 
bifunctionalised nanoparticles 
To determine the MRI potential of the magnetic nanoparticles, serial dilutions of the 
unfunctionalised Fe3O4 and bifunctionalised Fe3O4-NH2/COOH were prepared in 1% 
agarose solution at concentrations of 0.01, 0.05, 0.1 and 0.2 mM Fe. The samples were 
aliquoted in eppendorf tubes (300 µL) and placed in a polystyrene MRI holder. The 
samples were then scanned and images were acquired using a Bruker Avance III console 
and gradient system interfaced to a Magnex Scientific 7 T horizontal bore magnet at a 
1H resonant frequency of 300 MHz. T2 relaxation time was calculated from a set of 
RARE60 images acquired with TR=5000 ms and TE values of 11, 33, 55 and 77 ms.  
The MRI measurements were carried out by Ms. Karen Davies at the Department of 
Imaging Science and Biomedical Engineering, University of Manchester.  
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3.2.5 Cell culture 
Cell culture procedures were carried out inside a class II flowhood, following standard 
tissue culture techniques.15 Culture medium (DMEM), PBS, trypsin/EDTA were pre-
warmed to 37 °C in a water bath prior to use. Cells were incubated at 37 °C in a tissue 
culture incubator with humidified atmosphere of 5% CO2. 
3.2.5.1 Thawing frozen cells protocol 
Cell lines purchased from American Type Culture Collection were stored in frozen 
aliquots upon arrival. To be able to use them in culture, the cell aliquots were thawed at 
37 °C and resuspended by dropwise addition of pre-warmed culture medium (10 mL). 
The cells suspension was centrifuged at 1000 rpm to obtain a complete pellet. After 
centrifugation, the cells were gently resuspended in fresh culture medium (5 mL) and 
seeded into T25 culture flasks until confluent.  
3.2.5.2 Passaging of adherent Panc-1 cells in culture 
Once confluent, the cells were passaged regularly twice a week in a split ratio of 1:10. 
The spent culture medium was discarded and the cells were gently washed twice with 
PBS (10 mL). Extra care was taken in order to avoid disturbing the adherent cell layer. 
The PBS was discarded and the cells were detached from the flask (trypsinisation) by 
incubation with trypsin/EDTA (3 mL) for 4 min at 37 °C. For complete detachment of 
cells the flask was gently tapped twice and 7 mL of fresh culture medium was added to 
resuspend the cells. The cells were pelleted at 1000 rpm and resuspended in fresh 
culture medium (10 mL). At this stage the total number of cells was determined using a 
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hemocytometer. Two millilitres of resuspended cells were seeded into a T150 culture 
flask containing fresh culture medium (18 mL).  
3.2.5.3 Counting cells using a hemocytometer 
During the cells passaging procedure the total number of cells was determined using a 
hemocytometer. After trypsinisation and resuspension of the cells in fresh medium, an 
aliquot of the cells (10 µL) was added to a clean hemocytometer. Cells were counted in 
the four gridded squares of the hemocytometer (red areas in Figure 3.3). The averaged 
numbers from the four counts were multiplied by 104 to obtain the number of cells per 
mL. The counting procedure was repeated twice on two separate samples. 
 
Figure 3.3 Graphic representation of a hemocytometer used for counting of the cells. 
3.2.5.4 Cryogenic storage of cells  
Once cells were confluent, culture medium was removed and cells washed with PBS (10 
mL). The PBS wash was discarded and cells were detached from the flask by 
Included cells 
Excluded cells 
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trypsinisation (3 mL). Equal volume of fresh culture medium was added to resuspend 
the released cells. Cells were pelleted at 1000 rpm for 5 minutes. Media was removed 
and the cells were washed with PBS (10 mL) and the centrifuged for 5 minutes at 1000 
rpm. The cells were resuspened in fresh medium (5 mL) and aliquoted into cryotubes (1 
mL each). To each cryotube an aliquot of freezing medium (0.25 mL) was added (see 
Table 3.3). The cryotubes were placed on ice for 20 minutes before being stored at         
-80 oC. 
3.2.6 Cytotoxicity of functionalised nanoparticles 
3.2.6.1 Sterilisation of functionalised nanoparticles 
Sterile magnetic nanoparticle dispersions were obtained by autoclaving the 
unfunctionalised Fe3O4 and Fe3O4-NH2/COOH nanoparticles at 121 ⁰C for 30 minutes. 
Once sterilised the nanoparticles were transferred into cell culture medium in the 
laminar flow hood before addition to the cells.  
3.2.6.2 MTS cytotoxicity assay and pancreatic cancer cells  
The effect of functionalised nanoparticles on pancreatic cancer cells (Panc-1) was 
assessed at 48 hours using the MTS assay according to the manufacturer’s instructions. 
Panc-1 cells were seeded in 96-well plates (5000 cells/well) in medium (100 µL) and 
grown for 24 hours to allow cell adherence. The medium was then replaced with a fresh 
portion containing various concentrations of sterile Fe3O4 and Fe3O4-NH2/COOH 
nanoparticles (10-500 µg/mL). Control wells containing cells with only fresh media 
were also included. Cells were incubated for a further period of 48 hours. Then, the 
MTS reagent (10 µL) was added to each well. Absorbance readings at 450 nm were 
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taken at 3 hours following incubation with the MTS reagent. Values were corrected for 
the medium-nanoparticles blank reading; medium-nanoparticles blanks comprised wells 
without cells. Experiments were performed in triplicate using eight wells for each 
treatment. 
3.2.6.3 WST-8 cell proliferation assay and embryonic stem cells  
Mouse embryonic stem cells (E14) were incubated in the presence of functionalised 
nanoparticles to examine if the nanoparticles influence the cell proliferation cycle. The 
cells were seeded in 96-well tissue culture plates (10000 cells/well) in medium (100 µL) 
and grown for 24 hours at 37 °C to allow cell adhesion. At 24 hours post-seeding, sterile 
Fe3O4 and Fe3O4-NH2/COOH nanoparticles were diluted in fresh medium and added to 
the cells in the following concentrations: 10, 20, 50, 100 and 200 µg/mL. Control wells 
containing cells in medium were also included. After 72 hours, the reagent WST-8 (10 
µL) was added in each well. Absorbance measurements were carried out at 450 nm 
following 4 hours of incubation with WST-8. Experiments were performed in triplicate 
using three wells for each treatment. Values were corrected for the medium-
nanoparticles blank reading; medium-nanoparticles blanks comprised wells without 
cells. The cell viability was calculated against the control cells and presented in 
percentage.  
These experiments were performed by Dr. Iryna Palona at the School of Biological 
Sciences, University of Liverpool. 
3.2.6.4 Live/Dead cell assay 
Live/Dead assay is a ready to use staining kit and was utilised to simultaneously 
visualise viable and dead pancreatic cancer cells in the presence of bifunctionalised 
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nanoparticles using fluorescence microscopy. Panc-1 cells were seeded into 35 mm 
dishes in medium (10000 cells/mL). After 24 hours, Fe3O4-NH2/COOH nanoparticles 
were added to the cells in the following concentrations: 10, 25 and 50 µg/mL. Control 
dishes comprising of Panc-1 cells in fresh media were also included. Cells were 
incubated with nanoparticles for another 48 hours. The assay solution (100 µL) was 
added to each dish and the cells were incubated for 15 min at 37 °C. The cells 
fluorescence was detected using a fluorescence microscope with 490 nm excitation for 
simultaneous identification of viable (green) or dead cells (red). The cell viability was 
obtained from 5 different fields per sample and calculated by dividing the number of 
green by the total number of cells (green plus red cells). 
3.2.7 Interaction of EPCAM labelled nanoparticles with Panc-1 cells 
3.2.7.1 Evaluation of expression of EPCAM receptors on the cell surface 
A Standard immunohystochemistry technique was used to evaluate the expression of the 
specific receptors EPCAM on the cells surface (Figure 3.4). Panc-1 cells (10000/well) 
were seeded in 2-well chamber slides in medium (2 mL) and grown for 24 hours to 
allow cell adhesion. Next the medium was discarded; the cells washed with PBS and 
fixed using paraformaldehyde (1 mL, 4%). The fixed cells were incubated with blocking 
solution (1 mL, Table 3.4) for 1 hour at room temperature. Cells were incubated 
overnight at 4 °C with EPCAM antibody 1 (1:50 in PBS). After washing three times 
with PBS, the cells were incubated with 2, secondary antibody Cy3 labelled mouse anti-
rabbit IgG (1:100 in PBS) for 1 hour at 4 °C. After washing three times with PBS, cells 
were stained with DAPI to visualise nuclei and then mounted with Mowiol solution. The 
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cells were imaged using fluorescence microscopy to show the localisation of the specific 
receptors for EPCAM antibody. 
 
Figure 3.4 Immunostaining diagram for assessing the receptors expression on cancer cells. 
3.2.7.2 Antibody targeting experiments 
To determine the targeting abilities and the cellular uptake, Panc-1 cells (10000 
cells/mL) were seeded in glassbase dishes 24 hours prior to the addition of 100 µg/mL 
nanoparticles (Fe3O4-NH-RITC/CO-EPCAM, Fe3O4-NH-RITC/CO-ISO and    
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Fe3O4-NH-RITC/COOH). The cells were incubated in the presence of the 
nanoparticles for 1, 6 and 24 hours. After the set time intervals, the cells were washed 
with PBS (2 mL, five times) and fixed with 4% paraformaldehyde solution for 20 
minutes. Fixed cells were washed with PBS (2 mL, five times) and cellular nuclei were 
stained with DAPI solution (0.5 mL, Table 3.4).  
Fluorescence microscopy and confocal laser scanning microscopy were used to 
investigate the targeting properties of each type of nanoparticle.  
The confocal laser scanning microscopy imaging was performed by Dr. Alec Simpson at 
the Department of Cellular and Molecular Physiology, University of Liverpool.  
3.2.8 Statistical analysis  
Each cytotoxicity experiment was carried out in triplicate. Data are presented as means 
± standard deviation. Differences between values of groups were tested for statistical 
significance using unpaired Student t-test. A P value of less than 0.05 was considered to 
indicate a significant difference. StatsDirect, version 2.7.2, statistical software was used 
for statistical analysis. 
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3.3 Results and discussion 
3.3.1 Cytotoxicity of functionalised nanoparticles  
3.3.1.1 In vitro cytotoxicity with pancreatic cancer cells  
For functionalised nanoparticles to be suitable as diagnostic probes or therapeutic 
agents, they should show minimal toxicity to cells. In vitro toxicological studies and cell 
culture techniques were preferred due to their rapid, efficient and cost effective 
advantages.16 Even though in vitro cytotoxicity experiments must be validated by in vivo 
assessments in order to be meaningful, simple in vitro toxicity assays provide a general 
sense on nanoparticles potential toxicity and risk assessment.  
Cytotoxicity was evaluated using two different cell lines (Panc-1- pancreatic cancer 
cells and E-14 mouse embryonic stem cells) and at different concentrations in order to 
expand the outlook for potential signs of toxicity. As the designed nanoparticles are 
intended as targeting agents for pancreatic cancer, their toxicity was initially 
investigated with pancreatic tumour model cells (Panc-1) which were used in the 
targeting experiments. The degree of cell survival was evaluated by means of the 
standard MTS assay. The cells were incubated with unfunctionalised (Fe3O4) and 
bifunctionalised (Fe3O4-NH2/COOH) nanoparticles for 48 hours and the cell viability 
measured after this period. The results from the MTS assay showed no evidence of 
toxicity for nanoparticle levels up to 100 µg/mL after 48 hours of treatment. At these 
levels the cell viability was above 92% compared to control cells (Figure 3.5).  
For nanoparticle levels above 100 µg/mL the cell viability values were below 80% and 
there was a statistically significant difference compared to the controls. It has to be 
Cristina I. Olariu                         Tumour targeting and imaging potential of bifunctionalised nanoparticles 
 
134 
 
mentioned that above 100 µg/mL the cells were overdosed intentionally to see where the 
maximum limit is. Therefore the decrease in viability was expected.  
 
Figure 3.5 Cell viability of Panc-1 cells after 48 hours incubation with unfunctionalised 
(Fe3O4) and bifunctionalised (Fe3O4-NH2/COOH) nanoparticles at different 
concentrations ranging from 10 to 500 µg/mL. The results are presented as average ± 
standard deviation. Significant difference in cell viability was observed at concentrations 
above 100 µg/mL (Students t test: *p<0.05). 
It is important to notice that Fe3O4-NH2/COOH nanoparticles did not cause any 
additional toxic effect over and above that of unfunctionalised Fe3O4. Other groups have 
also reported that coated iron oxide nanoparticles have good biocompatibility not only in 
vitro but also in vivo and that the cytotoxicity effect is dependent on dose, compositions, 
nanoparticle size and cell types.17-21 In addition to these findings, this study showed that 
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the chemical modification of the nanoparticle surface does not induce toxicity. For the 
cell targeting experiments, concentrations of 100 µg/mL were used, and at this 
concentration, the results showed that the nanoparticles were not cytotoxic when 
compared with the controls. 
3.3.1.2 In vitro cytotoxicity with embryonic stem cells  
To establish if the functionalised nanoparticles can affect other types of cells, a second 
cell line was exposed to various concentrations of nanoparticles for a period of 72 hours. 
Embryonic stem cells (cell line E14) were chosen for this second evaluation because 
stem cells are known to be more sensitive to external factors like nanoparticles. The cell 
viability of embryonic stem cells was evaluated using the WST-8 assay which allows 
assessment of the cell viability after longer exposure times. The cell viability was 
calculated by comparing the absorption of nanoparticle-treated cells to that of control 
cells, which was defined as 100%. Nanoparticles were considered to have a toxic effect 
if the difference between cell growth of controls and cells exposed to nanoparticles was 
statistically significant at p<0.05, as determined by Student’s t test. After 72 hours of 
incubation with nanoparticles concentrations up to 50 µg/mL there was no sign of 
toxicity. The viability values for both types of investigated nanoparticles, Fe3O4 and 
Fe3O4-NH2/COOH, were above 95% compared to controls and there was no statistical 
difference between these groups (Figure 3.6). However at higher dose of nanoparticles, 
100 and 200 µg/mL, the cell survival decreased below 70% and there was a statistically 
significant difference between these groups and the controls (*p< 0.05).  
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Figure 3.6 Cell viability of E-14 cells after 72 hours incubation with non-functionalised 
(Fe3O4) and bifunctionalised (Fe3O4-NH2/COOH) nanoparticles at different 
concentrations ranging from 10 to 200 µg/mL. The results are presented as average ± 
standard deviation. Significant difference in cell viability was observed at concentrations 
above 50 µg/mL (Students t test: *p<0.05). 
From the WST-8 results with embryonic stem cells it is evident that these cells appear to 
be more sensitive than Panc-1 cells. This was not entirely unexpected as these cells are 
reported to be more sensitive to nanoparticle exposure.22-23 At the same time these 
results show that minimal concentrations of nanoparticles (10-50 µg/mL) do not cause 
toxic effects in these cells and are safe to be used for cell labeling and targeting 
experiments. 
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3.3.1.3 Live/Dead cell assay 
Cell viability was also investigated using the live–dead assay (green–red) upon exposure 
to nanoparticles. Live–dead cell viability assay is a double colour fluorescence assay 
that is based on the simultaneous detection of the live and dead cells using one 
excitation wavelength at 490 nm. The live cells have intracellular enzymes (esterases) 
that convert the non-fluorescent cell-penetrating acetoxymethyl ester of calcein (calcein 
AM) to the intensely green fluorescent calcein (emission at 515 nm) which is retained 
within the cells. On the other hand, propidium iodide enters only through the damaged 
membranes of dead cells and upon binding with the nuclear DNA forms a bright red 
fluorescent complex (emission at 617 nm).  
Pancreatic cancer cells, Panc-1, were grown in culture in the presence of different 
concentrations of bifunctionalised Fe3O4-NH2/COOH nanoparticles. Representative 
fluorescence microscopy images of Panc-1 cells exposed to Fe3O4-NH2/COOH 
nanoparticles are shown in Figure 3.7. The images showed that only the green 
fluorescence emission signal could be detected which implied that the cell viability was 
not affected after 48 hours of incubation with Fe3O4-NH2/COOH nanoparticles. For all 
nanoparticle levels, five different fields per sample were analysed and the cell viability 
was estimated to be more than 98% under the tested conditions. The viability was 
determined by dividing the number of green cells by the total number of cells (green 
plus red cells).  
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3.3.2 Fluorescent dye and protein coupling to Fe3O4-NH2/COOH 
nanoparticles 
Rhodamine B isothiocyanate (RITC) is a frequently used fluorescent tag for labelling 
biomolecules which shows an orange-red emission wavelength (λex = 543 nm, λem = 580 
nm). Similar to other isothiocyanate modified fluorophores, RITC is reactive only 
towards the free amine groups (–NH2) present in the lysine units of peptides and 
proteins. The free –NH2 groups on the Fe3O4-NH2/COOH nanoparticles were labelled 
with the RITC fluorescent tag in order to localise and follow the nanoparticles using 
fluorescence microscopy during cell labelling experiments. The resulting nanoparticles 
were denoted as Fe3O4-NH-RITC/COOH and the reaction schematic is illustrated in 
Scheme 3.1.  
 
Scheme 3.1 Illustration of the chemical synthesis of red fluorescently labelled nanoparticles 
Fe3O4-NH-RITC/COOH. 
The fluorescently labelled Fe3O4-NH-RITC/COOH nanoparticles were examined using 
fluorescence microscopy after washing the nanoparticles with Tris buffer (Table 3.1). 
Figure 3.8 shows representative fluorescence microscopy images of the                 
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A 30% yield is reasonable considering that the –NH2 functional groups are rather close 
to each other (~0.3 nm between groups) while the width of a rigid RITC molecule is 
around 1.0 nm (measured with ChemBio3D Ultra 12.0 software). As shown in       
Figure 3.9, the two neighbouring –NH2 groups to the RITC are likely to be blocked for 
further reactions.  
 
Figure 3.9 Schematic comparisons on the size of RITC molecules and the distance 
between amine groups on the surface of bifunctionalised Fe3O4-NH2/COOH 
nanoparticles. 
The conjugation of the RITC fluorescent dye to the amine groups required only mild 
reaction conditions (ambient temperature and a buffer solution with pH = 9.5) which 
implies that the –COOH functional groups are preserved and chemically reactive.  
To investigate whether the carboxyl functional groups are still chemically reactive on 
the Fe3O4-NH-RITC/COOH nanoparticles, a fluorescent model protein, bovine serum 
Width of a RITC ≈ 1.0 nm
Distance between 2 
neighbouring -NH2
groups ≈ 0.3 nm
Fe3O4 nanoparticle surface
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bioconjugations. For this reason, the –COOH groups can be used to conjugate with any 
other targeting biomolecule containing amine groups (specific antibodies, peptides, 
proteins, growth factors). The combination between antibodies and nanoparticles would 
not only provide chemical versatility but also targeting specificity to the nanoparticle 
system.  
3.3.3 Antibody coupling to Fe3O4-NH-RITC/COOH nanoparticles 
The fluorescently labelled Fe3O4-NH-RITC/COOH nanoparticles were given tumour-
targeting capabilities by decorating their surface with specific antibodies. The chosen 
antibody, EPCAM, is known to bind to specific proteins which are over-expressed on 
the surface of epithelial pancreatic cancer cells (Panc-1 cell line).24-25 The EPCAM 
antibodies were conjugated with the available carboxylic acid groups of the           
Fe3O4-NH-RITC/COOH nanoparticles using the carbodiimide coupling chemistry 
(EDC/sulfo-NHS). These nanoparticles were denoted as                                         
Fe3O4-NH-RITC/CO-EPCAM, to illustrate that the EPCAM antibody is attached on 
the –COOH groups while the fluorescent tag RITC is bound to the –NH2 groups. After 
the bioconjugation of EPCAM, quantitative determination of the amount of unreacted 
antibody was used to calculate the number of antibodies bound to the –COOH 
functional groups. This approach was necessary to accurately determine the antibody 
binding since the absorption from the magnetic nanoparticles prevented the direct 
measurement of conjugation in the product. The amount of unreacted antibody was 
determined using absorbance measurements of the supernatant and washing solutions 
after bioconjugation. Bradford assay was employed to quantify the number of unreacted 
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antibodies. First a standard calibration curve was established using known 
concentrations of antibody (Figure 3.11). 
 
Figure 3.11 Antibody concentration measured by Bradford assay and matched to the 
calibration curve having the equation y= 0.0103x+0.0039, R=0.9924.  
The amount of antibody bound to the nanoparticles was calculated using the equation: 
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Using the calibration curve, the unreacted antibody concentration in the supernatant and 
washing solutions was determined to be 15.97 µg/mL. This suggested that 7.03 µg/mL 
of EPCAM antibodies (equivalent to 32.07 × 1012 molecules) were bound onto the 
nanoparticles. Since there are 23.7 × 1012 nanoparticles in 1 mg material (Chapter 2, 
equations 2.1-2.4) the equivalent number of EPCAM molecules bound per nanoparticle 
was found to be 1.35. The approximate molecular dimensions for an Y shaped antibody 
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are 10 × 14 × 4.5 nm from published crystallographic data.26  Based on these dimensions 
the calculated antibody footprint on the nanoparticles surface can vary from 63 to      
140 nm2 depending on binding orientation and assuming rectangular footprints. 
Therefore, the obtained results for conjugated antibodies on the nanoparticles surface 
reasonably fit with the available –COOH groups and a random orientation. In addition 
to the antibody surface conjugation, retention of its bioactivity is important for 
producing nanoparticles capable of targeting and bio-recognition. The bioactivity was 
evaluated during in vitro targeting experiments which are presented in section 3.3.5. 
3.3.4 MRI capability of bifunctionalised nanoparticles  
To evaluate the MRI potential of the bifunctionalised nanoparticles, their T2 relaxation 
times was measured using a 7 T horizontal bore Magnex Scientific imaging system, 
operating at 300 MHz resonant frequency. Increasing concentrations of nanoparticles 
ranging from 0.01 to 0.2 mM Fe were prepared in 1% agarose gel and placed in a 
polystyrene holder for the measurements. Blanks consisting of 1% agarose gel were 
measured as a control. MRI analysis was performed at TR 5000 ms and multiple TE 
values of 11, 33, 55 and 77 ms for various concentrations of nanoparticles. These 
measurements were performed by Ms. Karen Davies at the Department of Imaging 
Science and Biomedical Engineering, University of Manchester. 
Their efficiency as T2 MRI enhancement agents was determined by calculation of the r2 
relaxivities as the slopes of the linear fit of the inverse relaxation times as a function of 
iron molar concentration (Figure 3.12). As expected, it was found that the inverse 
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relaxation times vary linearly with the iron concentration, according to the following 
equation (3.1):27-28 
                                            

    !"#$%&
 '#(	% )

 !
*,      (3.1) 
r2 is the transverse relaxivity, 1/T20 is the inverse relaxation time of the blank.  
 
Figure 3.12 Inverse transverse relaxation times 1/T2 for unfunctionalised Fe3O4 and 
bifunctionalised Fe3O4-NH2/COOH nanoparticles as a function of the iron molar 
concentration.  
The r2 relaxivity values were found to be 189 ± 5 s-1mM-1 and 199 ± 4 s-1mM-1 for Fe3O4 
and Fe3O4-NH2/COOH respectively. The bifunctionalised nanoparticles have similar r2 
relaxivity values as the starting material, Fe3O4 nanoparticles; therefore the surface 
chemical modifications did not diminish the MRI contrasting properties. The r2 
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relaxivity value for bifunctionalised Fe3O4-NH2/COOH nanoparticles is higher when 
compared with value of the clinical contrast agent Feridex I.V. (reported value of       
148 ± 2, measured at 7 T).29 As it was shown elsewhere, there are two major factors 
which can determine the enhancement of MRI signal: size of the nanoparticles and the 
coating thickness.30 In this case the effective contrasting properties were attributed to the 
thin organic coating on the surface of the Fe3O4-NH2/COOH nanoparticles and to the 
larger core size (25 nm compared with 5 nm). Figure 3.13 shows T2-weighted MRI 
images (TE/TR 11/5000 ms) of analysed nanoparticles at various concentrations in 1 % 
agarose gel.  
 
Figure 3.13 T2 weighted magnetic resonance images of a) Fe3O4 and                      
b)Fe3O4-NH2/COOH nanoparticles in 1% agarose gel at various molar  iron 
concentrations (0.01, 0.05, 0.1 and 0.2 mM) and at 25 ⁰C, 7 T MRI, TR=5000 ms, TE=11 
ms. Blanks consisting of 1% agarose gel were taken as a control.  
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Darkening of the grey discs in Figure 3.13 corresponds to the improvement in MRI 
contrast capabilities due to the increased concentration of Fe3O4 and Fe3O4-NH2/COOH 
nanoparticles.31 When magnetic nanoparticles are present in the agarose gels, the large 
magnetic moment generated by these nanoparticles causes a local inhomogeneity in the 
magnetic field. This local inhomogeneity causes a shortening of the T2 relaxation time 
of protons present in the agarose gels. Shortening of the T2 relaxation time of the 
protons translates to a negative image contrast on the MRI images (darkening effect or 
hypointensity). 
The Fe3O4-NH2/COOH nanoparticles produce an observable change in image contrast 
at concentrations as low as 0.05 mM iron (corresponding to 4.1µg/mL), which is well 
within the safety range indicated by the cytotoxicity data (Figure 3.5). These results 
confirmed the effective MRI contrasting capabilities of the bifunctionalised magnetic 
nanoparticles. Therefore, the Fe3O4-NH2/COOH nanoparticles potentially present 
suitable properties for usage as MRI contrasting agents. 
3.3.5 Targeting capabilities of antibody labelled nanoparticles 
3.3.5.1 Specificity of nanoparticles targeting 
The EPCAM cell receptor, also known as cluster of differentiation 326 (CD 326), is a 
membrane glycoprotein with the molecular weight of 40 kDa.32 It was reported to be 
ubiquitously overexpressed on the pancreatic cancer cells surface, making it an 
accessible target for binding and imaging.25,33 The cellular expression of EPCAM 
receptor on the surface of Panc-1 cells was evaluated using immunofluorescence 
labelling and imaged using fluorescence microscopy (Figure 3.14).  
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Figure 3.14 Phase contrast and fluorescent images showing the examination of EPCAM 
antigen expression on Panc-1 cells by immunofluorescence labelling. Cell nuclei stained 
with DAPI in blue. The EPCAM receptors visualised in red by labelling with IgG-Cy3 
conjugates. Scale bar represents 5 µm. 
The cell nuclei were stained with DAPI in blue and the expression of the EPCAM 
receptors was evidenced with rabbit anti-mouse IgG Cy3 conjugates (section 3.2.7.1). 
The images show the Panc-1 cells are strongly positive with high levels of EPCAM 
expression as evidenced by the associated red fluorescence. Therefore, the EPCAM 
receptors could be also accessed using antibody-nanoparticles conjugates.  
The nanoparticles used in the targeting experiments are summarised in Table 3.5. 
 
 
5 µm
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Table 3.5 Summary of the nanoparticle samples employed in the cell targeting experiments. 
Sample Properties EPCAM receptor 
reactive 
Fe3O4-NH-RITC/CO-EPCAM  Targeting YES 
Fe3O4-NH-RITC/CO-ISO Control 1 
 
NO 
Fe3O4-NH-RITC/COOH Control 2 NO 
 
All samples were applied at a concentration of 100 µg/mL. The red florescent tag 
(RITC) conjugated to the samples allowed the localisation of nanoparticles and their 
targeting abilities using fluorescence microscopy. The colocalisation of the cells was 
shown using the nuclear stain DAPI (blue).  
Figure 3.15 shows the fluorescence images of Panc-1 cells incubated with the three 
types of samples for 1 hour. Fluorescence microscopy images in Figure 3.15a and 3.15b 
show that the Fe3O4-NH-RITC/CO-EPCAM specifically target the Panc-1 cells. The 
targeting property was attributed to the surface-to-surface antibody-antigen interaction. 
This type of cell interaction has also been reported in case of dextran coated magnetic 
nanoparticle functionalised with monoclonal antibodies.28,34  
In contrast, the control particles, Fe3O4-NH-RITC/CO-ISO or                             
Fe3O4-NH-RITC/COOH, showed no binding to the cells in the first hour (Figure 3.15c 
and 3.15d) and therefore the cells present no associated fluorescence signal. The 
addition of the non-specific isotype control antibody (ISO) did not enhance the targeting 
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properties of the nanoparticles due to the fact that this antibody does not present the 
same specific antigen binding region as the EPCAM antibody.  
 
Figure 3.15 Fluorescence images of Panc-1 cells incubated for 1 hour with, a) and b) 
Fe3O4-NH-RITC/CO-EPCAM, c) Fe3O4-NH-RITC/CO-ISO, d) Fe3O4-NH-
RITC/COOH. Detection of cell nuclei was performed by DAPI staining (blue). All 
nanoparticles were applied at 100 µg/mL. Scale bar represents 25 µm. 
For cells incubated with Fe3O4-NH-RITC/CO-EPCAM nanoparticles, the red 
fluorescence signal was observed in the perinuclear region which is usually attributed to 
endosomal uptake as shown in Figure 3.15a and 3.15b. This suggested that the 
internalisation of Fe3O4-NH-RITC/CO-EPCAM nanoparticles occurs within an hour.  
a) Fe3O4-NH-RITC/CO-EPCAM
c) Fe3O4-NH-RITC/CO-ISO
b) Fe3O4-NH-RITC/CO-EPCAM
d) Fe3O4-NH-RITC/COOH
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The internalisation was further verified by examining sections of similarly treated Panc-
1 cells by confocal laser scanning microscopy (Figure 3.16a). The zoom-in area in 
Figure 3.16b further confirmed that the nanoparticles accumulated in the cells. 
Therefore these nanoparticles were internalized via a receptor mediated endocytosis 
facilitated by the successful binding onto the EPCAM receptors on cell membranes.34-35 
 
Figure 3.16 Confocal middle section images of Panc-1 cells incubated for 1 hour with, a) 
Fe3O4-NH-RITC/CO-EPCAM (scale bar represents 25 µm); b) Magnified images of the 
inset areas in (a), scale bar represents 5 µm. In blue the cell nuclei stained with DAPI and in 
red the nanoparticles tagged with RITC. 
Most probably the nanoparticles would be localised in the endosomal vesicles but the 
exact colocalisation of nanoparticles was not further evaluated. The uptake mechanism 
could be investigated by using selective inhibition of the different paths of 
internalisation.34 The nanoparticle colocalisation can be achieved by staining the 
different cell organelles and imaging with fluorescence microscopy.9,35  
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3.3.5.2. Effect of incubation period on cell uptake 
The incubation period of nanoparticles with cells can affect their uptake into cells, in 
terms there is more probability for nanoparticle-cell interactions. 
For comparison the targeting specificity and binding behaviour of the three types of 
nanoparticles was investigated for longer incubation times, 6 hours and 24 hours 
respectively. The experiments were carried out as in section 3.3.5.1 and fluorescence 
microscopy was used to visualise the targeting and binding behaviour of the 
nanoparticles. Figure 3.17 shows the fluorescence images of Panc-1 cells after 6 hours 
of exposure to the three types of nanoparticles.  
The images showed that Fe3O4-NH-RITC/CO-EPCAM nanoparticles have greater 
association with the cells and perinuclear localisation compared with the control 
nanoparticles (Figure 3.17a and 3.17b). At the same time, both controls showed some 
association with Panc-1 cells although it must be mentioned that the levels were lower 
than the specifically labelled nanoparticles (Figure 3.17c and 3.17d). Fluorescence 
images showed that the Fe3O4-NH-RITC/CO-ISO controls were mostly distributed on 
the cell membrane (Figure 3.17c), while a small amount of Fe3O4-NH-RITC/COOH 
nanoparticles (Figure 3.17d) were localised in the perinuclear region as the specifically 
labelled nanoparticles.  
Prolongation of incubation time showed that non-specific interactions were encouraged, 
however the levels of control nanoparticles associated with the cells was lower when 
compared with Fe3O4-NH-RITC/CO-EPCAM nanoparticles (Figure 3.17a and 3.17b). 
In case of Fe3O4-NH-RITC/COOH, a likely explanation for the observed behaviour 
could be the surface charge of the nanoparticles. Other research has suggested that 
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carboxylic groups on nanoparticles surfaces are involved in intracellular uptake.36-37 
Therefore according to the literature electrostatic attraction may have promoted the non-
specific uptake by fluid phase endocytosis. Despite these observations, the             
Fe3O4-NH-RITC/CO-EPCAM nanoparticles showed clear advantage for cell 
localisation and enhanced internalisation compared with the controls, leading to earlier 
and increased levels of nanoparticle delivery to the Panc-1 cells. 
 
Figure 3.17 Fluorescence images of Panc-1 cells incubated for 6 hours with, a) and b) 
Fe3O4-NH-RITC/CO-EPCAM, c) Fe3O4-NH-RITC/CO-ISO, d) Fe3O4-NH-
RITC/COOH. Detection of cell nuclei was performed by DAPI staining (blue). All 
nanoparticles were applied at 100 µg/mL. Scale bar represents 25 µm. 
Similar results were obtained after 24 hours of incubation as evidenced in Figure 3.18. 
a) Fe3O4-NH-RITC/CO-EPCAM b) Fe3O4-NH-RITC/CO-EPCAM
c) Fe3O4-NH-RITC/CO-ISO d) Fe3O4-NH-RITC/COOH
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Figure 3.18 Fluorescence images of Panc-1 cells incubated for 24 hours with, a) and b) 
Fe3O4-NH-RITC/CO-EPCAM, c) Fe3O4-NH-RITC/CO-ISO, d) Fe3O4-NH-
RITC/COOH. The cell nuclei were stained with DAPI in blue. All nanoparticles were 
applied at 0.1 mg/mL. Scale bar represents 25 µm. 
At 24 hours the Fe3O4-NH-RITC/CO-EPCAM nanoparticles were internalised in the 
Panc-1 cells in greater levels (Figure 3.18a and 3.18b). In comparison, the control 
nanoparticles are also associated with the cells (Figure 3.18c and 3.18d) but the level of 
fluorescence associated with the cells is minimal compared with the                        
Fe3O4-NH-RITC/CO-EPCAM nanoparticles. The control nanoparticles are thought to 
be internalised through non-specific endocytosis processes. Overall the cell targeting 
results indicate that the specific uptake of Fe3O4-NH-RITC/CO-EPCAM is highly 
a) Fe3O4-NH-RITC/CO-EPCAM b) Fe3O4-NH-RITC/CO-EPCAM
c) Fe3O4-NH-RITC/CO-ISO d) Fe3O4-NH-RITC/COOH
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promoted by the interaction between the EPCAM antibody and their specific receptors 
present on the cancer cell surface.  
3.4 Conclusions  
The aim of the work presented in this chapter was to evaluate the imaging and targeting 
potential of the bifunctionalised Fe3O4-NH2/COOH nanoparticles prepared and 
characterised in Chapter 2.  
For this the Fe3O4-NH2/COOH nanoparticles were successfully labelled with the RITC 
fluorescent dye and the specific antibody (EPCAM) taking advantage of the amine and 
carboxylic acid groups present on their surface.  
The in vitro targeting specificity of Fe3O4-NH-RITC/CO-EPCAM nanoparticles was 
illustrated by fluorescence and confocal microscopy. Fe3O4-NH-RITC/CO-EPCAM 
demonstrated excellent ability to localise and bind the epithelial specific EPCAM 
receptors on the Panc-1 pancreatic cancer cells in one hour and initiated a fast 
internalisation of nanoparticles. However the Fe3O4-NH-RITC/COOH and           
Fe3O4-NH-RITC/CO-ISO nanoparticles also showed some non-specific interaction at 
longer exposure times. The targeting experiments showed the proof-of-concept that the 
antibody conjugated magnetic nanoparticles were able to selectively localise specific 
receptors on cancer cells with specific exemplification for pancreatic cancer.  
In addition, the fluorescence imaging and targeting capability of these bifunctional 
nanoparticles was shown to be further complimented by the MR imaging capabilities. 
As expected the Fe3O4-NH2/COOH nanoparticles influenced the signal intensity on T2 
weighted MRI images as a function of iron molar concentration. Their relaxivity values 
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were found to be superior to that of the commercial agent Feridex I.V. This nanoparticle 
system is adaptable for conjugation of any other amino containing protein or peptide 
which can be further used for targeting specific receptors on cancer cells.   
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Chapter 4 
Self-assembled structures of SPIONs and bioinspired 
amphiphilic polyoxazolines 
4.1 Introduction 
A major challenge in cancer diagnosis today is the detection limit of the current medical 
imaging technologies which does not allow for identification of cancers at the early 
stage, more importantly at the molecular or cellular level. Magnetic resonance imaging 
(MRI) is a non-invasive medical imaging technique which offers the most powerful 
contrast for soft tissues. For tumour detection MRI has to be used in combination with 
contrast agents. Biocompatible superparamagnetic iron oxide nanoparticles (SPIONs) 
have emerged as feasible contrast agents for MRI and some formulations are already 
clinically used for detection of liver tumours or abnormal lymph nodes.1 However, the 
current MRI agents need to be optimised in order to achieve early stage diagnosis of 
other tumour types. The optimisation should include: synthesis of monodisperse and 
crystalline SPIONs, biocompatible and stealth coatings for improved colloidal stability 
and circulation times, incorporation of targeting ligands for selective and sensitive 
localisation of tumours.2-5 Research in the area of iron oxide nanoparticles synthesis has 
been ongoing for many years and SPIONs with improved quality (monodisperse, 
crystalline and with high magnetisation) were achieved using the high temperature 
decomposition of iron-organic ligand precursors.6-9 The monodisperse SPIONs 
synthesised using these methods are hydrophobic and can only be dispersed in organic 
solvents such as toluene or hexane. Therefore the SPIONs can not be directly introduced 
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in biological systems; before this can take place the surface of the SPIONs has to be 
coated with a protective hydrophilic layer.10 From this point of view, polymeric micelles 
are anticipated as suitable structures with a unique core-shell architecture that can offer 
efficient surface coating to hydrophobic SPIONs. The hydrophobic core of the 
polymeric micelles can encapsulate and protect the hydrophobic SPIONs, while the 
hydrophilic shell can carry bioactive molecules, drugs or fluorescent tags for 
multifunctional applications (combined optical imaging with MRI and targeted drug 
delivery). Encapsulation of SPIONs within the hydrophobic micellar core has the 
advantage of avoiding direct exposure and interaction of the SPIONs surface with blood 
proteins, providing longer circulation blood time. Poly(ethylene glycol) (PEG) based 
phospholipids (Figure 4.1a) are commonly employed for transferring hydrophobic 
SPIONs to hydrophilic aqueous media.11-14 However, these structures are usually 
expensive and PEG has been shown to have the tendency to auto-oxidize and to loose its 
protein resistant ability over time.15  
 
Figure 4.1 Polymeric structure of a) poly(ethylene glycol) based phospholipids and b) 
poly(2-ethyl-2-oxazoline). 
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Poly(2-oxazoline) based polymers have emerged as alternatives to PEG for applications 
in the biomedical field because they combine interesting properties such as 
hydrophilicity, biocompatibility and versatile end-group chemistry.16-17 Hydrophilic 
poly(2-ethyl-2-oxazoline) (PEtOX, Figure 4.1b) is approved by the Food and Drug 
Administration (FDA) as a food additive and was shown to exhibit stealth and protein 
repellent properties comparable to PEG.18-20 Polyoxazolines can be regarded as 
analogues of polypeptides and because of this structural similarity they are considered as 
bioinspired polymers.16,21-22 Due to their stealth capabilities various combinations of 
amphiphilic block-copolymers containing poly(2-oxazolines) have been developed for 
drug delivery purposes (Figure 4.2).  
 
 
Figure 4.2 Polyoxazoline based polymers a) Methyl-poly(2-methyl-2oxazoline)-b-poly(2-
buthyl-2-oxazoline)-b-poly(2-methyl-2-oxazoline)-piperidine triblock copolymer; b) Methyl-
poly(2-ethyl-2oxazoline)-b-poly(2-buthyl-2-oxazoline)-piperazine diblock copolymer; c) 
poly(L-lactide)-b-poly(2-ethyl-2-oxazoline)-b-poly(L-lactide); d) poly(2-ethyl-2-oxazoline)-b-
poly(ε-caprolactone) diblock copolymers.  
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Luxenhofer et al. developed well-defined amphiphilic di- and triblock copolymers based 
on polyoxazolines (Figure 4.2a and 4.2b) for encapsulation of the hydrophobic 
paclitaxel anti-cancer drug. The authors showed that the prepared micellar structures are 
stable, non-toxic, non-immunogenic and have high drug loading capabilities.23 Other 
examples include systems based on triblock poly(L-lactide)-b-poly(2-ethyl-2-
oxazoline)-b-poly(L-lactide) micelles (Figure 4.2c) as carriers of doxorubicin or poly(ε-
caprolactone)-poly(2-oxazoline) micelles (Figure 4.2d) carrying paclitaxel.24-25  
PEtOX has been studied as a potential solubilisation agent for fullerene C60. Tong et al. 
prepared C60-PEtOX complexes and studied their physicochemical properties along with 
their superoxide scavenging activities (Figure 4.3).26  
 
Figure 4.3 Formulation of C60-Polyoxazoline and proposed charge-transfer complex 
formation between fullerene and polymer. Figure adapted from ref. 26 
The authors showed that C60-polyoxazoline complexes are non-toxic, neuronal cell 
permeable, superoxide scavenging antioxidants that could be promising candidates for 
the treatment of brain-related diseases associated with increased levels of superoxide. 
The potential use of polyoxazoline based polymers as stabilising and functional coatings 
for inorganic materials has only recently started to be investigated. Volet et al. 
developed a method to anchor tailored amphiphilic poly(2-oxazoline)s on the surface of 
In toluene
/chloroform
Nanoformulation
C60-PEtOx
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silica nanoparticles using host–guest associations.27 The group used adsorbed polymer 
bearing cyclodextrin units as a host layer on silica surface before complexation with 
hydrophobically end-capped poly(2-methyl-2-oxazoline) (Figure 4.4).  
 
Figure 4.4 Silica nanoparticles (in grey) coated by poly(cyclodextrin) layer (in green) and 
POXZ–C12 layer (in blue). The figure was adapted from ref. 27 
To the best of our knowledge there are no reported SPIONs surface coated with poly(2-
oxazoline)s.  
The work in this chapter describes the synthesis of monodisperse SPIONs (Fe3O4) and 
their surface modification chemistry using amphiphilic poly(2-ethyl-2-oxazoline)s.  
A high-temperature decomposition method was used to prepare monodisperse SPIONs 
of 8 nm diameter in the presence of surfactant molecules such as oleic acid. A C16 alkyl 
end-capped poly(2-ethyl-2-oxazoline) amphiphilic polymer with hydroxyl functional 
group was synthesised and further modified with carboxylic acid functionalities. The 
Cyclodextrin unit
C12 end-capped POXZ
=
=
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cytotoxicity of the synthesised amphiphilic polyoxazolines was evaluated before their 
application as coating materials for hydrophobic SPIONs. The carboxyl-functional 
polymer was used to transfer, solubilise and stabilise the hydrophobic SPIONs in 
aqueous solutions. Different ratios of SPIONs and polymer were studied to evaluate the 
influence on the size and the stability of the formed multifunctional magneto-micellar 
structures (MMMs). The colloidal stability of the MMMs was evaluated in media 
similar to physiological conditions with salt concentrations up to a few hundred mM and 
pH range between 5 and 9. Both of these are typical conditions used in biological 
applications. To provide fluorescence imaging capabilities to the MMMs their surface 
was modified with fluorescent dye molecules. The carboxylic acid functional groups 
present on the surface of fluorescently labelled magneto-micelles allowed for covalent 
conjugation with bioactive molecules (proteins and antibodies). Quantification of the 
proteins and antibodies conjugated to the surface of the MMMs was estimated using a 
standard Bradford protein assay method. The cytotoxicity of fluorescent and non-
fluorescent MMMs was assessed with different cells lines using the standard cell 
proliferation assay MTS. The selective uptake and the targeting capabilities of the 
fluorescent MMMs conjugated with specific antibodies was evaluated using live cell 
confocal laser scanning microscopy with pancreatic cancer cells. Their MRI contrasting 
properties were assessed by relaxation time measurements with specific focus on the T2 
relaxation time. 
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4.2 Experimental Section 
4.2.1 Materials 
Iron(III) acetylacetonate (Fe(acac)3, ≥ 99.9% trace metals basis), 1,2-hexadecanediol 
(90%), oleic acid (≥ 99%), oleylamine (70%), benzyl ether (98%), 2-ethyl-2-oxazoline 
(≥ 99%), hexadecyl methanesulfonate salt, chloroform anhydrous (CHCl3, (≥ 99%), 
N,N-Dimethylformamide anhydrous (DMF, 99.8%), succinic anhydride (≥ 99%), 
triethylamine (≥ 99%), phosphotungstic acid solution (PTA solution, 10%, w/v), 
albumin from bovine serum (BSA, ≥ 98%), cytochrome C from equine heart (CytC, ≥ 
95%), anti-rabbit IgG (whole molecule) antibody produced in goat (IgG), phosphate 
buffered saline tablets (PBS, 10 mM phosphate buffer, 2.7 mM potassium chloride and 
137 mM sodium chloride, pH 7.4), Bradford reagent (for 1-1400 µg/ml protein), 
Corning Spin-X UF 20  MWCO 5kDa, Corning Spin-X UF 20  MWCO 30kDa, Corning 
Spin-X UF 20 MWCO 100 kDa, Vivaspin 20 centrifugal concentrator MWCO 300 kDa 
were purchased from Sigma Aldrich. Octadecyl rhodamine B chloride (Rh) was 
purchased from Life Technologies. Dialysis membranes with MWCO of 1000 Da, 50 
KDa and 300 KDa were purchased from Medicell International. 3-(4,5-Dimethylthiazol-
2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS assay) was 
purchased from Biomedica, Vienna, Austria. All aqueous solutions were prepared using 
ultrapure water Milli-Q (Millipore, resistivity 18.2 MΩ.cm at 25°C). All chemicals were 
used as received without any further purification.  
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4.2.2 Synthetic methods 
 
4.2.2.1 Synthesis of monodisperse Superparamagnetic Iron Oxide Nanoparticles 
(SPIONs) 
Hydrophobic SPIONs were synthesized by thermo-decomposition of iron triacetyl 
acetonate (Fe(acac)3) in the presence of oleic acid and oleylamine using a modified 
procedure published by Sun et al.6 A mixture of Fe(acac)3 (3.52 g, 10 mmol), 1,2-
hexadecanediol (12.92 g, 50 mmol), oleic acid (8.47 g, 9.5 mL, 30 mmol), oleylamine 
(8.02 g, 9.85 mL,  30 mmol) and benzyl ether (50 mL) was charged in a 3 neck round 
bottom flask. The flask was degassed three times using “evacuation-filling with 
nitrogen” cycles ending with filling with nitrogen. The mixture was heated at 2°/minute 
to 200 °C and maintained at this temperature for 2 hours. Then the temperature was 
increased to reflux (298 °C) and kept for another hour. During the whole reaction, the 
mixture was kept under nitrogen. The black coloured mixture was cooled down to room 
temperature. Under ambient conditions, ethanol (200 mL) was added to the mixture and 
the black material was precipitated and separated using centrifugation. The black 
product was dissolved in THF (100 mL) and centrifuged at 8000 rpm for 10 min to 
remove any undispersed residue. The nanoparticles were again precipitated with ethanol 
(200 mL), centrifuged (8000 rpm, 10 min) and finally redispersed in THF to a 
concentration of 5 mg/mL. The nanoparticles were stored at 4 °C until further use. 
4.2.2.2 Synthesis of hydroxyl functional amphiphilic polyoxazoline polymers  
Cationic ring-opening polymerisation was employed to synthesise amphiphilic poly(2-
ethyl-2-oxazoline) (PEtOX) polymeric structures with end-functional hydroxyl groups. 
The amphiphilic polymer structure comprised a C16 alkyl chain which is the 
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hydrophobic segment and the PEtOX polymer backbone as the hydrophilic segment 
containing an end-functional hydroxyl group.  
Hexadecyl methanesulfonate initiator (1.6 g, 0.005 mol) and 2-ethyl-2-oxazoline (10g, 
0.1 mol) were dispersed and mixed in 8 mL anhydrous chloroform in a Schlenk flask 
under nitrogen and then sealed with rubber septum. The reaction mixture was heated to 
75 °C and left under stirring overnight. The polymerisation was quenched by hydroxyl 
end-capping method using 20 mL of methanolic KOH (5%) for 3 hours, under stirring, 
at room temperature. Then the reaction mixture was concentrated to dryness using rotary 
evaporation. The product was extracted with chloroform from the formed solid followed 
by filtration. Subsequently, the polymer was purified three times by precipitation from 
chloroform into cooled diethyl ether. The sample was denoted Polymer 1.  
This experiment was performed by Dr. Erol Hasan at the University of Liverpool, 
Centre for Materials Discovery. 
4.2.2.3 Synthesis of carboxylic acid functional amphiphilic polyoxazoline polymers 
Amphiphilic polyoxazoline polymer containing carboxylic acid end-group was 
synthesised using an esterification reaction with succinic anhydride.28 Polymer 1 (800 
mg, 0.17 mmol hydroxyl groups) was dissolved in anhydrous DMF (5 mL) under 
nitrogen atmosphere. Succinic anhydride (178 mg, 1.7 mmol) and triethylamine (0.2 
mL, 1.7 mmol) dissolved in anhydrous DMF (5 mL) were added to the polymer 
solution. The reaction mixture was stirred for 24 hours at 45 °C under nitrogen. The 
modified polymer was purified three times by precipitation from DMF into cooled 
diethyl ether followed by 24 hours dialysis into methanol. The sample was denoted as 
Polymer 1S. 
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4.2.2.4 Self-assembly of SPIONs and bioinspired amphiphilic polyoxazoline 
polymers into multifunctional-magneto-micelles (MMMs) 
The formation of multifunctional-magneto-micellar structures (MMMs) between 
hydrophobic SPIONs and amphiphilic PEtOX polymers was performed using a solvent 
exchange method. The size and stability of the micellar structures could be controlled by 
varying the weight ratio of polymer to SPIONs and are summarised in Table 4.1 in the 
Results section. 
In a typical experiment, for weight ratio of polymer to SPIONs 10:1, hydrophobic 
SPIONs dispersed in THF (1 mg/mL, 1 mL) were added dropwise to a solution of the 
Polymer 1S dispersed in water (1 mg/mL, 10 mL) while sonicating at room 
temperature. Any residues of THF were removed by dialysis against deionised water or 
phosphate buffered saline (PBS) at room temperature for 48 hours (molecular weight cut 
off MWCO 50 kDa). After dialysis the MMMs solutions was stored at 4 °C until further 
use.  
Seven samples were prepared using different weight ratio of polymer to SPIONs and 
were denoted MMM-1, MMM-2, MMM-3, MMM-4, MMM-5, MMM-6 and   
MMM-7.  
4.2.2.5 Synthesis of fluorescently labelled magneto-micelles  
The preparation of fluorescently labelled MMMs followed the same assembly 
procedure as before except that a mixture of SPIONs (1 mg) and a fluorescent dye 
(Octadecyl Rhodamine B, Rh, 0.01 mg) in 1 mL THF/DMSO was added to the Polymer 
1S solution in deionised water (1 mg/mL, 10 mL). The mixed-assembled structures were 
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purified by dialysis to remove the organic solvents. The sample was denoted as          
Rh-MMM. 
4.2.2.6 Bioconjugation of Rh-MMM with proteins and antibody molecules  
Bioactive molecules such as proteins and antibodies were covalently conjugated to the 
Rh-MMM using the carbodiimide coupling chemistry between the carboxylic acid 
groups present on the coating polymer and the amino groups in the lysine residues of 
protein structures.  
A 2.5 mL aliquot of Rh-MMMs in PBS (0.75 mg/mL, 1.7 × 1012 micelles/mL,               
2.8 × 10-12 mol micelles/mL) was activated for 5 minutes with EDC (3 times molar 
excess with respect to the added protein) and for 10 minutes with sulfo-NHS (3 times 
molar excess with respect to the added protein) at room temperature. Then a 100 µL 
aliquot of serum albumin (BSA) or Cytochrome C (CytC) in PBS (2 mg/mL) or non-
specific immnunoglobulin G (IgG) in PBS (3 mg/mL) was added to the activated 
micelles. The mixture was allowed to react at room temperature for 4 hours. To remove 
the unreacted free BSA, CytC or IgG the reaction mixture was purified by dialysis 
against PBS and stored at 4 °C until further use. Rh-MMMs conjugated with BSA or 
CytC or IgG were denoted as Rh-MMM-BSA, Rh-MMM-CytC and Rh-MMM-IgG. 
Conjugation of Rh-MMMs with a specific antibody, namely CA19.9, was carried out 
using a maximum of 8 µg antibody per conjugation reaction due to a availability of this 
antibody. The sample was denoted as Rh-MMM-CA19.9. 
4.2.2.7 Quantification of protein molecules conjugated to the Rh-MMMs 
The concentration of protein/antibody molecules conjugated to the Rh-MMMs was 
estimated using the Bradford assay. After the conjugation reaction (see section 4.2.2.6) 
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any unreacted BSA, CytC and IgG were separated using centrifugal concentrators with 
MWCO which allowed the molecule filtration: 30 kDa, 100 kDa and 300 kDa. The 
filtrates from 3 washing steps containing the unreacted molecules were collected, 
concentrated and mixed with Bradford reagent to give a blue solution with a maximum 
absorbance at 595 nm. A calibration curve of known protein concentrations was plotted 
and the concentration of unreacted BSA, CytC, IgG was determined. The concentration 
of BSA, CytC, IgG conjugated on the nanoparticles was determined by difference from 
the initial concentration. The conjugation yield was calculated as: 
	 %   
 	 	 
		 	 	
 100 
Each reaction was performed in triplicate and the average value with standard deviation 
is reported. 
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4.2.3 Characterisation methods  
4.2.3.1 Thermogravimetric Analysis (TGA)  
 
TGA was carried out using a TA instrument Q600 thermal balance. Typically 2-5 mg of 
SPIONs or freeze-dried MMMs from deionised water were heated to 600 °C at 10 
°C/min in air and kept at 600 °C for 30 min. TGA was used for determination of the 
nanoparticle composition and surface coverage with small organic ligands or polymeric 
chains. 
4.2.3.2 Powder X-ray Diffraction (PXRD)  
Powder X-ray diffraction patterns of the synthesised SPIONs sealed in a 0.5 mm glass 
capillary were collected on a Bruker D8 diffractometer using Mo Kα radiation (λ = 
0.7107 Å). The PXRD data was used to identify the iron oxide phase composition and to 
confirm the size distribution of the nanoparticles (X’Pert Highscore Plus version 2.0). 
The particle size was calculated using the Scherrer equation: 
 


 
Where τ is the particle size, β the line broadening at half the maximum intensity 
(FWHM), k the shape factor (k=0.9), λ the x-ray wavelength (Mo, λ = 0.7107 Å) and θ 
the Bragg diffraction angle. 
4.2.3.3 Transmission Electron Microscopy (TEM)  
TEM images were recorded using a FEI Tecnai G2 Spirit BioTWIN instrument with a 
W filament and a SIS Megaview III digital camera, operating at 100 kV. The 
hydrophobic SPIONs dispersed in THF (50 µL sample) were deposited onto a carbon 
coated 300 mesh copper grid. The grids were then allowed to dry in air prior to imaging. 
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In case of magneto-micelles, the polyoxazoline shell was stained for TEM imaging 
using a 2% phosphotungstic acid solution (PTA) during sample preparation. The 
polyoxazoline coated sample dispersed in water was deposited on the TEM grid. The 
excess water was wicked with filter paper and an aliquot of 50 µL of 2% PTA was 
deposited on the grid. The grid was allowed to dry overnight in air prior to imaging. The 
polyoxazoline shell interacted with the PTA stain and gave a dark grey contrast on the 
TEM image as previously shown for polyamide type polymers. For a full description of 
the TEM staining technique see ref. 29 and 30. 
The size distribution of the nanoparticles was derived from TEM images using ImageJ 
software from 200 measurements. 
4.2.3.4 Fourier Transform Infrared spectroscopy (FTIR) 
FTIR spectra were recorded using a Bruker Tensor 27 Spectrometer. SPIONs samples 
were analysed as powder (precipitated and dried from THF dispersions). Polymer 
samples were first dissolved in chloroform at 10 mg/mL and then deposited onto a KBr 
plate to form a uniform layer after solvent evaporation. For each sample, 100 scans in 
the region from 400 to 4000 cm-1 with a resolution of 4 cm-1 were accumulated. Spectra 
were recorded and evaluated with OPUS/MAP version 4.0 software.  
4.2.3.5 Nuclear Magnetic Resonance (NMR) 
All 1H-NMR spectra of polymer solutions were recorded using a Bruker Avance NMR 
spectrometer (resonance frequency 400MHz 1H). DMSO-d6 and CDCl3 were used as 
solvents. The polymer composition and number average molecular weight (Mn) were 
calculated using the intensity ratio of the initiator signal to the signal of the monomer 
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units of the polymer. The NMR measurements were performed by Dr. Erol Hasan at the 
University of Liverpool, Centre for Materials Discovery. 
4.2.3.6 Gel Permeation Chromatography (GPC) 
The polymer samples were dissolved (2 mg/mL) in a mixture of THF/triethylamine 
(97.5/2.5, v/v) and filtered using 0.22 µm PTFE filters prior to GPC analysis. Molecular 
weights and molecular weight distributions were measured using a Viscotek TDA-302 
triple-detection GPC equipped with two ViscoGel HHR-N columns and a guard column 
with a mobile phase mixture of THF/triethylamine (97.5/2.5, v/v) at 35 ⁰C and a flow 
rate of 1 mL/min. The GPC measurements were performed by Dr. Erol Hasan at the 
University of Liverpool, Centre for Materials Discovery. 
4.2.3.7 Measurements of magnetic properties 
Magnetic measurements were performed in a Quantum Design MPMS XL 
Superconducting Quantum Interference Device (SQUID) magnetometer using the 
system DC measurement capabilities. Milligram quantities of the sample were placed in 
a gelatine capsule. Magnetisation measurements were made at room temperature by 
varying fields over a +1T to -1T range. The magnetic measurements were performed by 
Dr. Pavel Borisov at the University of Liverpool, Department of Chemistry. 
4.2.3.8 Dynamic Light Scattering (DLS)  
The hydrodynamic diameters of SPIONs and MMMs samples were measured using a 
Malvern Zetasizer Nano ZS equipped with a helium laser at a wavelength of 633 nm. 1 
mL sample was used for each measurement. Scattered light was collected at a fixed 
angle of 173⁰ and measurements were performed at 25 °C. The intensity-average 
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hydrodynamic diameters reported are obtained from 3 independent measurements; for 
each measurement at least 20 repeat runs were used.  
4.2.3.9 Zeta potential  
The zeta potential of the MMMs samples dispersed in deionised water or buffers were 
measured using a Malvern Zetasizer Nano ZS equipped with a helium laser 633 nm 
wavelength. An aliquot of 1 mL sample was used for each the measurement. The 
measurements were performed at 25 °C. The zeta potential values reported are obtained 
from 3 independent measurements; for each measurement at least 50 repeat runs were 
used. 
4.2.3.10 Fluorescence spectroscopy 
Fluorescence spectra were recorded on a Perkin Elmer LS 55 fluorescence spectrometer. 
All measurements were carried out at 25 °C using 4 mL aliquots of sample. The spectra 
of the Rh-MMM micellar structures were recorded from 590 to 700 nm using an 
excitation wavelength of 565 nm. Slit widths were set at 10 and 20 nm for the excitation 
and emission monochromators respectively. 
4.2.3.11 Ultraviolet–visible spectroscopy (UV/Vis) 
Absorbance spectra were recorded on a Perkin Elmer 650 S Spectrophotometer. All 
measurements were carried out at 25 °C using 4 mL aliquots of sample. The absorbance 
spectra of the fluorescently labelled Rh-MMM structures were recorded from 500 to 
650 nm. The absorbance values for the Bradford assay-protein complexes were recorded 
at 595 nm. 
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4.2.3.12 In vitro cytotoxicity evaluation of synthesised polymers and Rh-MMM 
using pancreatic cancer cells 
Viability of cells in the presence of the synthesised polymers was examined using the 
MTS assay. This cell viability test is based on the cleavage of the tetrazolium salt MTS 
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-         
tetrazolium by mitochondrial dehydrogenases in metabolically active cells.  
SUIT-2 and MiaPaca cells, derived from human pancreatic carcinoma, were seeded into 
96-well plates at 1500 and 3000 cells/well in a final volume of media of 100 µL/well. 
After 24 h incubation at 37˚C, polymer or Rh-MMM samples in media were added to 
the cells at different concentrations. At 48 hours, the media was removed and MTS 
assay in media at 1:10 dilution was added to each well. After 2 hours incubation at 37 
°C the absorbance was read at 450 nm. Values were corrected using media blank 
readings. Experiments were performed in triplicate using 8 wells for each condition. The 
cytotoxicity experiments were performed by Mr. Paul Sykes at the Liverpool Cancer 
Research UK Centre, Department of Molecular and Clinical Cancer Studies. 
4.2.3.13 Cell labelling using of fluorescent Rh-MMM  
Cell labelling experiments were carried out to evaluate the fluorescence imaging 
capabilities of the Rh-MMM magneto-micelles. BxPC-3 cells, derived from human 
pancreatic cancer, were seeded into 4 chamber glass bottom plates at 4500 
cells/chamber in a final volume of media of 1.5 mL/chamber. After 24 h incubation at 
37˚C, the Rh-MMM sample was added to the cells at different concentrations (0.5 and 
0.125 mM Fe, corresponding to a theoretical Rh dye concentration of 340 and 85 nM). 
After 12 hours of incubation with the nanoparticles, the live cells were imaged using a 
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Carl Zeiss 710 confocal scanning laser microscope. The cell labelling experiments were 
performed by Mr. Paul Sykes at the Liverpool Cancer Research UK Centre, Department 
of Molecular and Clinical Cancer Studies. 
4.2.3.14 Antibody cell targeting experiments using pancreatic cancer cells 
BxPC-3 cells expressing the CA19.9 antigen were used to evaluate the targeting 
capabilities of the antibody magneto-micelles conjugates. BxPC-3 cells were cultured 
into 4 chamber glass bottom plates at 4500 cells/chamber in a final volume of media of 
1.5 mL/chamber. After 24 h incubation at 37˚C, the Rh-MMM-CA19.9,                     
Rh-MMM-ISO and Rh-MMM samples were added to the cells at 0.1 mM Fe 
concentration (corresponding to a theoretical Rh dye concentration of 68 nM). The cells 
were incubated with the nanoparticles for an 18 hours period during which confocal 
microscopy slices were taken every 2 minutes, using a Carl Zeiss 710 confocal scanning 
laser microscope. The antibody targeting experiments were performed by Mr. Paul 
Sykes at the Liverpool Cancer Research UK Centre, Department of Molecular and 
Clinical Cancer Studies. 
4.2.3.15 Magnetic Resonance Imaging (MRI) capability of Rh-MMM 
To evaluate the MRI contrasting property of the magneto-micelles, serial dilutions of the 
Rh-MMM sample were prepared in deionised water at concentrations of 0.05, 0.075, 
0.01 and 0.15 mM Fe. The samples were aliquoted in eppendorf tubes (300 µL) and 
placed in a polystyrene MRI holder. The samples were then scanned and images were 
acquired using a Bruker Avance III console and gradient system interfaced to a Magnex 
Scientific 7 T horizontal bore magnet at a 1H resonant frequency of 300 MHz. T2 
relaxation time was calculated from a set of RARE60 images acquired with TR=5000 ms 
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and TE values of 11, 33, 55 and 77 ms. The MRI measurements were carried out by  
Ms. Karen Davies at the Department of Imaging Science and Biomedical Engineering, 
University of Manchester.  
4.2.3.16 Statistical analysis 
Each cytotoxicity experiment was performed in triplicate. Data are presented as means ± 
standard deviation. Differences between values of groups were tested for statistical 
significance using Student t-test. A P value of less than 0.05 was considered to indicate 
a significant difference.  
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4.3 Results and discussion 
4.3.1 Synthesis and characterisation of SPIONs 
Monodisperse SPIONs in the form of Fe3O4, which are commonly used as contrast 
agents for MRI, were synthesised by one pot thermal decomposition of iron 
triacetylacetonate precursor in the presence of oleic acid, oleylamine and                     
1,2 hexadecanediol (Figure 4.5). The method was adapted from Sun and co-workers.6,31  
 
Figure 4.5 General schematic for the synthesis of monodisperse SPIONs using thermal 
decomposition.  
The key condition for making monodisperse nanoparticles using this method is the 200 
°C heating step before increasing the temperature to reflux (298 °C when using benzyl 
ether as solvent).6,32 At the 200 °C temperature step the precursor starts to decompose 
and form nuclei, while the later increase in temperature is responsible for nanoparticles 
growth. The formation mechanism of the nanoparticles is not completely understood. 
Experimental observations suggested that the acetylacetonate ligands in Fe(acac)3  were 
replaced by 3 equivalents of oleic acid and that the nanoparticles were formed from 
condensation of the respective atomic species. The atomic species were formed during 
the reductive decomposition iron oleate complex in the presence of 1,2 hexadecanediol. 
It is reported that 1,2 hexadecanediol acts as an organic reducing agent and facilitates 
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the Fe3O4 formation. The atomic species cluster to form numerous nuclei which then 
aggregate into Fe3O4 nanoparticles. The resulting Fe3O4 nanoparticles are coated with a 
thin layer of oleic acid and therefore are hydrophobic. The hydrophobic SPIONs were 
characterised by different techniques including PXRD, TGA, FTIR, DLS and TEM to 
obtain the full structural and chemical composition of the nanoparticles. Structural 
information on the hydrophobic SPIONs was obtained from PXRD (Figure 4.6). The 
position and intensity of the diffraction peaks in the PXRD pattern were found to match 
well with standard magnetite diffraction data (JCPSD file No 19-0629) with no other 
iron oxide impurity phases.6,33  
 
Figure 4.6 PXRD pattern of the hydrophobic SPIONs. All diffraction peaks in the XRD 
pattern match with the reported standard magnetite according to JCPDS No. 19-0629. 
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(8.2 nm in diameter) and the organic shell coating (~2 nm, corresponding to the 
extended oleic acid chains).35  
 
Figure 4.8 The hydrodynamic diameter of the hydrophobic SPIONs dispersed in THF 
measured by DLS. 
Thermogravimetric analysis (TGA) in air of the hydrophobic SPIONs showed a weight 
loss of 12.4 % between 120 ⁰C and 600 ⁰C (Figure 4.9). The weight loss was attributed 
to the decomposition of the organic ligands present on the nanoparticle surface, 
corresponding to a monolayer of oleic acid. This correlates that each nanoparticle is 
covered by 380 oleic acid ligands on the surface (see Chapter 2, equation 2.13 for 
coverage calculations). The coverage values are in good agreement with previous 
literature reports.36,37   
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Figure 4.9 TGA of hydrophobic SPIONs showed a weight loss of 12.4 % corresponding 
to the decomposition of organic ligands found on the nanoparticle surface. 
Magnetic measurements were carried out on the SPIONs powder precipitated from THF 
dispersions. Figure 4.10 shows the field dependence of magnetisation measured at room 
temperature (300 K) from -1T to +1T. The hydrophobic SPIONs have a saturation 
magnetisation of 61.8 emu/g. As expected, the saturation magnetisation value obtained 
was lower than that of bulk magnetite (92 emu/g) which was attributed to particle size 
and to surface effects such as the presence of a magnetically inactive layer.38
 
The 
measured magnetisation value is in line with the magnetisation reported by Sun for 
similar size nanoparticles.32 
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Figure 4.10 Magnetic field dependence of magnetisation at room temperature for 
hydrophobic SPIONs. Inset shows a zoom-in plot between -500 Oe and 500 Oe magnetic 
field.   
The hydrophobic SPIONs exhibited the expected superparamagnetic behaviour. The 
hydrophobic SPIONs did not exhibit any remanence or coercivity at zero fields, 
meaning there is no hysteresis in the magnetisation curve. The superparamagnetism of 
SPIONs is attributed to their small size so that each nanoparticle is a single magnetic 
domain and the energy barrier for the spin reversal can be overcome by thermal 
vibrations. 
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4.3.2 Synthesis and characterisation of bioinspired amphiphilic 
polyoxazoline polymers 
Bioinspired amphiphilic poly(2-ethyl-2-oxazoline) polymers were  prepared using 
cationic ring opening polymerisation. It is documented that the polymerization of 2-
oxazolines started with functional initiators and terminated with a variety of 
nucleophiles leads to well-defined polymeric structures functionalised at both terminal 
ends.39 A general schematic for the polymerisation process is shown in Figure 4.11. 
 
 
 
Figure 4.11 Schematic representation of the cationic ring opening polymerisation of 2-
oxazolines. Ini-X represents an electrophilic initiator where X is the leaving group which 
forms the counter ion. Nu represents the nucleophilic terminating agent which can be used 
to end-cap the polymerisation.  
PEtOX polymers with amphiphilic character, bearing a hydroxyl (-OH) end-
functionality and an alkyl chain (C16) as hydrophobic segment, were prepared using 
hexadecyl methanesulfonate initiators (see Figure 4.12 for schematic representation of 
the polymerisation steps). The prepared polymer sample was denoted as Polymer 1.  
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Figure 4.12 Synthesis steps for amphiphilic α-hexadecyl, ω-hydroxyl poly(2-ethyl-2-
oxazoline) polymer, Polymer 1. 
The resulting polymer after termination step with methanolic KOH had a molecular 
weight of 4500 as calculated from 1H-NMR. In the 1H-NMR spectrum of the Polymer 1 
with Mn=4500 shown in Figure 4.13 all peaks could be assigned indicating the 
successful polymerisation and propagation reaction without side reactions based on the 
1H-NMR analysis. The characteristic proton peaks for the polymer backbone (-N-CH2-
CH2-) were found at 3.4 ppm, while the pendant methyl protons were present at 1 ppm. 
The α- terminus methyl protons in the C16 hydrophobic segment were found at 0.8 ppm 
and  the methylene group protons in the alkyl chain at 1.2 ppm, Figure 4.13.  
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Figure 4.13 1H NMR representative spectra (in CDCl3, 400 MHz) of the hexadecyl 
methanesulfonate initiator and hydroxyl functional amphiphilic polyoxazoline (Polymer 1) 
and assignment of the proton signals.  
The molecular weight of the polymers calculated from 1H-NMR was confirmed by GPC 
measurements. The GPC results showed Mn= 4500 and Mw= 5600 and the 
polydispersity index (PDI) was calculated as 1.21. The GPC elution trace is 
symmetrical, monomodal, with no shoulder indicative of a well-defined polymer 
(Figure 4.14).  
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Figure 4.14 GPC elution profile for Polymer 1 (THF/triethylamine, polystyrene 
standards). 
Polymer 1 was modified with carboxylic acid end-functional groups using an 
esterification reaction with succinic anhydride catalysed by triethylamine. The modified 
polymer sample was denoted as Polymer 1S (Figure 4.15). The reaction of an alcohol 
with an acid anhydride is well-established in organic chemistry and has been 
successfully used for modification of other polymers.28 Polymer 1 was reacted with 10 
fold molar excess of succinic anhydride per OH residue in anhydrous DMF as shown in 
Figure 4.15.  
 
Retention Volume (mL)
 17.07  17.44  17.81  18.18  18.54  18.91  19.28  19.65  20.02
250.93
230.16
209.39
188.62
167.86
147.09
126.32
105.55
 84.78
271.70
 64.02
16.70  20.38
Retention volume (m )
R
ef
ra
ct
iv
e 
In
de
x
 
R
es
po
n
se
 
(m
V
)
Cristina I. Olariu            Self-assembled structures of SPIONs and bioinspired amphiphilic polyoxazolines 
 
192 
 
 
Figure 4.15 Schematic representation of the chemical modification of hydroxyl group in 
Polymer 1 with succinic anhydride. 
 
The attachment of the succinic acid functionality to Polymer 1 was confirmed by 1H 
NMR, FTIR and zeta potential measurements. The 1H NMR spectra for non-modified 
Polymer 1 and succinylated Polymer 1S are shown in Figure 4.16.  
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Figure 4.16 Representative 1H NMR spectra (in DMSO, 400 MHz) of (a) of Polymer 1 
and (b) Polymer 1S and assignment of the proton signals to the schematic representation 
of the polymeric structure. 
The 1H NMR spectrum of modified Polymer 1S showed the presence of an extra peak 
at 4.2 ppm belonging to the protons in the polymer backbone which are the closest to the 
ester peak in the succinate linkage.40 The protons belonging to the succinic anhydride 
ring would show as a single characteristic peak at 3 ppm. As part of succinic anhydride 
they are not distinct from one another. However, the protons closest to the ester linkage 
between the succinic acid and the PEtOX polymer were identified at 2.4 ppm. The 
protons closest to the carboxylate end group are overlapping with the methylene protons 
in the polymer backbone at 2.2 ppm. The complete functionalisation with carboxylic 
acid groups was established based on the integral values of the peaks a and h which 
were 3 and 2. 
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The successful modification of the polymer with carboxylic acid functional groups was 
additionally confirmed using FTIR spectroscopy (Figure 4.17). The characteristic band 
of the carbonyl (C=O) deriving from free carboxylic acid groups was evidenced at 1720 
cm-1 in the succinylated Polymer 1S spectrum. This peak was not present in the 
Polymer 1 spectrum. The rest of the peaks fully overlap with the spectrum for Polymer 
1, indicating no alteration to the structure of the polymer backbone. The characteristic 
bands for the C-H stretching vibrations in –CH2 and –CH3 were present in the region 
between 2975 and 2871 cm-1. Additionally the C=O stretching from the PEtOX was 
evidenced at 1640 cm-1. Overall the FTIR analysis showed that the Polymer 1 was 
modified with carboxylic acid groups.  
 
Figure 4.17 FTIR spectra of Polymer 1 (a) and Polymer 1S (b) amphiphilic 
polyoxazolines. 
4000 3500 3000 2500 2000 1500 1000 500
b)
 Polymer 1
 Polymer 1S
Tr
a
n
m
itt
a
n
ce
 
(a.
u
.
)
Wavenumber (cm-1)
C=O in free
carboxylic
acid
a)
Cristina I. Olariu            Self-assembled structures of SPIONs and bioinspired amphiphilic polyoxazolines 
 
195 
 
The presence of end-functional carboxylic groups on the polymer was further confirmed 
by zeta potential measurements of aqueous solutions of Polymer 1S at different pH 
values (Figure 4.18).  
 
 
 
 
pH 2 4 6 8 
ZP (mV) 1.8 ± 0.5 -1.3± 0.8 -5.7 ±0.2 -14.2 ± 0.3 
 
Figure 4.18 Schematic representation of the protonation/deprotonation of the carboxylic 
end-functional groups and zeta potential values of polymeric solutions at different pHs. 
It was found that the polymer solutions have a zeta potential of -14.2 ± 0.3 mV at pH 8 
attributed to the deprotonated carboxylic groups. At low pH values the zeta potential 
increases so that at pH 2 a positive value of 1.8 ± 0.5 mV was recorded due to full 
protonation of the carboxylic end-functional groups. These measurements showed that 
the isoelectric point of the polymer is around pH 3. Literature reports that the pKa value 
for succinic acid is 4.16.41 Therefore a pKa value below 4 was found reasonable in this 
case.  
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Taken together these results showed that Polymer 1 was successfully modified to have a 
–COOH end-functionality which will provide opportunities to couple specific bioactive 
molecules and to confer targeting capabilities to the polymeric structures. 
4.3.3 Cytotoxicity pre-screening of synthesised amphiphilic poly(2-
ethyl-2-oxazoline) polymers 
The effect of the amphiphilic polymers (Polymer 1 and Polymer 1S) on viability of 
cells was assessed using the MTS cell proliferation assay. The assay measures the 
metabolic activity of living cells and their ability to reduce the MTS tetrazolium dye into 
a coloured formazan compound which absorbs at 450 nm. Nonviable cells lose their 
metabolic capacity and do not generate a colored signal.  
Human pancreatic cancer cells (SUIT-2) were incubated with the polymers for 48 hours 
and the viability was compared with non-treated cells as control. As the cell viability is 
usually concentration dependent, the cells were exposed to polymer concentrations 
ranging from 0–1 mM.  
Although the PEtOX polymer without hydrophobic segment is not toxic and used as a 
food additive it was important to confirm that the modifications of the structure did not 
modify the behaviour of the polymer. 
Under these conditions the MTS results showed that introducing a hydrophobic segment 
on the polymer structure did not cause any visible toxicity over 48 hours on the cell type 
investigated. At the same time modification of the end-functionality from hydroxyl to 
carboxylic acid did not change the toxicity profile. As seen in Figure 4.19 the average 
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viability of SUIT-2 cells treated with Polymer 1 and Polymer 1S for 48 hours was 90-
95 % for all concentrations investigated.  
The cytotoxicity data was analysed using Student’s t test and no significant difference 
was observed for all groups (p>0.05). 
 
Figure 4.19 Cell viability of human pancreatic cancer derived cells (SUIT-2) after 
incubation for 48 hours with different polymers at various concentrations. The viability was 
measured by a MTS assay. The results are the average ± standard deviation.  
Considering the physicochemical properties and pre-screening toxicity results, the 
synthesised polymer structures would be suitable candidates for coating the surface of 
hydrophobic SPIONs. 
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4.3.4 Self-assembly of SPIONs and bioinspired amphiphilic 
polyoxazoline polymers into multifunctional-magneto-micelles 
(MMMs) 
Monodisperse SPIONs prepared using the high temperature decomposition method are 
hydrophobic and can only be dispersed in organic solvents such as hexane, THF or 
chloroform. In order to make the nanoparticles water soluble and biocompatible, a 
surface modification step is necessary. Bioinspired amphiphilic polyoxazoline polymers 
are suitable candidates to make the hydrophobic SPIONs dispersible in aqueous 
medium. Amphiphilic block copolymers can assemble into core-shell micelles with 
hydrophobic core and hydrophilic shell. The core can be loaded with hydrophobic 
compounds or nanoparticles through a co-micellisation approach. In this case the 
hydrophobic segment of the polymer will interact with the hydrophobic SPIONs, while 
the hydrophilic PEtOX polymer will provide solubility and stability in aqueous 
environments. At the same time the hydroxyl or carboxylic acid end-functionalities 
available on the polymer allow for further functionalisations with bioactive molecules. 
The polyoxazoline polymers are reported to have excellent colloidal stability in 
physiological buffers, low interaction with serum proteins resulting in longer blood 
circulation time and bioavailability.19,21  
For preparation of MMMs a solvent exchange method was adopted with dialysis as the 
final purification step. Briefly, a dispersion of hydrophobic SPIONs in THF was added 
to an aqueous solution of Polymer 1S and mixed using sonication to achieve a brown 
transparent solution. Then the organic solvent was removed using dialysis. The 
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schematic representation of the self-assembly between hydrophobic SPIONs and 
amphiphilic polyoxazoline is shown in Figure 4.20.  
 
Figure 4.20 Schematic representation of the synthetic procedure used to prepare MMMs 
that encapsulate SPIONs within the polyoxazoline micelles.  
The general parameters which were varied during the assembly procedure were the 
polymer and SPIONs concentrations as shown in Table 4.1.  
Table 4.1 Self-assembly parameters varied during the procedure, average hydrodynamic 
diameters measured by DLS and stability of MMMs obtained. 
Micelles Polymer 
1S 
(mg) 
SPIONs 
(mg) 
Solvent 
(mL) 
Z-averagea 
(d/nm) 
Observations 
MMM-1 
 
10 1 10 91.8 ± 1.5 Stable 
MMM-2 
 
 
5 1 10 112.0 ±1.1  Precipitation  
after 1 month 
MMM-3 
 
1 1 10 134.4 ± 3.2 Precipitation 
after 1 month 
SonicationAddition of  SPIONs
to polymer solution
Dialysis
MMMs
Clear Solution
Polymer 1S SPIONs
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MMM-4 
 
20 1 10 93.9 ± 2.0 Stable 
MMM-5 
 
40 1 10 94.0 ± 2.6 
 
Stable  
MMM-6 10 2 10 121.7 ± 1.2 Precipitation 
after 1 month 
 
MMM-7 10 4 10 140.9 ± 1.8 Precipitation 
after 1 month 
a Average intensity–weighted size and standard deviation values obtained from 3 
measurements using a Zetasizer DLS. 
 
For preparation of MMMs, 1 mg SPIONs were assembled with various amounts of 
Polymer 1S (1-40 mg, Mn = 4500). Figure 4.21 shows the size evolution of the MMMs 
when the polymer was varied from 1 to 40 mg during the assembly process. Increasing 
the amount of polymer from 1 to 10 mg led to a decrease in the size of the assembled 
hybrid magneto-micellar structures. The size decrease is because more polymer chains 
are available per hydrophobic SPION and less SPIONs are included in one micellar 
core; therefore the final size of the assembled magneto-micelle decreases up to a point 
when equilibrium is reached. The average diameter measured using DLS for MMM-1 
was 91.8 ± 1.5 nm, while for MMM-2 and MMM-3, prepared with lower amounts of 
polymer, the z-average diameter was 112.0 ± 1.1 and 134.4 ± 3.2 nm respectively. 
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Figure 4.21 Size evolutions of MMMs measured by DLS at various mass proportions of 
amphiphilic polymer with 1 mg SPIONs. 
From Figure 4.21 it can be noticed that when the used polymer mass was more than 10 
mg, the size of MMM-4 and MMM-5 was not significantly different from MMM-1. 
The size evolution of MMMs was also assessed when the SPIONs loading was 
increased (e.g. 2 mg and 4 mg) while keeping the amount of polymer constant at 10 mg. 
The samples were denoted as MMM-6 and MMM-7 (Figure 4.22). The rationale for 
using higher SPIONs loadings is related to the possibility of having increased magnetic 
properties and therefore enhanced abilities to shorten the T2 relaxation times of protons 
in case of application as MRI contrast agents. The average hydrodynamic size of the 
obtained MMMs increased with the increase in SPIONs loading. From DLS 
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measurements the average diameters for MMM-6 and MMM-7 were found to be 121.7 
± 1.2 and 140.9 ± 1.8 nm respectively (shown in Figure 4.22).  
 
Figure 4.22 Hydrodynamic diameters distribution measured by DLS for MMM-6 and 
MMM-7 prepared with higher loadings of SPIONs while keeping the mass of polymer 
constant at 10 mg. 
Figure 4.23 shows the optical images of MMMs formulated with 1 mg SPIONs in the 
core. At 10:1 and 20:1 w/w ratios between the polymer and the SPIONs, the solutions 
maintained a brown transparent colour without apparent precipitation for a month due to 
the self-assembled micellar state. Whereas for the lower polymer/SPIONs ratios 
investigated, precipitation was observed after 1 month. This suggested that the minimum 
polymer mass required to obtain stable MMMs is 10 mg.  
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Figure 4.23 Digital photographs of different hybrid micellar structures: MMM-1 (A), 
MMM-4 (B), MMM-2 (C) and MMM-3 (D) dispersed in deionised water after 1 month.  
 
The micellisation experiments showed that particle size and stability were highly 
dependent on the polymer/SPION wt ratio used in the self-assembly process, i.e. larger 
MMMs size with higher SPIONs loadings. Highly monodisperse MMMs with average 
sizes of 92 nm were obtained consistently when polymer/SPIONs ratio was at least 10:1. 
Therefore, all samples from hereafter were prepared with the fixed w/w ratio of 10:1 
between polymer and SPIONs. 
The MMM-1 hybrid structures were characterised by various physico-chemical 
techniques such as TGA, FTIR, SQUID magnetometry, DLS, zeta potential and TEM to 
examine the distribution of SPIONs in the polymeric micelles.  
TGA measurements for SPIONs, Polymer 1S and MMM-1 were performed to 
determine the composition of the structures (Figure 4.24). The weight losses were 
12.4% and 88% for SPIONs and MMM-1 respectively. The weight loss in the SPIONs 
was attributed to the thermal decomposition of organic ligands on their surface. The 
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weight loss in MMM-1 had two steps: one step between 120-400 ⁰C attributed to the 
decomposition of the hydrophobic part and the second one between 400-600 ⁰C was 
attributed to the decomposition of the hydrophilic polymer backbone. Based on the TGA 
results the iron oxide nanoparticles loading in MMM-1 was calculated to be 12 wt%.  
 
Figure 4.24 TGA of hydrophobic SPIONs, Polymer 1S and MMM-1 hybrid structures.  
Further evidence for the assembly of the SPIONs into MMM-1 hybrids was obtained 
from FTIR spectroscopy. Figure 4.25 shows the FTIR spectra of Polymer 1S 
containing the carboxylic acid end-functionality (a), the hydrophobic SPIONs (b) and 
the assembled magneto-micellar structures MMM-1 (c). The FTIR spectrum of MMM-
1 in Figure 4.25c showed the characteristic bands arising from the presence of both 
components: iron oxide nanoparticles and the polyoxazoline polymer. This proved that 
the micelles were a composite mixture of these two different materials. 
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Figure 4.25  FTIR spectra of (a) Polymer 1S, (b) hydrophobic SPIONs and (c) assembled 
MMM-1 hybrid structures.  
The bands at 485 and 580 cm-1 in the spectrum of MMM-1, characteristic for Fe-O 
stretching indicated the presence of iron oxide nanoparticles. The band at 1730 cm-1 
corresponding to C=O stretch of the free carboxylic acid groups of the polymer is also 
present in the assembled MMM-1 structures. The CH2 asymmetric and symmetric 
stretching bands are evidenced at 2935 and 2850 cm-1 and can be found in both the 
polymer and the oleic acid ligands. It is important to notice the absence of the 1730 cm-1 
band for the C=O stretching in free carboxylic acid groups from the oleic acid coating in 
hydrophobic SPIONs (Figure 4.25b). Moreover, the bands at 1080 and 1023 cm-1 
corresponding to the C-O stretching showed that the oxygen atoms in the carboxylate 
are coordinated onto the surface of the SPIONs as previously reported.38  
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circular area that confirm
assembled structures of SPIONs and bioinspired amphiphilic polyoxazolines
206 
-1 structures was analysed by transmission electron 
shown in Figure 4.26.  
MMM-1 assembled structures at (a) lower and (b) higher 
 owing to its low electron density, while 
ed that they are loaded in the hydrophobic core of 
 
 
MMM-1 
Cristina I. Olariu            Self-assembled structures of SPIONs and bioinspired amphiphilic polyoxazolines 
 
207 
 
due to their interaction with the hydrophobic part of Polymer 1S. The SPIONs are 
densely packed and homogeneously distributed within the micellar core, forming multi-
SPIONs loaded polymeric micelles (magneto-micelles). The average diameter of the 
magnetic core of MMM-1 structures was determined to be 61 ± 4 nm. From DLS the 
measured intensity-average hydrodynamic diameter of MMM-1 was 92 nm. During 
DLS measurements the magneto-micelles are dispersed in aqueous solutions and 
therefore the polymer chains are expanded in solution. 
The micellar morphology was improved after staining the polymer with 2% PTA, which 
enhanced the hydrophilic polymeric corona (Figure 4.27). Due to the nature of the 
polymer the micellar structures look positively stained rather than negatively stained, 
because the metal atoms in the stain solution are chemically interacting with reactive 
sites in the polymer structure. 
The hydrophilic polymeric corona was evidenced as a thin diffuse layer around the 
uniformly distributed SPIONs inside the hydrophobic core. The SPIONs were seen as 
clear dark spots embedded in the low contrast micellar core. This type of magneto-
micellar conformation is most probably due to the fact that THF is a good solvent for 
both hydrophobic SPIONs and for the hydrophobic segment of the amphiphilic polymer. 
The structures are similar to the ones obtained by the groups of Taton et al.42 and      
Park et al. 43 when using amphiphilic block copolymers composed of poly(acrylic acid) 
and poly-styrene (PAA-b-PS) for coating the hydrophobic magnetic nanoparticles.  
 
Cristina I. Olariu            Self-
 
 
 
Figure 4.27 TEM images of 
polymeric corona. 
After the TEM staining procedure the average size of the magneto
determined as 76 ± 7 nm. 
were smaller than from 
hydrated and expanded when dispersed in aqueous solutions during DLS measurements.
 
 
assembled structures of SPIONs and bioinspired amphiphilic polyoxazolines
208 
MMM-1 hybrids stained with 2% PTA to enhance the 
The MMM-1 sizes observed under the electron microscope 
DLS measurements. This was because the polymeric corona is 
 
 
-micelles was 
 
Cristina I. Olariu            Self-assembled structures of SPIONs and bioinspired amphiphilic polyoxazolines 
 
209 
 
To determine the magnetic properties of MMM-1, the lyophilized powder was analyzed 
using a superconducting quantum interference device (SQUID) at room temperature 
(300 K). The magnetisation curve shows that MMM-1 exhibited the expected 
superparamagnetic property due to the absence of a remanent magnetisation when the 
applied magnetic field is removed (Figure 4.28).  
 
Figure 4.28 Magnetic field dependence of magnetisation at room temperature for 
hydrophobic SPIONs (black) and assembled MMM-1 (blue) magnetic structures. Inset 
shows a zoom-in plot between -500 Oe and 500 Oe magnetic field.   
The measured magnetisation at saturation for MMM-1 structures was 7.6 emu/g. 
Compared with the value measured for SPIONs, 61.8 emu/g material, the magneto-
micelles have a lower magnetisation which is attributed to the presence of the non-
magnetic polymeric shell. The contribution for the magnetisation value in MMM-1 is 
based only on the ratio of SPIONs present. According to the thermogravimetric analysis 
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the percentage weight of magnetic cores accounts only for 12% of the total mass of the 
MMM-1 structures, therefore a value of 0.12 × 61.8 would be expected. Similar 
reduction in magnetisation values was observed for other polymer coated systems and 
was attributed to the presence of organic shell.44-46 
4.3.5 Evaluation of MMMs stability  
The stability of the MMM-1 was assessed in PBS, over time and under pH values 
between 4 and 10. The stability in PBS (buffer which mimics the ionic strength of the 
body fluids) was evaluated by an absorption assay as reported by R. de Palma et al.37 
The procedure involved monitoring the time-evolution of the absorbance of the MMM-
1 solution (in water and PBS) at a fixed wavelength of 850 nm, where the absorbance 
correlates with the concentration and stability of magneto-micellar structures present in 
solution. If the magneto-micelles are not stable during the aging time, they are likely to 
agglomerate resulting in large particles which would precipitate, therefore showing a 
decrease in absorbance.  
The time dependent absorbance results showed that MMM-1 has good stability in PBS 
comparable to the stability in water. MMM-1 solution remained transparent and did not 
show significant decrease in absorbance during the continuous 24 hour monitoring at 
ambient temperature, which confirmed that the magneto-micellar structures are stable in 
PBS buffer (Figure 4.29).  
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Figure 4.29 Evolution of MMM-1 absorbance dispersed in water (black) and PBS (red) 
during 24 hours.  
DLS measurements also confirmed that MMM-1 had excellent colloidal stability in 
both water and PBS (Figure 4.30) after 21 days, since there was no apparent change in 
size or any sign of agglomeration. During this period the solution was kept in the fridge 
at 4 °C and the size of MMM-1 was measured by DLS at the shown time points on non-
filtered samples. DLS would show an increase in size if the structures would not be 
stable. The MMM-1 solutions in PBS were monitored for another 2 months while kept 
in the fridge. During this time the solutions remained transparent and the measured 
average hydrodynamic diameter at 2 months was 93.4 ± 1.2 nm. 
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Figure 4.30 Size stability evaluations of MMM-1 magnetic structures using DLS 
measurements at different time points. 
The size stability and zeta potential values of MMM-1 were also evaluated at different 
pH values and the results are shown in Figure 4.31. The average size of MMM-1 did 
not show a significant change upon pH variation. The measured hydrodynamic diameter 
values were from 89.2 ± 0.9 nm to 96.3 ± 2.5 nm. The negative charge on the surface of 
MMM-1 due to the deprotonation of the COOH groups was confirmed using zeta 
potential measurements. As can be seen in Figure 4.31, the zeta potential values at pH 8 
and pH 10 were -15.8 ± 0.2 mV and -19 ± 1.2 mV respectively. The surface negative 
charges are also responsible for enhanced the stability of the MMM-1 in solution 
together with the steric stabilisation by the polymeric chains. The isoelectric point for 
MMM-1 was around pH 6. Comparing with the pKa of 4.16 for succinic acid the 
increase it was found reasonable considering that pKa values can vary depending on the 
molecular weight and the polymeric conformational changes. 
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Figure 4.31 Evaluation of size stability and zeta potential of MMM-1 in aqueous solution 
at different pH values.  
Taken together the results from the absorbance assay, DLS and zeta potential 
measurements in different dispersion media show that the MMM-1 structures have good 
colloidal stability properties. MMM-1 solutions were found stable in PBS (buffer which 
mimics the ionic strength of the body fluids 135 mM NaCl, 27 mM KCl) and at pH 
values found in the biological environments (between 5 and 8). These are typical 
conditions used in biological applications.  
The hydrodynamic diameter of MMM-1 is well within the acceptable size range (20-
200 nm) for in vivo applications and preferential accumulation at tumour sites through 
an enhanced permeability and retention effect (EPR).47-48 Therefore the MMM-1 
structures could be suitable as MRI contrast agents and tumour diagnosis markers based 
on the EPR effect. 
4 5 6 7 8 9 10
0
20
40
60
80
100
120
 Size MMM-1 
 Zeta potential MMM-1
pH
Si
ze
 
(d.
n
m
)
-20
-15
-10
-5
0
5
10
 
Ze
ta
 
po
te
n
tia
l (m
V)
Cristina I. Olariu            Self-assembled structures of SPIONs and bioinspired amphiphilic polyoxazolines 
 
214 
 
4.3.6 Fluorescence labelling of MMMs structures 
To be able to trace the MMMs during cellular uptake studies, a red fluorescent dye, 
octadecyl Rhodamine B (Rh), was selected to be encapsulated into the MMMs during 
the initial self-assembly process. The Rh fluorescent molecule is widely used to label 
cell membrane because the C18 long alkyl tail inserts within the lipid bilayer while the 
fluorophore stays at the aqueous interface. This behaviour was previously reported in 
the case of poly(styrene)-b-poly(methacrylic acid) (PS-PMA) polymeric micelles when 
Rh strongly binds at the core-shell interface of the micelle with the alkyl tail inserted in 
the PS core.49 In the case of the magneto-micellar system MMM-1 the C18 aliphatic tail 
of the fluorescent dye will interact with the hydrophobic segment of the amphiphilic 
polymer, the oleic acid and together will stabilise the surface of SPIONs (Figure 4.32).  
 
Figure 4.32 Schematic representation of the synthesis of fluorescent magneto-micelles 
(Rh-MMMs).  
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Fluorescent magneto-micelles were prepared by assembly of Polymer 1S: SPIONs: Rh 
at 10:1:0.01 wt ratio. The fluorescent sample was denoted as Rh-MMM.  
To confirm the incorporation of the fluorescent dye within the magneto-micellar 
structures, the Rh-MMMs were analysed using UV/Vis absorbance and fluorescence 
spectroscopy. The absorption spectrum of the Rh-MMM showed the characteristic 
maximum absorption for the Rh fluorescent molecule at 565 nm as seen in Figure 
4.33a.  
Figure 4.33b shows the fluorescence emission spectrum of Rh-MMM at the excitation 
wavelength of 565 nm showing the maximum emission wavelength at 605 nm for Rh-
MMM. A red shift was observed for the Rh-MMM structures compared with the 
reported emission of the dye (λemi =580 nm measured in methanol, from the 
manufacturer). The red emission shift confirmed the assembly of the Rh dye tail with 
the hydrophobic segments of the polymer. Similar shifts in emission have been 
previously reported in other systems when there is an interaction between the dye and 
the surrounding hydrophobic environment, in this case, the hydrophobic segment of the 
polymer and hydrophobic ligands on SPIONs.50-51  
Cristina I. Olariu            Self-assembled structures of SPIONs and bioinspired amphiphilic polyoxazolines 
 
216 
 
 
 
Figure 4.33 Spectrophotometric characterisation of fluorescently labelled Rh-MMM 
micellar structures. a) UV/Vis spectrum showing the maximum absorbance at 565 nm 
indicating the presence of the Rh  dye, b) fluorescence emission spectrum at λex=565 nm 
showing intensity maximum at 605 nm confirming the effective fluorescence labelling of 
magneto-micelles. 
DLS studies of the Rh-MMM confirmed the presence of monodisperse nanoparticles 
with an average diameter of 91.2 ± 1.8 nm. Compared with the non-fluorescent MMM-
1 structures, the labelling with the fluorescent molecule Rh did not affect the size and 
stability of the micelles. Figure 4.34 shows the DLS size measurements of the 
fluorescent (Rh-MMM) and the corresponding non-fluorescent (MMM-1) samples. 
Both distributions are overlapping with each other, confirming that the addition of Rh 
dye did not change the particle/micelle assembly. 
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Figure 4.34 Size distribution of the fluorescent Rh-MMM (red) and non-fluorescent 
MMM-1 (blue) structures. 
The fluorescence signal of the Rh-MMM structures could not be quantified due to the 
emission shift. However, the fluorescently labelled Rh-MMM displayed strong 
fluorescence intensities and the signal was found to be sufficient to detect the presence 
of the magneto-micelles during cell labelling experiments (Figure 4.35).  
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even at concentrations as low as 0.125 mM Fe, corresponding to a theoretical 
concentration of Rh dye of 85 nM. 
4.3.7 Protein and antibody bioconjugations to fluorescently labelled 
magneto-micelles (Rh-MMMs) 
The Rh-MMMs have multiple reactive carboxylic acid surface groups originating from 
the polyoxazoline coating. The carboxylic acid groups can be chemically conjugated 
under mild conditions with primary amino groups via carbodiimide coupling with 
EDC/sulfo-NHS, providing a convenient route for coupling of amine containing 
bioactive molecules such as proteins and antibodies. EDC can react with the carboxylic 
acid groups to form a reactive O-acylisourea intermediate. The addition of sulfo-NHS 
stabilizes the intermediate by converting it to an amine-reactive sulfo-NHS ester, thus 
increasing the efficiency of EDC-mediated coupling reactions. This succinimidyl 
activated species can then react with a nucleophile such as a primary amine to form an 
amide bond.52 
Rh-MMMs were covalently conjugated with two model proteins (BSA and CytC) and a 
model antibody molecule (IgG) to demonstrate the protein immobilisation capability and 
the chemical reactivity of the carboxylic acid groups. The bioconjugation reactions were 
carried out at pH 7.4 in order to maintain the stability of Rh-MMMs during the EDC 
and sulfo-NHS mediated coupling. The EDC/sulfo-NHS coupling reactions had been 
reported to occur with high efficiency at pH values between 4.5 and 7.5.52 When 
performed at neutral pH the sulfo-NHS-ester reactions were usually performed in 
phosphate-buffered saline (PBS) at pH 7.2-7.5.53 Using a 7.4 pH buffer allowed to 
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minimise the positive charges of the amine groups on protein molecules and therefore 
increase their reactivity towards the succinimidyl activated species. Using this method 
stable protein or antibody conjugates were prepared. After the conjugation reactions the 
formed micelle-conjugates showed a hydrodynamic size increase 117.3 ± 2.1 nm for 
Rh-MMM-BSA, 96.2 ± 1.8 nm for Rh-MMM-CytC and 126.4 ± 1.8 nm for Rh-
MMM-IgG (Table 4.2). The size increase was attributed to the conjugation of the 
protein and antibody molecules to the nanoparticle surface. Zeta potential measurements 
were utilised to characterise the protein and antibody conjugates. It was found that the 
Rh-MMM-BSA conjugates were more negatively charged than Rh-MMMs due to the 
overall negative charge of BSA at pH 7.4 (isoelectric point 4.8). On the other hand in 
case of the Rh-MMM-CytC conjugates an increase in zeta potential was observed due 
to the positively charged CytC proteins (isoelectric point 10.2). The zeta potential of the 
Rh-MMM-IgG conjugates was not influenced by the presence of coupled antibody 
molecules as the IgG isoelectric point is between 6.5 and 7.5.54 
A standard Bradford protein assay method was used to quantify the concentration and 
the conjugation rate of protein or antibody to the Rh-MMMs. The unreacted 
biomolecules were separated from the micelle-conjugates using centrifugal filtration and 
mixed with the assay to give a blue coloured complex. The protein concentration was 
measured by matching to standard calibration curves of known protein concentrations in 
each case. The conjugation rate was calculated using the formula: 
	 % 
 	 	
		 	 	
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The resulting conjugation rates from the coupling reaction with each type of protein and 
antibody are shown in Table 4.2. The EDC/sulfo-NHS coupling reactions are reported 
to have high efficiencies up to 95%.55 The average conjugation rate with BSA, CytC and 
IgG in this case was 88%. The EDC/sulfo-NHS conjugation rates were found to be 
comparable for the three types of bioactive molecules involved. At the same time the 
conjugation rates were comparable with the values reported by others.55-56 
Table 4.2 Z-average hydrodynamic sizes, zeta-potential and bioconjugation rates of 
MMM-1, Rh-MMM, Rh-MMM-BSA, Rh-MMM-CytC and Rh-MMM-IgG 
Sample Z-average 
diametera 
(d/nm) 
Zeta potential  
(mV) 
Bioconjugation rateb  
(%) 
 
MMM-1 
 
 
91.8 ± 1.5 
 
-22.5 ± 0.2 
 
- 
 
- 
 
88.6 ± 0.7 
 
87.3 ± 0.6 
 
88 ± 1.2 
 
Rh-MMM 
 
91.2 ± 1.8 -19.2 ± 0.8  
Rh-MMM-BSA 
 
117.3 ± 2.1  -33.7 ± 0.3 
Rh-MMM-CytC 
 
96.2 ± 1.8  -12.8 ± 0.2  
Rh-MMM-IgG 
 
126.4 ± 1.8   -20.8 ± 0.9 
aAverage intensity–weighted diameter and standard deviation values obtained from 3 
measurements using a Zetasizer DLS. bAverage and standard deviation values of 
bioconjugation obtained from three independent reactions. 
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The results from particle size and zeta-potential measurements as well as from Bradford 
protein quantification assay showed that the Rh-MMMs were successfully labelled with 
bioactive molecules using carboxylic acid groups available on the micelle surface. 
4.3.8 Evaluation of the cytotoxicity of Rh-MMMs 
When evaluating toxicity it is necessary to consider how the assembled SPION-polymer 
system will interact with the body. To evaluate the potential for biomedical applications 
of the Rh-MMMs both in vitro and in vivo, their potential toxicity was tested using the 
standard proliferation MTS assay on two different cell lines (Figure 4.36). 
 
Figure 4.36 Cell viability SUIT-2 and MiaPaca cells after 48 hour incubation with Rh-
MMM at various concentrations. The results are presented as average ± standard 
deviation.  
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Human pancreatic cancer cells (SUIT-2 and MiaPaca) were used to examine the 
cytotoxicity in vitro following exposure to Rh-MMM at different Fe concentrations. As 
shown in Figure 4.36, there was little effect of the Rh-MMM on the cell viability in the 
nanoparticle range evaluated, 0 - 1 mM Fe. The average viability of both types of cells 
treated with Rh-MMMs was above 90% for all concentrations. The cytotoxicity data 
was analysed using Student’s t test and no significant difference was observed between 
all groups (p>0.05). 
It should be noted that at concentrations between 0.1-0.125 mM Fe that are typically 
used in cell labelling and targeting experiments the cytotoxicity values were above 95% 
for both cell lines. 
4.3.9 Cancer cell targeting experiments using antibody-magneto 
micelles conjugates 
To evaluate the potential for specific targeting, Rh-MMMs were conjugated with a 
specific antibody, namely CA19.9, resulting in Rh-MMM-CA19.9 conjugates. This 
antibody is known to bind to the CA19.9 antigen which is highly expressed on the  
surface of BxPC-3 cells, making it an accessible target for binding and imaging.57 
Therefore BxPC-3 cells were incubated with Rh-MMM-CA19.9 nanoparticles and two 
controls: non-conjugated Rh-MMM and nonspecific Rh-MMM-ISO nanoparticles, 
where ISO stands for isotype control antibody-that does not have no binding specificity 
for CA19.9 antigen.  
These experiments were performed by Mr. Paul Sykes at the Liverpool Cancer Research 
UK Centre, Department of Molecular and Clinical Cancer Studies. 
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The specific cellular binding and uptake was monitored during an 18 hours live cell 
experiment using a confocal laser scanning microscope which was programmed to take 
image slices every 2 minutes. Representative confocal images of the nanoparticles cell 
binding at 2 and 6 hours are show in Figure 4.37. The images showed that the Rh-
MMM-CA19.9 magneto-micelles are able to specifically localise and bind to the BxPC-
3 cells. These nanoparticles were distributed into the cell cytoplasm in the perinuclear 
region, forming localised clusters which are usually attributed to endosomal uptake. 
Cells incubated with the controls showed only minimal uptake of the non-conjugated 
and nonspecific nanoparticles. The cellular uptake of nonspecific nanoparticles was also 
observed in the previous experiments presented in Chapter 3 and by other groups during 
targeting experiments.58-59 However, the Rh-MMM-CA19.9 conjugates showed at all 
times more binding avidity due to the antibody-antigen interactions which positively 
influenced their internalisation into the cells. Therefore, specific targeting to CA19.9 
expressing cells was successfully achieved by conjugation of the Rh-MMMs with the 
CA19.9 antibody.  
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The results presented here demonstrate that the conjugation of the magneto-micelles 
with a targeting ligand such as CA19.9 antibody is essential for specific binding and 
uptake into pancreatic cancer cells. High levels of uptake could be achieved for         
Rh-MMM-CA19.9, Figure 4.37, thus setting these nanoparticles as potential 
candidates for use as targeted imaging agents. 
4.3.10 MRI capability of Rh-MMM 
The MRI capability of Rh-MMM was evaluated by T2 relaxation time measurements. 
These measurements were carried out using a 7 T horizontal bore Magnex Scientific 
imaging system, operating at 300 MHz resonant frequency. The T2 relaxation times 
were measured for increasing concentrations of nanoparticles ranging from 0.05 to 0.15 
mM Fe. The Rh-MMM magneto-micelles were measured in deionised water and blanks 
consisting of deionised water were taken as a control. MRI analysis was performed at 
TR 5000 ms and multiple TE values of 11, 33, 55 and 77 ms for various concentrations 
of nanoparticles. These measurements were performed by Ms. Karen Davies at the 
Department of Imaging Science and Biomedical Engineering, University of Manchester. 
Their efficiency as T2 MRI enhancement agents was determined by calculation of the r2 
relaxivities as the slopes of the linear fit of the inverse relaxation times as a function of 
iron concentration (Figure 4.38).  
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Figure 4.38 Inverse transverse relaxation times 1/T2 for Rh-MMM magneto-micelles 
nanoparticles as a function of the iron molar concentration. 
The inverse relaxation times varied linearly with the iron concentration60 and the r2 
relaxivity value for Rh-MMM was found to be 285 ± 9 s-1mM-1. The relaxivity value is 
two times higher than that of the clinical contrast agent Feridex I.V. (reported value of 
148 ± 2, measured at 7 T).61  The increased value of r2 is attributed to the effect of 
clustering of SPIONs within polymeric micelles.62-63 Therefore is interesting to compare 
the results obtained in this work to those reported for other SPION clusters encapsulated 
in polymeric micellar. For example, Ai et al.63 have shown that increasing the SPIONs 
loading and the SPION size within polymeric micelles, the r2 values can vary from 25 to 
471 s-1mM-1. The investigators obtained a similar r2 value with the one obtained in this 
work for 8 nm SPIONs encapsulated into the hydrophobic cores of polymeric micelles.63 
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In another study it was reported that a PEG based magneto-micellar system having a 
diameter of approximately 97 nm and a SPIONs loading of 15%, similar size and 
loading to the ones obtained in this work, produces an r2 relaxivity of 254 s-1mM-1.64 
The results quoted in these studies support those reported in the present work. They 
indicate that clusters of SPIONs have enhanced the transverse relaxivity.  
Figure 4.39 shows the T2-weighted MRI image (TE/TR 11/5000 ms) of the analysed 
nanoparticles at various iron molar concentrations.  
 
Figure 4.39 T2 weighted magnetic resonance images of Rh-MMM in deionised water at 
various molar  iron concentrations (0.05, 0.075, 0.1 and 0.15 mM) and at 25 ⁰C, 7 T MRI, 
TR=5000 ms, TE=11 ms. Blanks consisting of deionised water were taken as a control. 
The T2 weighted image showed that the Rh-MMM nanoparticles produce an observable 
change in T2 signal. The image appears darker, hypointensity, as the iron molar 
concentration increases. The nanoparticles produce a darker contrast effect at 
concentrations as low as 0.05 mM Fe which could lower the administration dose.  
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These results confirmed the effective MRI contrasting capabilities of the magneto-
micelles. Therefore, the Rh-MMMs potentially present suitable properties for use as 
MRI contrast enhancement agents. 
4.4 Conclusions 
 
The micellisation strategy presented in this chapter is an effective method to develop 
stable and multifunctional magneto-micelles (MMMs). Monodisperse hydrophobic 
SPIONs coated with a monolayer of oleic acid were successfully synthesised and 
transferred into aqueous solutions using synthetic amphiphilic polymers based on 
poly(2-ethyl-2-oxazoline). The polymers comprised of a short C16 hydrophobic segment 
and a 4.5k hydrophilic polymer segment with a carboxylic acid end functional group. 
Using this polymer structure various formulations of MMMs were prepared with 
average hydrodynamic diameters between 91 and 140 nm. The prepared MMMs have 
sizes below the accepted limit of 200 nm which is reported as effective for 
extravasations and accumulation at the tumour sites by the EPR effect.46 
The stability of the prepared MMMs was intensively studied in media similar to 
physiological conditions. The MMMs were found stable in water, phosphate buffered 
saline (ionic strength which mimics the body fluids) as well as at different pH values. 
The MMMs did not exhibit any sign of aggregation or size change for more than 2 
months.  
Fluorescent tags were introduced in the structure of the magneto-micelles during the 
assembly process to provide fluorescence imaging capabilities to the nanoparticles. The 
fluorescent signal was used to monitor the nanoparticles localisation during targeting or 
cell labelling experiments. The carboxylic acid groups on surface of MMMs offered an 
Cristina I. Olariu            Self-assembled structures of SPIONs and bioinspired amphiphilic polyoxazolines 
 
230 
 
advantageous possibility for coupling of various bioactive molecules through 
bioconjugation reactions. The CA19.9 antibody-labelled MMMs were able to efficiently 
target and internalise into pancreatic cancer cells expressing the CA19.9 antigen. Their 
performance in the relaxivity measurements suggested that the clustering effect of the 
SPIONs within the polymeric micelle core is particularly favourable for enhancing the 
T2 contrast on MRI images. The development of multifunctional nanoparticles with 
complementary properties such as targeting, optical and MRI imaging is a challenging 
task. This is because it requires meeting the different needs without compromising the 
efficiency of either one. Overall the results have shown that SPIONs, bioinspired 
polymers, fluorescent molecules and targeting ligands can be incorporated into stable 
magneto-micelles which have the expected targeting and dual imaging capabilities. 
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Chapter 5 
Conclusions and outlook 
In this work, multifunctional magnetic nanoparticles were developed for advanced 
biomedical applications, specifically for targeted detection of cancer cells using 
simultaneous optical and enhanced MRI contrast imaging. 
Silanisation was demonstrated to be an efficient approach to introduce functional groups 
on the surface of SPIONs via covalent interactions. For example, amine and carboxylic 
acid-functionalised SPIONs were successfully synthesised and studied in terms of level 
of surface coverage, size, dispersability in aqueous solutions and magnetic properties. 
After coupling with fluorescent dyes and specific antibodies, these multifunctional 
nanoparticles were tested in vitro for their potential to target cancer cells. The 
conjugated antibody SPIONs demonstrated superior ability to localise and bind specific 
receptors on pancreatic cancer cells compared to the non-conjugated counterparts. These 
nanoparticles showed good relaxivity properties and contrast enhancement in T2 
weighted magnetic resonance imaging. This multifunctional system is adaptable for 
conjugation of any amino containing protein or peptide and therefore can be further used for 
targeting specific receptors on other types of cancer cells. 
Besides covalent interactions, hydrophobic interactions were also employed to 
successfully synthesise multifunctional magneto-micelles incorporating four essential 
components (1) clustered hydrophobic SPIONs inside the core of the polymeric micelle 
for ultrasensitive MRI detection; (2) stealth polyoxazoline shell for long circulation  
blood time and bioavailability; (3) encapsulated fluorophores for fluorescent imaging 
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capabilities and (4) antibodies for target-specific detection of cancer cells. This 
colloidally stable and multifunctional system showed excellent ability to localise and 
accumulate in pancreatic cancer cells via receptor-mediated endocytosis. The clustering 
of SPIONs inside the magneto-micelles core provided enhanced relaxivity and magnetic 
resonance imaging capabilities compared with commercial MRI agents. These 
interesting properties make the multifunctional magneto-micelles promising candidates 
for future in vivo evaluations.  
To take the work presented in this thesis forward, extensive biological evaluations of the 
prepared multifunctional magneto-micelles (MMMs) are needed, especially if these 
materials are to be translated into clinic. Characterisations could include:  
(1) Screening of the colloidal stability of the MMMs in buffers containing proteins 
(similar protein concentrations found in the human blood) or in human serum;  
(2) Evaluation of the iron oxide core degradation and iron leaching from the magneto-
micelles – this could be achieved using model experiments and parameters which mimic 
the endosomal/lysosomal environment;  
(3) Quantitative analysis of the nanoparticle uptake at the cellular level which could be 
achieved using special staining for iron and comparing with standard curves;  
(4) Evaluation of the antibody binding efficiency during in vitro competitive inhibition 
experiments – this could be achieved by saturating the cell receptors with specific 
antibodies and then apply the antibody-nanoparticle conjugates.   
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Furthermore site specific antibody conjugation strategies could be developed. This 
would provide a greater level of control over the number and the orientation of the 
antibodies conjugated to the magneto-micelles. One approach could involve the 
fragmentation of the antibody molecule using proteolytic enzymes such as pepsin 
followed by a mild reduction of the disulfide bonds with mercaptoethylamine to obtain 
two separate F(ab’) fragments. Each F(ab’) fragment would have a reduced size ~55 
kDa and exposed thiol functional groups which would enable an oriented attachment of 
the antibody onto the surface of the MMMs. The conjugations reactions could be 
followed by comparative in vitro studies of whole antibody-conjugated and fragmented 
antibody-conjugated SPIONs as targeting agents for over expressed tumour receptors. 
To further extend the capabilities of the magneto-micellar system, hydrophobic anti-
cancer drugs could be encapsulated in the hydrophobic core together with the SPIONs 
and fluorescent molecules. For example, paclitaxel or methotrexate could be used as 
model drugs to test their encapsulation efficiency. The successful encapsulation of the 
drugs could be followed by in vitro cytotoxicity evaluations as a measure of their 
therapeutic effectiveness and as targeted drug delivery agents in vivo. In such a 
scenario, the magneto-micellar system could have combined therapeutic and diagnostic 
applications (theranostic nanoparticles). 
Other future work would include in vivo animal targeting studies, where antibody-
conjugated and non-conjugated MMMs are directly injected into the blood stream 
followed by analysis of the tumour selective localisation capabilities. From histological 
analysis of tumour tissues the advantage of using specific antibody-conjugated MMMs 
could be identified. In vivo studies would allow for determination of the feasibility of 
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such MMMs to be used as targeted contrast agents for MRI. Additionally in vivo studies 
of the nanoparticle blood circulation times, their interaction with blood proteins and 
their clearance by the cells of the immune system would be the key mission for the 
future.   
Overall the results presented in this work are a contribution to the development of 
multifunctional nanocomposites for biomedical applications and may open exciting 
opportunities for early stage diagnosis of cancer. 
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